Sentence,class,file
http://urn.fi/URN:ISBN:978-952-302-194-5.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://urn.fi/URN:ISBN:978-952-245-894-0.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://urn.fi/URN:ISBN:978-952-245-662-5.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://urn.fi/URN:NBN:fi-fe201205085096.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://urn.fi/ URN:NBN:fi-fe201205085094  11.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://atlas.ecdc.europa.eu/public/index.aspx?Instance=GeneralAtlas.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
http://dx.doi.org/10.1371/journal.pmed.0030353.,Non-OADS,/arxiv_data1/oa_pdf/23/38/10.1177_1178636117691253.PMC5348086.pdf
"For both of the low–birth weight groups, no attenuation of the ORs was seen when adjusting for sexonly (Supplemental Digital Content, Table 1, Supplemental Digital Content 1, http://links.lww.com/CJP/A366), and testing for interaction did not indicate eﬀect modiﬁcationby sex ( P-values > 0.7).",Non-OADS,/arxiv_data1/oa_pdf/32/b2/ajp-33-348.PMC5348108.pdf
"In further sub- analyses adjusting for current smoking, the associations between a low birth weight and pain remained unchanged(Supplemental Digital Content, Table 2, Supplemental Digital Content 2, http://links.lww.com/CJP/A367).",Non-OADS,/arxiv_data1/oa_pdf/32/b2/ajp-33-348.PMC5348108.pdf
"Fur- thermore, including the number of surgeries before 14 yearsof age as a covariate in subanalyses on participants withavailable data did not change the ORs substantially (Sup- plemental Digital Content, Table 3, Supplemental Digital Content 3, http://links.lww.com/CJP/A368).",Non-OADS,/arxiv_data1/oa_pdf/32/b2/ajp-33-348.PMC5348108.pdf
"(Supplemental Digital Content, Table 4, Supplemental Digital Content 4, http://links.lww.com/CJP/A369).",Non-OADS,/arxiv_data1/oa_pdf/32/b2/ajp-33-348.PMC5348108.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/23/main.PMC5348116.pdf
But  perhaps  a  more  tangeable http://dx.doi.org/10.1016/j.bdq.2017.01.002 2214-7535/© 2017  Published  by  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/18/23/main.PMC5348116.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/23/main.PMC5348116.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/c2/main.PMC5348117.pdf
http://dx.doi.org/10.1016/j.bdq.2017.01.001 2214-7535/© 2017  Published  by  Elsevier  GmbH.,Non-OADS,/arxiv_data1/oa_pdf/3d/c2/main.PMC5348117.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/c2/main.PMC5348117.pdf
8  (5)  (2002)  935–942 https://www.ncbi.nlm.nih.gov/pubmed/12006504 .,Non-OADS,/arxiv_data1/oa_pdf/3d/c2/main.PMC5348117.pdf
"https://doi.org/10.1177/1178638816684830Nutrition and Metabolic Insights  1–7 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178638816684830 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Children experience rapid changes in their diets during early  childhood at a time that they are also forming their eating hab-its.",Non-OADS,/arxiv_data1/oa_pdf/03/0f/10.1177_1178638816684830.PMC5348121.pdf
http://www.ssib.org/web/past_programs/SSIB_2002_ Abstracts.pdf  26.,Non-OADS,/arxiv_data1/oa_pdf/03/0f/10.1177_1178638816684830.PMC5348121.pdf
"https://doi.org/10.1177/1178630217691268Environmental Health Insights  1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178630217691268 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Pesticide poisoning is a commonly underdiagnosed condition  among farmers, particularly in rural areas and in many develop-ing 1–3 and developed countries.4 Generally, pesticide-related  morbidity is higher in rural farming communities because these locations suffer a scarcity of health care workers needed to diagnose and treat acute pesticide poisoning (APP).",Non-OADS,/arxiv_data1/oa_pdf/be/9d/10.1177_1178630217691268.PMC5348122.pdf
World Health Statistics 2007. http://www.who.int/whosis/whostat2007/en/index.html.,OADS,/arxiv_data1/oa_pdf/be/9d/10.1177_1178630217691268.PMC5348122.pdf
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.468.7470&rep=rep1&type=pdf.,OADS,/arxiv_data1/oa_pdf/be/9d/10.1177_1178630217691268.PMC5348122.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/be/9d/10.1177_1178630217691268.PMC5348122.pdf
"https://doi.org/10.1177/1178623X17694150Magnetic Resonance Insights Volume 10: 1–8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178623X17694150 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Cardiovascular disease and stroke are among the leading causes  of morbidity and mortality in the United States, with total yearly costs exceeding $300 billion.",Non-OADS,/arxiv_data1/oa_pdf/01/62/10.1177_1178623x17694150.PMC5348123.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/48/1f/jpr-10-527.PMC5348136.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/48/1f/jpr-10-527.PMC5348136.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 527–533Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  527 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S129287Observing continuous change in heart  rate variability and photoplethysmography- derived parameters during the process of pain  production/relief with thermal stimuli Jing-Jhao Ye Kuan-Ting Lee Jing-Siang Lin Chiung-Cheng Chuang Department of Biomedical  Engineering, Chung Yuan Christian University, Chung Li, TaiwanAbstract: Continuously monitoring and efficiently managing pain has become an important  issue.",Non-OADS,/arxiv_data1/oa_pdf/48/1f/jpr-10-527.PMC5348136.pdf
"200, Zhongbei Road, Zhongli City, Taoyuan County, 32023, TaiwanTel +886 3 265 4510Fax +886 3 265 4599Email cheng965@cycu.edu.twJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Y e et alRunning head recto: Observing changes in HRV and PPG during pain production/reliefDOI: http://dx.doi.org/10.2147/JPR.S129287",Non-OADS,/arxiv_data1/oa_pdf/48/1f/jpr-10-527.PMC5348136.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/48/1f/jpr-10-527.PMC5348136.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 533 Observing changes in HRV and PPG during pain production/relief Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/48/1f/jpr-10-527.PMC5348136.pdf
Medicine (2017) 96:8(e6000)Received: 8 December 2016 / Received in ﬁnal form: 27 December 2016 / Accepted: 28 December 2016 http://dx.doi.org/10.1097/MD.0000000000006000Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c3/4c/medi-96-e6000.PMC5348138.pdf
Available at: http://www.who.int/mediacentre/ factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/c3/4c/medi-96-e6000.PMC5348138.pdf
Medicine (2017) 96:8(e6118)Received: 12 October 2016 / Received in ﬁnal form: 19 January 2017 / Accepted: 23 January 2017 http://dx.doi.org/10.1097/MD.0000000000006118Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/75/a7/medi-96-e6118.PMC5348139.pdf
Medicine (2016) 95:33(e4506)Received: 9 April 2016 / Received in ﬁnal form: 13 July 2016 / Accepted: 13 July 2016 http://dx.doi.org/10.1097/MD.0000000000004506Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/5d/medi-95-e4506.PMC5348140.pdf
Medicine (2017) 96:10(e5626)Received: 26 April 2016 / Received in ﬁnal form: 7 September 2016 / Accepted: 18 November 2016 http://dx.doi.org/10.1097/MD.0000000000005626Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/15/medi-96-e5626.PMC5348142.pdf
"The patients were asked if they had any dif ﬁculties when ﬁnishing the questionnaire or whether there was any ambiguity in the items.The committee collected the feedback and then created a ﬁnal version of SC-PASS (see Supplement ﬁle, http://links.lww.com/ MD/B520).",Non-OADS,/arxiv_data1/oa_pdf/98/15/medi-96-e5626.PMC5348142.pdf
Medicine (2017) 96:10(e5650)Received: 4 August 2016 / Received in ﬁnal form: 18 November 2016 / Accepted: 22 November 2016 http://dx.doi.org/10.1097/MD.0000000000005650Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d9/e9/medi-96-e5650.PMC5348143.pdf
"The LHID contained life-time longitudinal claims data ofboth outpatient and inpatient cares for 1,000,000 bene ﬁciaries who were randomly sampled from 23.74 million enrollees in the National Health Insurance (NHI) program (http://www.nhi.gov.tw/english/index.aspx).",OADS,/arxiv_data1/oa_pdf/d9/e9/medi-96-e5650.PMC5348143.pdf
Medicine (2017) 96:10(e5896)Received: 19 October 2016 / Received in ﬁnal form: 16 December 2016 / Accepted: 21 December 2016 http://dx.doi.org/10.1097/MD.0000000000005896Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/72/28/medi-96-e5896.PMC5348145.pdf
Medicine (2017) 96:10(e6089)Received: 2 September 2016 / Received in ﬁnal form: 5 December 2016 / Accepted: 17 January 2017 http://dx.doi.org/10.1097/MD.0000000000006089Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6a/f1/medi-96-e6089.PMC5348148.pdf
Medicine (2017) 96:10(e6134)Received: 16 May 2016 / Received in ﬁnal form: 22 January 2017 / Accepted: 24 January 2017 http://dx.doi.org/10.1097/MD.0000000000006134Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f3/49/medi-96-e6134.PMC5348149.pdf
Medicine (2017) 96:10(e6156)Received: 25 September 2016 / Received in ﬁnal form: 10 January 2017 / Accepted: 26 January 2017 http://dx.doi.org/10.1097/MD.0000000000006156Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f6/5c/medi-96-e6156.PMC5348151.pdf
Medicine (2017) 96:10(e6158)Received: 31 October 2016 / Received in ﬁnal form: 23 January 2017 / Accepted: 26 January 2017 http://dx.doi.org/10.1097/MD.0000000000006158Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/87/da/medi-96-e6158.PMC5348152.pdf
Medicine (2017) 96:10(e6192)Received: 20 November 2016 / Received in ﬁnal form: 30 January 2017 / Accepted: 31 January 2017 http://dx.doi.org/10.1097/MD.0000000000006192Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/14/5f/medi-96-e6192.PMC5348158.pdf
Medicine (2017) 96:10(e6204)Received: 2 November 2016 / Received in ﬁnal form: 29 January 2017 / Accepted: 30 January 2017 http://dx.doi.org/10.1097/MD.0000000000006204Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d9/e7/medi-96-e6204.PMC5348159.pdf
Medicine (2017) 96:10(e6205)Received: 14 October 2016 / Received in ﬁnal form: 29 December 2016 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006205Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c5/da/medi-96-e6205.PMC5348160.pdf
"All patientsfulﬁlled the IgG4-RD “modi ﬁed”comprehensive diagnostic criteria, [7]deﬁned by in all patients: clinical or radiological diffuse/localized swelling or masses in characteristic single ormultiple organs; in possible and de ﬁnite cases: elevated serum IgG4 levels ( >1.35g/L); in probable and de ﬁnite cases: lympho- plasmacytic polyclonal in ﬁltrate, ﬁbrosis, obliterative phlebitis, and/or increased numbers of eosinophils, with either a ratio of IgG4+/IgG+ (or IgG4+/CD138+) cells >40% or >10 IgG4+ plasma cells/HPF (supplemental Table 1, http://links.lww.com/MD/B594).",Non-OADS,/arxiv_data1/oa_pdf/c5/da/medi-96-e6205.PMC5348160.pdf
"Patients were de ﬁned as having IgG4-ROD when they had ≥1 ophthalmic manifestation(s) and above-mentioned histological criteria for IgG4-RD in either orbital, periorbital or extra-orbital tissues (supplemental Table 1, http://links.lww.com/MD/B594).",Non-OADS,/arxiv_data1/oa_pdf/c5/da/medi-96-e6205.PMC5348160.pdf
"According to the current French Legislation (Loi Huriet- Sérusclat 88-1138, December 20, 1988, and its subsequentamendments, text available at http://www.chu-toulouse.fr/IMG/ pdf/loihuriet.pdf), an observational study that does not change routine management of patients does not need to be declared orsubmitted to the opinion of a research ethics board.",Non-OADS,/arxiv_data1/oa_pdf/c5/da/medi-96-e6205.PMC5348160.pdf
"All patients ful ﬁlled the de ﬁnition of either de ﬁnite or probable IgG4-RD according to the “modi ﬁed”comprehensive diagnostic criteria (supplemental Table 1, http://links.lww.com/MD/B594).",Non-OADS,/arxiv_data1/oa_pdf/c5/da/medi-96-e6205.PMC5348160.pdf
"Antinuclear autoantibodies were found in 7 of 17 patients, between 1/80 and 1/320 but no patient had either dsDNA or extractable nuclear antigen (especially SSA or SSB) positive autoantibodies (Supplemental Table 2, http://links.lww.com/MD/B594).3.5.",Non-OADS,/arxiv_data1/oa_pdf/c5/da/medi-96-e6205.PMC5348160.pdf
Medicine (2017) 96:10(e6209)Received: 5 September 2016 / Received in ﬁnal form: 2 February 2017 / Accepted: 3 February 2017 http://dx.doi.org/10.1097/MD.0000000000006209Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c1/7a/medi-96-e6209.PMC5348161.pdf
Medicine (2017) 96:10(e6221)Received: 22 November 2016 / Received in ﬁnal form: 16 January 2017 / Accepted: 2 February 2017 http://dx.doi.org/10.1097/MD.0000000000006221Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b0/b3/medi-96-e6221.PMC5348162.pdf
Medicine (2017) 96:10(e6229)Received: 14 November 2016 / Received in ﬁnal form: 31 January 2017 / Accepted: 31 January 2017 http://dx.doi.org/10.1097/MD.0000000000006229Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8b/dc/medi-96-e6229.PMC5348163.pdf
Medicine (2017) 96:10(e6240)Received: 3 September 2016 / Received in ﬁnal form: 21 January 2017 / Accepted: 4 February 2017 http://dx.doi.org/10.1097/MD.0000000000006240Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/43/e4/medi-96-e6240.PMC5348166.pdf
Medicine (2017) 96:10(e6242)Received: 26 October 2016 / Received in ﬁnal form: 5 February 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006242Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b3/22/medi-96-e6242.PMC5348167.pdf
"HBeAg SC is de ﬁned as the loss of HBeAg expression in the peripheral blood of the host (quantitative HBeAg <1.00S/CO, signal/cutoff ratio), together with the antibodies that recognizeHBeAg (anti-HBeAg) (quantitative hepatitis B e antibody <1.00 S/CO), the detailed HBeAg measurements are shown (Tables 1and 2, Supplemental Digital Content 1, 2, http://links.lww.com/ MD/B590).",Non-OADS,/arxiv_data1/oa_pdf/b3/22/medi-96-e6242.PMC5348167.pdf
"[20]The TRBV gene sequences that were obtained were translated into thecorresponding amino acid sequence using Chromas (version 2.22; Technelysium, South Brisbane, QLD, Australia), and basic local alignment search tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) wasused to de ﬁne the CDR3 and BJ segments in each TRBV family.",OADS,/arxiv_data1/oa_pdf/b3/22/medi-96-e6242.PMC5348167.pdf
"1, Supplemental Digital Content 3, http://links.lww.com/MD/B590).",Non-OADS,/arxiv_data1/oa_pdf/b3/22/medi-96-e6242.PMC5348167.pdf
"2, Supplemental Digital Content 4, http://links.lww.com/MD/B590), but patients with SC had decreased frequency of Tregs.",Non-OADS,/arxiv_data1/oa_pdf/b3/22/medi-96-e6242.PMC5348167.pdf
Medicine (2017) 96:10(e6244)Received: 2 June 2016 / Received in ﬁnal form: 5 February 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006244Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e8/b1/medi-96-e6244.PMC5348169.pdf
Medicine (2017) 96:10(e6246)Received: 27 November 2016 / Received in ﬁnal form: 5 February 2017 / Accepted: 7 February 2017 http://dx.doi.org/10.1097/MD.0000000000006246Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/de/84/medi-96-e6246.PMC5348170.pdf
Medicine (2017) 96:10(e6247)Received: 12 December 2016 / Received in ﬁnal form: 7 February 2017 / Accepted: 7 February 2017 http://dx.doi.org/10.1097/MD.0000000000006247Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3a/ca/medi-96-e6247.PMC5348171.pdf
Medicine (2017) 96:10(e6248)Received: 7 December 2016 / Received in ﬁnal form: 6 February 2017 / Accepted: 7 February 2017 http://dx.doi.org/10.1097/MD.0000000000006248Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/3f/medi-96-e6248.PMC5348172.pdf
Medicine (2017) 96:10(e6250)Received: 9 August 2016 / Received in ﬁnal form: 6 February 2017 / Accepted: 7 February 2017 http://dx.doi.org/10.1097/MD.0000000000006250Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/75/98/medi-96-e6250.PMC5348173.pdf
Medicine (2017) 96:10(e6251)Received: 26 November 2016 / Received in ﬁnal form: 24 January 2017 / Accepted: 8 February 2017 http://dx.doi.org/10.1097/MD.0000000000006251Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7b/32/medi-96-e6251.PMC5348174.pdf
Chinese Clinical Trial Registry (http://www.chictr.org.cn).,Non-OADS,/arxiv_data1/oa_pdf/52/e4/medi-96-e6253.PMC5348175.pdf
Medicine (2017) 96:10(e6253)Received: 21 October 2016 / Received in ﬁnal form: 4 February 2017 / Accepted: 8 February 2017 http://dx.doi.org/10.1097/MD.0000000000006253Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/52/e4/medi-96-e6253.PMC5348175.pdf
"2A, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/52/e4/medi-96-e6253.PMC5348175.pdf
"2C and D, http://links.lww.com/MD/ B589).Table 1 Subject demographics.",Non-OADS,/arxiv_data1/oa_pdf/52/e4/medi-96-e6253.PMC5348175.pdf
"3A –D, http://links.lww.com/MD/ B589).",Non-OADS,/arxiv_data1/oa_pdf/52/e4/medi-96-e6253.PMC5348175.pdf
Medicine (2017) 96:10(e6255)Received: 25 August 2016 / Received in ﬁnal form: 8 February 2017 / Accepted: 8 February 2017 http://dx.doi.org/10.1097/MD.0000000000006255Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/27/7c/medi-96-e6255.PMC5348177.pdf
Medicine (2017) 96:10(e6259)Received: 26 October 2016 / Received in ﬁnal form: 5 February 2017 / Accepted: 7 February 2017 http://dx.doi.org/10.1097/MD.0000000000006259Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c9/7d/medi-96-e6259.PMC5348179.pdf
Medicine (2017) 96:10(e6262)Received: 12 October 2016 / Received in ﬁnal form: 25 January 2017 / Accepted: 6 February 2017 http://dx.doi.org/10.1097/MD.0000000000006262Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/10/medi-96-e6262.PMC5348181.pdf
Medicine (2017) 96:10(e6263)Received: 8 October 2016 / Received in ﬁnal form: 19 January 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006263Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2c/70/medi-96-e6263.PMC5348182.pdf
Medicine (2017) 96:10(e6264)Received: 25 August 2016 / Received in ﬁnal form: 7 February 2017 / Accepted: 8 February 2017 http://dx.doi.org/10.1097/MD.0000000000006264Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/52/77/medi-96-e6264.PMC5348183.pdf
Medicine (2017) 96:10(e6266)Received: 6 November 2016 / Received in ﬁnal form: 7 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006266Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e0/00/medi-96-e6266.PMC5348184.pdf
Medicine (2017) 96:10(e6267)Received: 13 September 2016 / Received in ﬁnal form: 7 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006267Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/67/50/medi-96-e6267.PMC5348185.pdf
Medicine (2017) 96:10(e6268)Received: 1 December 2016 / Received in ﬁnal form: 6 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006268Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8b/90/medi-96-e6268.PMC5348186.pdf
Medicine (2017) 96:10(e6269)Received: 10 September 2016 / Received in ﬁnal form: 4 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006269Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/66/53/medi-96-e6269.PMC5348187.pdf
Medicine (2017) 96:10(e6270)Received: 15 September 2016 / Received in ﬁnal form: 3 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006270Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bd/7c/medi-96-e6270.PMC5348188.pdf
Medicine (2017) 96:10(e6272)Received: 8 April 2016 / Received in ﬁnal form: 2 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006272Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5e/bb/medi-96-e6272.PMC5348189.pdf
"After propensity score matching, 79 well-balanced pairs of patientswere used for comparison of mortality (Supplementary Table 1,http://links.lww.com/MD/B585).",Non-OADS,/arxiv_data1/oa_pdf/5e/bb/medi-96-e6272.PMC5348189.pdf
"Also, no signiﬁcant differences were found between underweight and normal-weight motorcycle riders for ISS regardless of the subtype of injury severity, in-hospital mortality, in-hospital mortality controlled by the confounder ISS, in-hospital mortality of 35 pairsof patients after propensity score matching (SupplementaryTable 2, http://links.lww.com/MD/B585), in-hospital LOS, pro- portion of patients admitted into the ICU, and LOS in the ICU.",Non-OADS,/arxiv_data1/oa_pdf/5e/bb/medi-96-e6272.PMC5348189.pdf
"habit in most of the motorcycle riders but not in patients with fall injuries, and the existence of different presentations of GCS scores in patients with motorcycle and fall accidents, we suspected that the higher ISS and mortality in underweightpatients with fall accidents may be attributed to head injuries; however, the absence of a difference in head and neck injuries based on AIS analysis and on the incidences of associated headtrauma (Supplementary Tables 1 and 2, http://links.lww.com/MD/B585) does not support this hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/5e/bb/medi-96-e6272.PMC5348189.pdf
Medicine (2017) 96:10(e6273)Received: 12 December 2016 / Received in ﬁnal form: 1 February 2017 / Accepted: 9 February 2017 http://dx.doi.org/10.1097/MD.0000000000006273Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fe/61/medi-96-e6273.PMC5348190.pdf
Medicine (2017) 96:10(e6282)Received: 14 December 2016 / Received in ﬁnal form: 9 February 2017 / Accepted: 13 February 2017 http://dx.doi.org/10.1097/MD.0000000000006282Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
"[23,24,50 –53] HIV-1 subtype was obtained by phylogenic analyses of pol gene sequences using reference sequences for HIV-1 genetic subtypes and circulating recombinant forms obtained from the Los Alamos Database (available at: http://hiv-web.lanl.gov).",OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
” Protease and RT sequences were submitted to European Nucleotide Archive with the following accession numbers:LT577626 to LT577673 and LT726745 to LT726792 (available at: http://www.ebi.ac.uk/ena/data/view/).,OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Global AIDS response progress reporting 2015 (Updated December 2015).Available at: http://www.unaids.org/en/resources/documents/2015/ GARPR_2015_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: http://www.unaids.org/ en/resources/documents/2015/15_by_15_a_global_target_achieved.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: https://www.dhsprogram.com/pubs/pdf/FR263/FR263.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: http://www.who.int/hiv/pub/guidelines/arv2013/ download/en/.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: http://www.who.int/publications/2010/9789241599801_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: http://www.msf.org/shadomx/ apps/fms/fmsdownload.cfm?,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: https://aidsinfo.nih.gov/content ﬁles/pediatricguide lines001391.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: http://apps.who.int/adolescent/second- decade/ ﬁles/1612_MNCAH_HWA_Executive_Summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Available at: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/30/medi-96-e6282.PMC5348195.pdf
Medicine (2017) 96:10(e6283)Received: 7 November 2016 / Received in ﬁnal form: 9 February 2017 / Accepted: 11 February 2017 http://dx.doi.org/10.1097/MD.0000000000006283Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f4/dd/medi-96-e6283.PMC5348196.pdf
Available at: http://jalt.org/test/ bro_25.htm.,Non-OADS,/arxiv_data1/oa_pdf/f4/dd/medi-96-e6283.PMC5348196.pdf
Medicine (2017) 96:10(e6286)Received: 13 January 2017 / Received in ﬁnal form: 8 February 2017 / Accepted: 13 February 2017 http://dx.doi.org/10.1097/MD.0000000000006286Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/59/8e/medi-96-e6286.PMC5348198.pdf
Medicine (2017) 96:10(e6287)Received: 31 January 2017 / Received in ﬁnal form: 14 February 2017 / Accepted: 15 February 2017 http://dx.doi.org/10.1097/MD.0000000000006287Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1d/c3/medi-96-e6287.PMC5348199.pdf
Medicine (2017) 96:10(e6288)Received: 7 February 2017 / Received in ﬁnal form: 9 February 2017 / Accepted: 13 February 2017 http://dx.doi.org/10.1097/MD.0000000000006288Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5f/51/medi-96-e6288.PMC5348200.pdf
Medicine (2017) 96:10(e6289)Received: 29 September 2016 / Received in ﬁnal form: 16 January 2017 / Accepted: 11 February 2017 http://dx.doi.org/10.1097/MD.0000000000006289Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d8/87/medi-96-e6289.PMC5348201.pdf
Medicine (2017) 96:10(e6293)Received: 10 June 2016 / Received in ﬁnal form: 31 December 2016 / Accepted: 13 February 2017 http://dx.doi.org/10.1097/MD.0000000000006293Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ed/3e/medi-96-e6293.PMC5348203.pdf
Medicine (2017) 96:10(e6296)Received: 21 March 2016 / Received in ﬁnal form: 11 February 2017 / Accepted: 14 February 2017 http://dx.doi.org/10.1097/MD.0000000000006296Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8b/73/medi-96-e6296.PMC5348204.pdf
Medicine (2017) 96:10(e6299)Received: 4 July 2016 / Received in ﬁnal form: 17 January 2017 / Accepted: 14 February 2017 http://dx.doi.org/10.1097/MD.0000000000006299Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/3c/0b/medi-96-e6299.PMC5348205.pdf
Medicine (2017) 96:10(e6301)Received: 27 March 2016 / Received in ﬁnal form: 9 February 2017 / Accepted: 10 February 2017 http://dx.doi.org/10.1097/MD.0000000000006301Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/97/0c/medi-96-e6301.PMC5348206.pdf
Medicine (2017) 96:10(e6309)Received: 10 November 2016 / Received in ﬁnal form: 9 February 2017 / Accepted: 13 February 2017 http://dx.doi.org/10.1097/MD.0000000000006309Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f8/c1/medi-96-e6309.PMC5348208.pdf
Medicine (2017) 96:10(e6310)Received: 16 December 2016 / Received in ﬁnal form: 20 January 2017 / Accepted: 10 February 2017 http://dx.doi.org/10.1097/MD.0000000000006310Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/1e/medi-96-e6310.PMC5348209.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/83/main.PMC5348211.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2016.12.010,OADS,/arxiv_data1/oa_pdf/ae/83/main.PMC5348211.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8c/43/1349-7235-56-0243.PMC5348446.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/8c/43/1349-7235-56-0243.PMC5348446.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ba/df/1349-7235-56-0253.PMC5348447.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ba/df/1349-7235-56-0253.PMC5348447.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a7/5d/1349-7235-56-0259.PMC5348448.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a7/5d/1349-7235-56-0259.PMC5348448.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/5b/2b/1349-7235-56-0269.PMC5348449.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/5b/2b/1349-7235-56-0269.PMC5348449.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/ba/79/1349-7235-56-0275.PMC5348450.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/ba/79/1349-7235-56-0275.PMC5348450.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c1/8f/1349-7235-56-0283.PMC5348451.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c1/8f/1349-7235-56-0283.PMC5348451.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/b4/10/1349-7235-56-0289.PMC5348452.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/b4/10/1349-7235-56-0289.PMC5348452.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/93/fe/1349-7235-56-0295.PMC5348453.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/93/fe/1349-7235-56-0295.PMC5348453.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9e/eb/1349-7235-56-0301.PMC5348454.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/9e/eb/1349-7235-56-0301.PMC5348454.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/c0/65/1349-7235-56-0307.PMC5348455.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/c0/65/1349-7235-56-0307.PMC5348455.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d1/31/1349-7235-56-0315.PMC5348456.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d1/31/1349-7235-56-0315.PMC5348456.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/32/52/1349-7235-56-0321.PMC5348457.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/32/52/1349-7235-56-0321.PMC5348457.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/08/7f/1349-7235-56-0327.PMC5348458.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/08/7f/1349-7235-56-0327.PMC5348458.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8b/f5/1349-7235-56-0335.PMC5348459.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/8b/f5/1349-7235-56-0335.PMC5348459.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/99/38/1349-7235-56-0341.PMC5348460.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/99/38/1349-7235-56-0341.PMC5348460.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/9d/dc/1349-7235-56-0347.PMC5348461.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/9d/dc/1349-7235-56-0347.PMC5348461.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a5/db/1349-7235-56-0353.PMC5348462.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/a5/db/1349-7235-56-0353.PMC5348462.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/1e/76/1349-7235-56-0357.PMC5348463.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/1e/76/1349-7235-56-0357.PMC5348463.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/63/3f/1349-7235-56-0363.PMC5348464.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/63/3f/1349-7235-56-0363.PMC5348464.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/7a/5b/1349-7235-56-0369.PMC5348465.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/7a/5b/1349-7235-56-0369.PMC5348465.pdf
"In addition, an analysis of whole-genome sequencing data with blastn (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch) revealed thatthe isolate carried virulence genes rmpA,terA,iroN,a n d iucA(10-12).",OADS,/arxiv_data1/oa_pdf/d2/63/1349-7235-56-0373.PMC5348466.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/d2/63/1349-7235-56-0373.PMC5348466.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/d2/63/1349-7235-56-0373.PMC5348466.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/8b/3b/1349-7235-56-0377.PMC5348467.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/8b/3b/1349-7235-56-0377.PMC5348467.pdf
"Toview the details of this license, please visi t (https://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/64/43/1349-7235-56-0381.PMC5348468.pdf
⡥2017 The Japanese Society of Internal Medicine http://www.naika.or.jp/imonline/index.html,Non-OADS,/arxiv_data1/oa_pdf/64/43/1349-7235-56-0381.PMC5348468.pdf
"Accepted for publication Feb 08, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.01 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.01   Introduction Cancer is one of the major non-communicable diseases in the world, including China.",Non-OADS,/arxiv_data1/oa_pdf/da/01/cjcr-29-1-1.PMC5348470.pdf
"Available  online:  http://www.iacr.com.fr/ index.php?option=com_content&view=category&layo ut=blog&id=68&Itemid=4455.Chen W, Zheng R, Zuo T, et al.",OADS,/arxiv_data1/oa_pdf/da/01/cjcr-29-1-1.PMC5348470.pdf
"Accepted for publication Feb 10, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.02 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.02   Introduction Since the 1970s, incidence rate and mortality for cancer have been rising in China.",Non-OADS,/arxiv_data1/oa_pdf/86/04/cjcr-29-1-11.PMC5348471.pdf
"Accepted for publication Feb 10, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.03 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.03    Original Article  © Chinese Journal of Cancer Research.",Non-OADS,/arxiv_data1/oa_pdf/90/03/cjcr-29-1-18.PMC5348472.pdf
"Accepted for publication Jan 03, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.04 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.04   Introduction Gastric cancer (GC) remains one of the most commonmalignancies and is responsible for the third leading cause of cancer-related deaths in China (1).",Non-OADS,/arxiv_data1/oa_pdf/17/ec/cjcr-29-1-25.PMC5348473.pdf
"Accepted for publication Jan 12, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.05 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.05   Introduction Liver metastasis occurs frequently in colorectal cancer and develops in about 50% of patients (1).",Non-OADS,/arxiv_data1/oa_pdf/35/cd/cjcr-29-1-36.PMC5348474.pdf
"Accepted for publication Jan 09, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.06 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.06   Introduction Cervical cancer (CC) ranks as the fourth leading cause of cancer-related death among women worldwide, and the molecular pathogenesis of CC is not well understood (1,2).",Non-OADS,/arxiv_data1/oa_pdf/54/04/cjcr-29-1-45.PMC5348475.pdf
"Accepted for publication Jan 09, 2017. doi: 10.21147/j.issn.1000-9604.2017.01.07 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.07   Introduction Diffuse large B-cell lymphoma (DLBCL) represents the most common type of lymphatic neoplasm and has obvious heterogeneity in its histology, immunology, genetics, molecular biology and clinical presentation (1).",Non-OADS,/arxiv_data1/oa_pdf/04/31/cjcr-29-1-57.PMC5348476.pdf
"Accepted for publication Dec 13, 2016. doi: 10.21147/j.issn.1000-9604.2017.01.08 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.08   Introduction Lymphoblastic lymphoma (LBL) is a highly aggressivemalignancy that arises from T-/B-precursor lymphoblasts.",Non-OADS,/arxiv_data1/oa_pdf/26/0d/cjcr-29-1-66.PMC5348477.pdf
"Accepted for publication Jun 20, 2016. doi: 10.21147/j.issn.1000-9604.2017.01.09 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.09   Introduction Cancer is one of the major chronic diseases in China and around the world.",Non-OADS,/arxiv_data1/oa_pdf/99/30/cjcr-29-1-75.PMC5348478.pdf
"Accepted for publication Dec 28, 2016. doi: 10.21147/j.issn.1000-9604.2017.01.10 View this article at: http://dx.doi.org/10.21147/j.issn.1000-9604.2017.01.10   Introduction Although the incidence of gastric cancer has decreased over the years, it is the fifth leading cause of cancer worldwide after lung, breast, colorectal and prostate cancers and it is the third most common cause of cancer deaths worldwide after lung and liver cancers (1,2).",Non-OADS,/arxiv_data1/oa_pdf/45/37/cjcr-29-1-86.PMC5348479.pdf
"In the present study, we investigated the mechanism  underlying ER stress in response to exposure to blue LED  light using murine photoreceptor cells, with particular  emphasis on the involvement of S-opsin.Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> Received 24 November 2016 | Accepted 3 March 2017 | Published 5 March 2017© 2017 Molecular Vision 52The involvement of ATF4 and S-opsin in retinal photoreceptor cell  damage induced by blue LED light Emi Ooe,1,2 Kazuhiro Tsuruma,1 Yoshiki Kuse,1 Saori Kobayashi,2 Masamitsu Shimazawa,1 Hideaki Hara1 1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Daigakunishi, Gifu, Japan;  2Wakasa Seikatsu Co. Ltd, 22 Naginataboko-cho, Shijo-Karasuma, Shimogyo-ku, Kyoto, Japan Purpose:  Blue light is a high-energy emitting light with a short wavelength in the visible light spectrum.",Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
"Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  53METHODS Materials:  The murine photoreceptor-derived cell line, 661W,  was obtained as a gift from Dr. Muayyad R. Al-Ubaidi  (University of Houston, Department of Biomedical Engi - neering, Houston, TX).",Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
"Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  54Real-time RT–PCR:  To evaluate the effect of exposure to blue  LED light on expression of atf4, grp94 , and bip/grp78  mRNA,  the murine photoreceptor cells were seeded in 12-well plates  at a density of 3 × 104 cells per well.",Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  55bicinchoninic acid assay (BCA) protein assay kit (Thermo  Fisher Scientific Inc.) with BSA (BSA) as the standard.,Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
"Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  56RESULTS UPR factor mRNA levels in murine photoreceptor cells  induced by exposure to blue LED light:  Murine photoreceptor  cells were exposed to 450  lx blue light, and changes in mRNA  expression at different time points were measured using  quantitative real-time RT–PCR.",Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  57induced by exposure to blue LED light in murine photore - ceptor cells (Figure 5).,Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  58mRNA levels increased between 6 and 12 h of exposure to  blue LED light.,Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
Molecular Vision  2017; 23:52-59 <http://www.molvis.org/molvis/v 23/52> © 2017 Molecular Vision  5911.,Non-OADS,/arxiv_data1/oa_pdf/da/90/mv-v23-52.PMC5348537.pdf
"Thus,  MG are highly sensitive to genetic and environmental stress Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> Received 18 August 2016 | Accepted 6 March 2017 | Published 8 March 2017© 2017 Molecular Vision 90Reduced phosphoCREB in Müller glia during retinal  degeneration in rd10 mice Enheng Dong,1 Amelia Bachleda,2 Yubin Xiong,1 Shoji Osawa,1 Ellen R. Weiss1,2,3 (The first two authors contributed equally to this study.)",Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
"Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  91in neurons and to physical damage (e.g., diabetic retinopathy,  proliferative retinopathies, retinitis pigmentosa, and retinal  detachment) [ 7-10].",Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
"Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  92Immunocytochemical analysis:  Mice raised in cyclic light  were euthanized under ambient white light, and dark-raised  animals were euthanized under red light (LED with a peak  wavelength at 660 nm ± 20 nm, LEDtronics, Inc., Torrance,  CA) by cervical dislocation following procedures in compli - ance with the Institutional Animal Care and Use Committee  at the University of North Carolina at Chapel Hill and in  adherence to the ARVO Statement for Use of Animals in  Research.",Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  93fluorescence.,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  94 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  95 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
"Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  96density of an area of pCREB staining (green) in 20 randomly  selected MG cells (identified by SOX9 staining; red) and 20  randomly selected pCREB-positive cells in the inner nuclear  layer (INL) that were not MG (non-Müller glia; NMG) was  quantified using Fiji (NIH Image, NIH).",OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  97 Figure 5. rd10  retinas from dark- reared mice undergo slower degen - eration compared with retinas from  cyclic light-reared mice.,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
"Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  98also observed at P22, as shown by the staining of MG with  the anti-SOX2 antibody (white arrowheads; Figure 1J,K).",Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  99MG in the dark-reared animals at P67 were still located in the  INL (Figure 5A).,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  100the dark-adapted retina where cGMP levels are high and the  ion channels are maintained in an open state.,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  10114.,Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
"Molecular Vision  2017; 23:90-102 <http://www.molvis.org/molvis/v 23/90> © 2017 Molecular Vision  102Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/29/e0/mv-v23-90.PMC5348538.pdf
"FOXM1-binding site prediction, chromatin immunoprecipitation (ChIP) and Luciferase reporter assays PWMSCAN was used for the computational prediction of the FOXM1 downstream targets.61,62The known FOXM1-binding sites are represented in terms of the PWM, as annotated in the TRANSFAC database,63with a consensus motif of 'ARATKGAST' (http://cistrome.org/ ~ jian/motif_collection/databases/Transfac/raw_html/M00630?view = LocusReport&protei- n_acc = PR000007731).",OADS,/arxiv_data1/oa_pdf/e0/dc/onc2016307a.PMC5348575.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)DLX1 acts as a crucial target of FOXM1 DW Chan et al 1416 Oncogene (2017) 1404 –1416",Non-OADS,/arxiv_data1/oa_pdf/e0/dc/onc2016307a.PMC5348575.pdf
"See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode Spencer S, et al.BMJ Quality Improvement Reports 2017; 6:u212406.w4933.",Non-OADS,/arxiv_data1/oa_pdf/36/c4/bmjqir.u212406.w4933.PMC5348586.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/66/bmjqir.u211783.w5035.PMC5348587.pdf
Medications safety thermometer 2014. https://www.safetythermometer.nhs.uk.,Non-OADS,/arxiv_data1/oa_pdf/c1/66/bmjqir.u211783.w5035.PMC5348587.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/bmjqir.u211402.w6306.PMC5348588.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcodeREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/bmjqir.u214811.w5926.PMC5348589.pdf
URL:http://www.rheumatology.org/portals/0/files/Rheumatic%20Diseases%20in%20America%20The%20Problem.%20The%20impact.%20The%20answers..pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/bmjqir.u214811.w5926.PMC5348589.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/8a/main.PMC5348590.pdf
http://dx.doi.org/10.1016/j.idcr.2017.03.002 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/8a/main.PMC5348590.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  27–28 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/cb/8a/main.PMC5348590.pdf
This i s an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ExercisePhysical activity measurementChildren 1.,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.025 2211-3355/© 2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
https://sites.google.,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
https://www.cdc.gov/physicalactivity/basics/pa-health/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
https://www.cde.state.co.us/assessment/generalinfo .,OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
http://search.proquest.com/docview/ 1700478735 .,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
https://www.healthypeople.gov/2020/topics-objectives/topic/ physical-activity .,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
http://dx.doi.org/10.1139/apnm-2014-0125 .,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
http://dx.doi.org/10.1016/j.ypmed.,OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
http://dx.doi.org/10.1249/01.mss.0000235359.,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
https://nces.ed.gov/surveys/sass/tables/sass0708_035_s1s.,OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
28 (2):44 –51.http://dx.doi.org/10.1177/0892020613511264 .,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
http://dx.doi.org/ 10.1097/00005768-200005000-00014 .,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
https://health.gov/PAGUIDELINES/pdf/paguide.pdf .161 T.K.,Non-OADS,/arxiv_data1/oa_pdf/ba/22/main.PMC5348591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/08/main.PMC5348593.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.008 121,OADS,/arxiv_data1/oa_pdf/b2/08/main.PMC5348593.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/7b/main.PMC5348594.pdf
http://dx.doi.org/10.1016/j.jdcr.2016.12.006 124,OADS,/arxiv_data1/oa_pdf/b7/7b/main.PMC5348594.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c6/d7/main.PMC5348595.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.006 127,OADS,/arxiv_data1/oa_pdf/c6/d7/main.PMC5348595.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/0d/main.PMC5348596.pdf
http://dx.doi.org/10.1016/j.idcr.2017.02.010 2214-2509/©  2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/0d/main.PMC5348596.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  29–31 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/30/0d/main.PMC5348596.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/48/main.PMC5348597.pdf
"Upon  admission, http://dx.doi.org/10.1016/j.ijscr.2017.02.029 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c2/48/main.PMC5348597.pdf
Search strategy Studies were identi ﬁed from EMBASE and MEDLINE databases via http://dx.doi.org/10.1016/j.lrr.2017.02.002 Received 4 September 2016; Received in revised form 9 February 2017; Accepted 23 February 2017⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/94/93/main.PMC5348598.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/93/main.PMC5348598.pdf
[cited 11 April 2016]; Available from: 〈http://www.ohri.ca/ programs/clinical_epidemiology/oxford.htm 〉.,Non-OADS,/arxiv_data1/oa_pdf/94/93/main.PMC5348598.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/53/main.PMC5348600.pdf
The  abdomen  was  slightly  distended  and  her  peristalsis http://dx.doi.org/10.1016/j.ijscr.2017.02.018 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/fe/53/main.PMC5348600.pdf
"17  (5)  (2013) e299–303, http://dx.doi.org/10.1016/j.ijid.2012.11.032 .",OADS,/arxiv_data1/oa_pdf/fe/53/main.PMC5348600.pdf
"34  (2016)  180–186,  http://dx.doi.org/10.1016/j.ijsu.2016.08.014 .",Non-OADS,/arxiv_data1/oa_pdf/fe/53/main.PMC5348600.pdf
"The incidence of ESS in the United States is approximately 300 –600 year, and surgery Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.03.002 2352-5789/© 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/49/main.PMC5348601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/49/main.PMC5348601.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2017.03.001 2352-5789/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5348602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/88/main.PMC5348602.pdf
http://dx.doi.org/10.1016/j.idcr.2017.01.005 2214-2509/©  2017  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/af/e3/main.PMC5348603.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  8  (2017)  32–33 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locat  e/idcr,Non-OADS,/arxiv_data1/oa_pdf/af/e3/main.PMC5348603.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/1c/main.PMC5348604.pdf
"Blood  examination  revealed an  increase  of  inﬂammatory  reactions,  and  contrast-enhanced computed  tomography  revealed  invagination  of  the  small  intestine http://dx.doi.org/10.1016/j.ijscr.2017.02.005 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/f1/1c/main.PMC5348604.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sudarshan Ramachandran, PhD, FRC  Path, Professor, Department of Clinical Biochemistry, Heart of  England NHS Foundation Trust, Rectory Road, Sutton Coldfield,  West Midlands B75 7RR,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/WJD-8-104.PMC5348622.pdf
"sud.ramachandran@heartofengland.nhs.uk Telephone:  +44 ­ 121 ­ 4247246 Fax: +44 ­ 121 ­ 3111800 Received: October 27, 2016 Peer-review started: October 31, 2016 First decision: December 1, 2016 Revised:  December 14, 2016 Accepted: January 2, 2017 Article in press:  January 3, 2017 Publishe d online:  March 15, 2017ORIGINAL ARTICLE 104 March 15, 2017 |Volume 8 |Issue 3| WJD|www.wjgnet.comStatin, testosterone and phosphodiesterase 5-inhibitor  treatments and age related mortality in diabetesSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4239/wjd.v8.i3.104World J Diabetes   2017 March 15; 8(3): 104-111 ISSN 1948-9358 (online)  Retrospective Cohort Study",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/WJD-8-104.PMC5348622.pdf
"Hackett G, Jones PW, Strange RC, Ramachandran S. Statin,  testosterone and phosphodiesterase 5 ­ inhibitor treatments and age  related mortality in diabete s. World J Diabetes 2017; 8(3): 104 ­ 111   Available from: URL:  http://www.wjgnet.com/1948-9358/full/v8/ i3/104.htm  DOI: http://dx.doi.org/10.4239/wjd.v8.i3.104 INTRODUCTION In 1825, Benjamin Gompertz described a law defining  human mortality based on the equation, μ(x) = α x  eβx, with μ(x) being the mortality rate at age x years  and, α and β (considered to be the ageing rate) being  constants[1].",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/WJD-8-104.PMC5348622.pdf
Data on the United Kingdom Government Web  Archive ( http://webarchive.nationalarchives.gov.uk/20160 35 30 25 20 15 10   5   0Probability of mortality (%)Unadjusted for treatments Unadjusted for treatments + 95%CI Unadjusted for treatments - 95%CI 50            55            60           65            70           75           80 Age (years)80 70 60 50 40 30 20 10   0Probability of mortality (%)Statin/untreated Statin/untreated + 95%CI Statin/untreated - 95%CI Statin/treated Statin/treated + 95%CI Statin/treated - 95%CI 50            55            60           65            70           75           80 Age (years) 60 50 40 30 20 10   0Probability of mortality (%)Low T/untreated Low T/untreated + 95%CI Low T/untreated - 95%CI Low T/treated Low T/treated + 95%CI Low T/treated - 95%CI 50            55            60           65            70           75           80 Age (years) 80 70 60 50 40 30 20 10   0Probability of mortality (%)Not on any treatment Not on any treatment + 95%CI Not on any treatment - 95%CI All 3 treatments All 3 treatments + 95%CI All 3 treatments - 95%CI 50            55            60           65            70           75           80 Age (years)80 70 60 50 40 30 20 10   0Probability of mortality (%)PDE5I/untreated  PDE5I/untreated + 95%CI PDE5I/untreated - 95%CI PDE5I/treated PDE5I/treated + 95%CI PDE5I/treated - 95%CI 50            55            60           65            70           75           80 Age (years) Figure 3  Association between probability of mortality and age.,Non-OADS,/arxiv_data1/oa_pdf/6d/e4/WJD-8-104.PMC5348622.pdf
"110 March 15, 2017 |Volume 8 |Issue 3| WJD|www.wjgnet.com105160709/http://www.ons.gov.uk/ons/rel/vsob1/death- reg-sum-tables/2013/sty-mortality-rates-by-age.htm l  - accessed 2016 Oct 24) shows firstly, the relevance of  the Gompertz model; mortality rates between 1963 and  2013 demonstrate an exponential pattern similar to that  described nearly 200 years ago by Gompertz.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/WJD-8-104.PMC5348622.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/WJD-8-104.PMC5348622.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Ashok Kumar Tripathi, PhD, Professor,  Biochemistry and Immunology Laboratory, Department of  Biochemistry, University College of Medical Sciences (University  of Delhi) and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi  110095, India.",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/WJD-8-112.PMC5348623.pdf
"aktripathiucms@gmail.co m Telephone: +91-11-22582972 Received: July 11, 2016 Peer-review started: July 14, 2016 First decision:  September 12, 2016 Revised:  October 6, 2016 Accepted:  November 21, 2016 Article in press:  November 23, 2016 Published online:  March 15, 2017 Abstract AIM To investigate the role of genetic variants of angiotensin  converting enzyme (ACE) and angiotensinogen (AGT)  genes in the antiproteinuric efficacy of ACE inhibitor  therapy in diabetic nephropathy (DN) patients.ORIGINAL ARTICLE 112 March 15, 2017 |Volume 8 |Issue 3| WJD|www.wjgnet.comRole of angiotensin converting enzyme and angiotensinogen  gene polymorphisms in angiotensin converting enzyme  inhibitor-mediated antiproteinuric action in type 2 diabetic  nephropathy patientsSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4239/wjd.v8.i3.112World J Diabetes   2017 March 15; 8(3): 112-119 ISSN 1948-9358 (online)  Prospective Study",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/WJD-8-112.PMC5348623.pdf
World J Diabetes  2017; 8(3): 112-119  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/WJD-8-112.PMC5348623.pdf
com/1948-9358/full/v8/i3/112.htm  DOI: http://dx.doi.org/10.4239/ wjd.v8.i3.112INTRODUCTION Diabetic nephropathy (DN) is a clinical syndrome  that occurs approximately in 20%-30% of patients  with diabetes mellitus (DM).,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/WJD-8-112.PMC5348623.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/WJD-8-112.PMC5348623.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Salim Surani, MD, MPH, MSHM, FACP,  FCCP , FAASM, Department of Medicine, Texas A and M University,  Corpus Christi, 1177 West Wheeler Ave, Suite 117, Aransas Pass,  TX 78413, United States.",Non-OADS,/arxiv_data1/oa_pdf/f5/c5/WJD-8-89.PMC5348624.pdf
World J Diabetes  2017; 8(3): 89-96  Ava ilable from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/f5/c5/WJD-8-89.PMC5348624.pdf
"com/1948-9358/full/v8/i3/89.htm  DOI: http://dx.doi.org/10.4239/MINIREVIEWS 89 March 15, 2017 |Volume 8 |Issue 3| WJD|www.wjgnet.comManagement of critically ill patients with diabetesSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4239/wjd.v8.i3.89World J Diabetes   2017 March 15; 8(3): 89-96 ISSN 1948-9358 (online)",Non-OADS,/arxiv_data1/oa_pdf/f5/c5/WJD-8-89.PMC5348624.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f5/c5/WJD-8-89.PMC5348624.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Takeshi Nikawa, MD, PhD, Professor,  Department of Nutritional Physiology, Institute of Biomedical  Sciences, Tokushima University Graduate School, 3-18-15 Kura - moto-cho, Tokushima 770-8503,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/2f/2a/WJD-8-97.PMC5348625.pdf
"MINIREVIEWS 97 March 15, 2017 |Volume 8 |Issue 3| WJD|www.wjgnet.comInvolvement of Cbl-b-mediated macrophage inactivation in  insulin resistanceSubmit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4239/wjd.v8.i3.97World J Diabetes   2017 March 15; 8(3): 97-103 ISSN 1948-9358 (online)",Non-OADS,/arxiv_data1/oa_pdf/2f/2a/WJD-8-97.PMC5348625.pdf
World J Diabetes  2017; 8(3): 97-103  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/2f/2a/WJD-8-97.PMC5348625.pdf
"com/1948-9358/full/v8/i3/97.htm  DOI: http://dx.doi.org/10.4239/ wjd.v8.i3.97 INTRODUCTION In 2014, more than 1.9 billion adults were overweight,  and of these, over 600 million were obese[1].",Non-OADS,/arxiv_data1/oa_pdf/2f/2a/WJD-8-97.PMC5348625.pdf
"Available from: URL: http://www.who.int/mediacentre/ factsheets/fs311/en/ 2 Wellen KE , Thompson CB.",Non-OADS,/arxiv_data1/oa_pdf/2f/2a/WJD-8-97.PMC5348625.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2f/2a/WJD-8-97.PMC5348625.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Laura Elnitski, PhD, Senior Investigator,  Head, Genomic Functional Analysis Section, National Human  Genome Research Institute, National Institutes of Health, 5625  Fishers Lane, Rockville, MD 20852,  United States.",Non-OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
"Here,  we summarize previous work on the topic and discuss  unanswered questions regarding commonalities and  differences of CIMP tumors from esophageal, gastric, and Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4251/wjgo.v9.i3.105World J Gastrointest Oncol   2017 March 15; 9(3): 105-120 ISSN 1948-5204 (online)",Non-OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
wjgnet.com/1948-5204/full/v9/i3/105.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
RESEARCH Data We downloaded level 3 DNA methylation data from TCGA’ s data portal (https://tcga-data.nci.nih.gov/tcga/).,OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
"We also  downloaded level 3 RNA-Seq data from the Broad Institute  TCGA Genome Data Analysis Center (standard run dated  06/01/2015, http://dx.doi.org/10.7908/C1251HBG).",OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
"In  addition, somatic mutation data for all four cancer types  were downloaded through the bulk download interface  of the TCGA portal (https://tcga-data.nci.nih.gov/tcga/ findArchives.htm).",OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/46/12/WJGO-9-105.PMC5348626.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscriptCorrespondence to: Melissa Ching Ching Teo, Senior Con - sultant/Head, MBBS, MMed (Surg), FRCSEd, FAMS, MPH,  Adjunct Associate Professor, Division of Surgical Oncology,  National Cancer Centre Singapore, 11 Hospital Drive, Singapore  169610, Singapore.",Non-OADS,/arxiv_data1/oa_pdf/9b/bd/WJGO-9-121.PMC5348627.pdf
These Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4251/wjgo.v9.i3.121World J Gastrointest Oncol   2017 March 15; 9(3): 121-128 ISSN 1948-5204 (online) Retrospective Cohort Study,Non-OADS,/arxiv_data1/oa_pdf/9b/bd/WJGO-9-121.PMC5348627.pdf
World J Gastrointest Oncol  2017; 9(3):  121-128  Available from: URL: http://www.wjgnet.com/1948-5204/ full/v9/i3/121.htm  DOI: http://dx.doi.org/10.4251/wjgo.v9.i3.,Non-OADS,/arxiv_data1/oa_pdf/9b/bd/WJGO-9-121.PMC5348627.pdf
Available from: URL:  http://globocan.iarc.fr/old/FactSheets/cancers/stomach-new.asp 4 Lee HP .,Non-OADS,/arxiv_data1/oa_pdf/9b/bd/WJGO-9-121.PMC5348627.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9b/bd/WJGO-9-121.PMC5348627.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to : Kanthi Rekha Badipatla, MD, Gastro-enterology Fellow, Division of Gastroenterology, Department  of Medicine, Bronx Lebanon Hospital Center, Affiliated to Icahn  School of Medicine at Mount Sinai, 1650 Grand Concourse, Bronx,  NY 10457, Unites States.",Non-OADS,/arxiv_data1/oa_pdf/68/b8/WJGO-9-129.PMC5348628.pdf
"With increasing use of endoscopy and colonoscopy  in the current era, physicians should be mindful of the  uncommon differ entials as well.Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4251/wjgo.v9.i3.129World J Gastrointest Oncol   2017 March 15; 9(3): 129-134 ISSN 1948-5204 (online)",Non-OADS,/arxiv_data1/oa_pdf/68/b8/WJGO-9-129.PMC5348628.pdf
World J Gastrointest Oncol  2017; 9(3): 129­134   Available from: URL: http://www.wjgnet.com/1948 ­5204/full/v9/ i3/129.htm  DOI: http://dx.doi.org/10.4251/wjgo.v9.i3.,Non-OADS,/arxiv_data1/oa_pdf/68/b8/WJGO-9-129.PMC5348628.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/68/b8/WJGO-9-129.PMC5348628.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source: Unsolicited manuscript Correspondence to: Massimiliano Salati, MD, Department of  Medical and Surgical Sciences for Children and Adults, Division  of Medical Oncology, University Hospital of Modena and Reggio  Emilia, via del Pozzo, 41124 Modena, Italy.",Non-OADS,/arxiv_data1/oa_pdf/40/77/WJGO-9-135.PMC5348629.pdf
"Given the intermediate risk of  recurrence, no adjuvant therapy was recommended and Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4251/wjgo.v9.i3.135World J Gastrointest Oncol   2017 March 15; 9(3): 135-141 ISSN 1948-5204 (online)",Non-OADS,/arxiv_data1/oa_pdf/40/77/WJGO-9-135.PMC5348629.pdf
World J Gastrointest Oncol  2017; 9(3): 135-141  Available from:  URL: http://www.wjgnet.com/1948-5204/full/v9/i3/135.htm  DOI:  http://dx.doi.org/10.4251/wjgo.v9.i3.,Non-OADS,/arxiv_data1/oa_pdf/40/77/WJGO-9-135.PMC5348629.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/40/77/WJGO-9-135.PMC5348629.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Kjetil Søreide, MD, PhD, Professor,  Consultant Surgeon, Department of Gastrointestinal Surgery,  HPB Unit, Stavanger University Hospital, P.O.",Non-OADS,/arxiv_data1/oa_pdf/14/6b/WJGO-9-98.PMC5348630.pdf
"Core tip: As a general rule, “good” colorectal liver meta - stasis (CRLM) cases amenable for surgery have fewer bad Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4251/wjgo.v9.i3.98World J Gastrointest Oncol   2017 March 15; 9(3): 98-104 ISSN 1948-5204 (online)",Non-OADS,/arxiv_data1/oa_pdf/14/6b/WJGO-9-98.PMC5348630.pdf
World J  Gastrointest Oncol  2017; 9(3): 98-104  Available from: URL:  http://www.wjgnet.com/1948-5204/full/v9/i3/98.htm  DOI: http:// dx.doi.org/10.4251/wjgo.v9.i3.,Non-OADS,/arxiv_data1/oa_pdf/14/6b/WJGO-9-98.PMC5348630.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/14/6b/WJGO-9-98.PMC5348630.pdf
"@ERSpublications Whole-body vibration training is a feasible and safe exercise modality even in patients with severe COPD http://ow.ly/FNK5307VSPC Cite this article as: Gloeckl R, Richter P, Winterkamp S, et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
ERJ Open Res 2017; 3: 00101-2016 [https://doi.org/10.1183/23120541.00101-2016].,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
https://doi.org/10.1183/23120541.00101-2016 ERJ Open Res 2017; 3: 00101-2016 ORIGINAL ARTICLE COPD,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
The squat exercises were timed so https://doi.org/10.1183/23120541.00101-2016 2COPD | R. GLOECKL ET AL.,OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
CPET: cardiopulmonary exercise testing; PWR: peak work rate; WBV:whole-body vibration.Day 1 CPET Day 2 10 min cycling  at 60% PWR Random order 1 min squats  with WBV1 min squats  without WBV 3 min standing with WBV2 min squats  with WBV2 min squats  without WBV 3 min squats  with WBV3 min squats  without WBV https://doi.org/10.1183/23120541.00101-2016 3COPD | R. GLOECKL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
https://doi.org/10.1183/23120541.00101-2016 4COPD | R. GLOECKL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
https://doi.org/10.1183/23120541.00101-2016 5COPD | R. GLOECKL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
https://doi.org/10.1183/23120541.00101-2016 6COPD | R. GLOECKL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
"Therefore, a dynamic squat WBVT programme seems to be preferable to isometric WBVT.FIGURE 3 Ratio of minute ventilation to oxygen uptake ( VE/ V′O2) during squat exercises with and without whole body vibration training (WBVT).25 Rest 1 min 2 min 3 min30354045VE/V’O2With WBVT Without WBVT FIGURE 4 Ratio of minute ventilation to carbon dioxide output(VE/V′ CO2) during squat exercises with (closed circles) and without (open circles) whole body vibrationtraining (WBVT).30 Rest 1 min 2 min 3 min3540455055VE/V’CO2With WBVT Without WBVT https://doi.org/10.1183/23120541.00101-2016 7COPD | R. GLOECKL ET AL.",Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
https://doi.org/10.1183/23120541.00101-2016 8COPD | R. GLOECKL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
https://doi.org/10.1183/23120541.00101-2016 9COPD | R. GLOECKL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/1d/53/00101-2016.PMC5348635.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/e3/82/jcs-6-1.PMC5348658.pdf
Available from: http://rc.majlis.ir/fa/  law/show/93465   12.,Non-OADS,/arxiv_data1/oa_pdf/e3/82/jcs-6-1.PMC5348658.pdf
This work is published by Journ al of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/68/21/jcs-6-19.PMC5348659.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under th e terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/ca/jcs-6-29.PMC5348660.pdf
This work is published by Journal of Caring Sciences as an open access article d istributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/03/jcs-6-39.PMC5348661.pdf
This work is publis hed by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/17/jcs-6-49.PMC5348662.pdf
Available from:  http://www.ino.ir .,Non-OADS,/arxiv_data1/oa_pdf/a0/17/jcs-6-49.PMC5348662.pdf
This work is published by Journal of Caring Sciences as an open access article distributed   under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9d/bb/jcs-6-59.PMC5348664.pdf
Available  from: http://iec.behdasht.gov.ir/ index.,OADS,/arxiv_data1/oa_pdf/9d/bb/jcs-6-59.PMC5348664.pdf
This work is published by Journal of Caring Sciences as an open access article distributed  under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by -nc/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/91/15/jcs-6-81.PMC5348666.pdf
"World Health Organization: Glasgow Declaration on Hepatitis,  2015. http://www.who.int/hepatitis/glasgow -declaration- on-vira l-hepatitis/en/.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
Updated April 2016. http://www.who.int/hepatitis/publications/ hepatitis -c-guidelines -2016/en/.,Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"Updated November 15,  2016. http://www.who.int/features/qa/zika/en/.",OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"February 17, 2016. http://www.medscape.com/viewarticle/859014.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"When It's  Something More, 2016. http://my.clevelandclinic.org/health /tran- scripts/1578_recurrent‑fever‑when‑it‑s‑a‑virus‑when‑it‑s‑som ething -more.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
2016. https://www.quora.com/Why -do-doctors -pres cribe -antibiotics -for-viruses -viral -infections.,Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"Campaign SS: Guidelines, Society of Critical Care Medicine, 2016.  http://www.survivingsepsis.org /guidelines /Pages /default.aspx.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"Gizmodo, July 8, 2015. http://gizmodo.com/new‑study‑ reveals -just-how-sick-families -with- kids-get-1722654292.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"UpToDate, 2016. http://www.uptodate.com/contents/approach -to -the-child -with-recurrent -infections.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"February 8, 2016. http://www.who.int/ influenza/publications/riskassessment_AH1N1pdm09_201602/ en /.",Non-OADS,/arxiv_data1/oa_pdf/7f/83/etm-13-02-0364.PMC5348700.pdf
"FBAT was conducted using the PBAT  package ( http://www.hsph.harvard.edu /fbat/pbat.htm)  with the  FBAT -PC test statistic parameter in the SNP & Variation Suite  (SVS) version  8 (goldenhelix.com/products/SNP_Variation/ index.html ), which includes an FBAT extension (FBAT -PC)  for longitudinal phenotypes, repeated measurements and  correlated phenotypes  (11).",OADS,/arxiv_data1/oa_pdf/73/01/etm-13-02-0523.PMC5348709.pdf
"K. W. M. ’s financial disclosures prior to August 1, 2013 can be viewed at https://www.dcri.org/about-us/conflict-of-interest/ Mahaffey-COI_2011-2013.pdf; disclosures after August 1, 2013 can be viewed at http://med.stanford.edu/profiles/kenneth-mahaffey.G.",Non-OADS,/arxiv_data1/oa_pdf/af/84/DOM-19-387.PMC5348724.pdf
Available at: http://www.ema.europa.eu/ema/i ndex.jsp?curl=pages/medicines/ human/referrals/SGLT2_inhibitors_(previously_Canagliflozin)/human_ referral_prac_000059.jsp&mid=WC0b01ac05805c516f.,Non-OADS,/arxiv_data1/oa_pdf/af/84/DOM-19-387.PMC5348724.pdf
Available at: http://www.fda.gov/ Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedical Products/ucm461876.htm.,Non-OADS,/arxiv_data1/oa_pdf/af/84/DOM-19-387.PMC5348724.pdf
CDC;2009. http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.,OADS,/arxiv_data1/oa_pdf/85/c3/OBY-25-591.PMC5348725.pdf
"Food Surveys Research Group, Beltsville Human Nutrition Research Center, AgriculturalResearch Service, USDA: Beltsville, MD; 2014. http://www.ars.usda.gov/ARSUserFiles/80400530/pdf/fped/FPED_0506.pdf 33.",Non-OADS,/arxiv_data1/oa_pdf/85/c3/OBY-25-591.PMC5348725.pdf
Australian Dietary Guidelines (2013) https://www.nhmrc.gov.au/guidelines/publications/n55.,Non-OADS,/arxiv_data1/oa_pdf/85/c3/OBY-25-591.PMC5348725.pdf
The English version questionnaire  can be viewed online for free (details at http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/JRMS-21-133.PMC5348825.pdf
MATERIALS AND METHODS Patient setting This trial has been registered at http://www.irct.ir/ Registration with ID number IRCT2016040527135N2 and  has been approved by the Isfahan University of Medical  Sciences Ethical Board.,Non-OADS,/arxiv_data1/oa_pdf/51/b5/JRMS-21-131.PMC5348837.pdf
Available from: https://www.amar.org.ir/Portals/1/ Iran/90.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/4e/JRMS-21-136.PMC5348839.pdf
Available from: http://www.who.int/nmh/events/un_ncd_ summit2011/en/.,Non-OADS,/arxiv_data1/oa_pdf/6f/4e/JRMS-21-136.PMC5348839.pdf
Available from:  http://www.apps.who.int/iris/bitstream/10665/204348/1/ zikasitrep_5Feb2016_eng.pdf.,OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available  from: http://www.emergency.cdc.gov/coca/transcripts/2016/ call‑transcript‑022516.asp.,OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available from: http://www.cdc.gov/ zika/hc‑providers/testing‑for‑zikavirus.html.,Non-OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available from: http://www.cdc.gov/zika/symptoms/.,Non-OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available from: http://www.reuters.,Non-OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available from: http://www.cdc.gov/mmwr/ volumes/65/wr/mm6502e1.htm.,OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available  from: http://www.cdc.gov/zika/prevention/index.html.,Non-OADS,/arxiv_data1/oa_pdf/69/26/JRPP-6-1.PMC5348849.pdf
Available  from: http://www.pbs.gov.au/info/industry/listing/elements/pbac‑ meetings/psd/2013‑08/antipsychotics.,Non-OADS,/arxiv_data1/oa_pdf/8d/91/JRPP-6-12.PMC5348850.pdf
"Dec 17, 2013 Available from: http://www.medscape.com/ viewarticle/817961#vp_2 [Last accessed on 2015 Sep 13].",Non-OADS,/arxiv_data1/oa_pdf/8d/91/JRPP-6-12.PMC5348850.pdf
Available from: http://www.latuda.,Non-OADS,/arxiv_data1/oa_pdf/8d/91/JRPP-6-12.PMC5348850.pdf
Available from:http://www.ama‑assn.org/ ama1/pub/up‑load/mm/472/electronic‑e‑prescribing.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://campus.ahima.org/audio/2009/ RB051909.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from:  http://www.mgma.com/Libraries/Assets/Government Affairs/ Issues/Health Information Technology/E‑prescribing/2011‑ Clinicians‑Guide‑to‑e‑prescribing.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.gao.gov/assets/320/315811.pdf.,OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.politics.ox.ac.uk/ materials/publications/15224/workingpaperno5ulrikedeetjen.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.ehealth.uvic.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from:  http://www.srdc.com.tr/metu‑srdc/projects/ride/.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.hprocard.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.cms.gov/ Medicare/Quality‑Initiatives‑Patient‑Assessment‑Instruments/ ERxIncentive/E‑Prescribing_Measure.html.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.birmingham.ac.uk/ Documents/college‑mds/haps/projects/cfhep/projects/004/ CfHEP‑004‑Final‑Report‑27‑Jan‑2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.surescripts.com/docs/default‑source/ national‑progress‑reports/surescripts_2013_national_progress_,OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available  from: http://www.inera.se/Infrastrukturtjanster/Sjunet/.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from:  http://www.rand.org/pubs/technical_reports/TR941.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/JRPP-6-3.PMC5348854.pdf
Available from: http://www.apps.who.int/medicinedocs/documents/ s22114en/s22114en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/a2/JRPP-6-40.PMC5348856.pdf
Available from: http://www.cdc.gov/HAI/settings/lab/visa_vrsa_ lab_detection.html.,OADS,/arxiv_data1/oa_pdf/7a/dc/JRPP-6-60.PMC5348860.pdf
Available from: http://www.ihi.org/IHI/Topics/ PatientSafety/MedicationSystems/Tools/Medication+Reconciliati on+Review.htm.,Non-OADS,/arxiv_data1/oa_pdf/32/0a/JRPP-6-61.PMC5348861.pdf
"Statistical analysis Statistical analysis was performed using MedCalc  Statistical Software version 16.8 (MedCalc Software  bvba, Ostend, Belgium; https://www.medcalc.org; 2016).",OADS,/arxiv_data1/oa_pdf/44/0f/JRMS-21-127.PMC5348966.pdf
Available from: http://www.groups.,Non-OADS,/arxiv_data1/oa_pdf/44/0f/JRMS-21-127.PMC5348966.pdf
Available from: http://www.wpic.pitt.edu/research/dementia_epidemiology/IndoUS/Instruments/Geriatric%20 Depression%20Scale-Hindi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/30/IJCM-42-13.PMC5348997.pdf
World Federation for Medical Education: foundation and constitutionAvailable from: http://wfme.org/about/wfme-constitution.,Non-OADS,/arxiv_data1/oa_pdf/b1/48/IJCM-42-19.PMC5348998.pdf
3rd edAvailable from:  http://conference.pixel-online.net/foe2013/common/download/Paper_pdf/083-ITL13-FP-Sachou-FOE2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/48/IJCM-42-19.PMC5348998.pdf
2010; Available from: http://nacoonline.org/upload/AR 2009-10/NACO_AR_English corrected .pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/47/IJCM-42-24.PMC5348999.pdf
2010; Available from: http://nacoonline.org/upload/AR 2009-10/NACO_AR_English corrected .pdf.,Non-OADS,/arxiv_data1/oa_pdf/95/47/IJCM-42-24.PMC5348999.pdf
Available from: http://www.whoindia.org/LinkFiles/ Human_Resources_Health_Workforce_in_India_-_Apr07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e2/4d/IJCM-42-30.PMC5349000.pdf
"Cape Town: PMNCH  2006; Available from: http://www.who.int/pmnch/media/publications/aonsectionIII_2.pdfAntenatal care.In Joy L and Kate K, editors.",Non-OADS,/arxiv_data1/oa_pdf/57/04/IJCM-42-37.PMC5349001.pdf
Available from: http://www.rchiips.org/pdf/rch3/state/India.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/04/IJCM-42-37.PMC5349001.pdf
Available from: http://health.bih.nic.in/Docs/Guidelines/ Guidelines-PHC-2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/04/IJCM-42-37.PMC5349001.pdf
Available from: http://www.nrhmorissa.gov.,Non-OADS,/arxiv_data1/oa_pdf/57/04/IJCM-42-37.PMC5349001.pdf
Available  from: https://en.wikipedia.org/wiki/.,Non-OADS,/arxiv_data1/oa_pdf/e2/a9/IJCM-42-4.PMC5349002.pdf
Available at: http://www.globalhealthaction.net/index.php/gha/article/view/20066>.,Non-OADS,/arxiv_data1/oa_pdf/6e/c5/IJCM-42-43.PMC5349003.pdf
doi:http://dx.doi.org/10.3402/gha.v6i0.20066.,OADS,/arxiv_data1/oa_pdf/6e/c5/IJCM-42-43.PMC5349003.pdf
Available from: http://www.fssai.gov.in/GazettedNotifications.,Non-OADS,/arxiv_data1/oa_pdf/6e/c5/IJCM-42-43.PMC5349003.pdf
Available from: https://ifballiance.org/sites/default/files/ IndiaPledge.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/c5/IJCM-42-43.PMC5349003.pdf
Available from: http://www.stroke.org/sites/default/files/resources/DiabetesBrochure.pdf 35.,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/IJCM-42-46.PMC5349004.pdf
Available from: http://www.who.int/features/factfiles/noncommunicable_diseases/en/.,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/IJCM-42-46.PMC5349004.pdf
Available from: http://www.nhp.gov.in/world-arthritis-day.,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/IJCM-42-46.PMC5349004.pdf
Wave 1:2012-Available from: http://apps.who.int/healthinfo/systems/ surveydata/index.php/catalog/65.,OADS,/arxiv_data1/oa_pdf/e7/e7/IJCM-42-46.PMC5349004.pdf
Available from: http://www.iipsindia.org/.,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/IJCM-42-46.PMC5349004.pdf
"Gwetu TP , Chhagan MK, Craib M and Kauchali S (2013)  Hemocue Validation for the Diagnosis of Anaemia in Children:  A Semi Systematic Review Pediat Therapeut , 4:1 1 http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e7/2b/IJCM-42-54.PMC5349006.pdf
"Secularism, Religion, and the Public Sphere , accessed 18 May 2016, accessible @: http://blogs.ssr c.org/tif/2010/02/03/a-postsecular- world-society/ Habermas, Ju ¨rgen and Ratzinger, Joseph (2004) ‘Vorpolitische moralische Grundlagen eines freiheitlichen Staates’ [Pre-political Conditions of the Liberal State], zur debatte 34(1): 1–12.48 Philosophy and Social Criticism 43(1)",Non-OADS,/arxiv_data1/oa_pdf/5d/dc/10.1177_0191453716651665.PMC5349085.pdf
"419, last accessed 27 October 2015, accessible @: http://ssrn.com/abstract ¼2474241 Nussbaum, Martha (2007) Liberty of Conscience: In Defense of America’s Tradition of Religious Equality .",Non-OADS,/arxiv_data1/oa_pdf/5d/dc/10.1177_0191453716651665.PMC5349085.pdf
"@ERSpublications School holiday periods are associated with an increased incidence of adult pneumococcalcommunity-acquired pneumonia http://ow.ly/JiAb3089Gii Cite this article as: Daniel P, Rodrigo C, Bewick T, et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
ERJ Open Res 2017; 3: 00100-2016 [https://doi.org/ 10.1183/23120541.00100-2016].,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
Conflict of interest: Disclosures can be found alongside this article at openres.ersjournals.com https://doi.org/10.1183/23120541.00100-2016 ERJ Open Res 2017; 3: 00100-2016 ORIGINAL ARTICLE PNEUMONIA,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
"The following variables were included: age, sex, active malignancy, chronic liver disease, https://doi.org/10.1183/23120541.00100-2016 2PNEUMONIA | P. DANIEL ET AL.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
"In a separate sensitivity analysis, exclusion of patients https://doi.org/10.1183/23120541.00100-2016 3PNEUMONIA | P. DANIEL ET AL.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
https://doi.org/10.1183/23120541.00100-2016 4PNEUMONIA | P. DANIEL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
https://doi.org/10.1183/23120541.00100-2016 5PNEUMONIA | P. DANIEL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
https://doi.org/10.1183/23120541.00100-2016 6PNEUMONIA | P. DANIEL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
https://doi.org/10.1183/23120541.00100-2016 7PNEUMONIA | P. DANIEL ET AL.,Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
"http://webarchive.nationalarchives.gov.uk/ 20140629102627/http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1211441442288 Date last accessed: March 1, 2016. https://doi.org/10.1183/23120541.00100-2016 8PNEUMONIA | P. DANIEL ET AL.",Non-OADS,/arxiv_data1/oa_pdf/bc/5e/00100-2016.PMC5349095.pdf
"@ERSpublications DLCOis a powerful prognostic marker in IPF http://ow.ly/EaEr307VTRN Cite this article as: Sharp C, Adamali HI, Millar AB.",OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
ERJ Open Res 2017; 3: 00096-2016 [https://doi.org/10.1183/23120541.00096-2016].,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
https://doi.org/10.1183/23120541.00096-2016 ERJ Open Res 2017; 3: 00096-2016 ORIGINAL ARTICLE IDIOPATHIC PULMONARY FIBROSIS,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
Change in FVC and DLCO https://doi.org/10.1183/23120541.00096-2016 2IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
https://doi.org/10.1183/23120541.00096-2016 3IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
https://doi.org/10.1183/23120541.00096-2016 4IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
https://doi.org/10.1183/23120541.00096-2016 5IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
https://doi.org/10.1183/23120541.00096-2016 6IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
p<0.001 byMann –Whitney test.20 10 0 –10 –20 –30Average annual FVC change % No fall in FVC >10% Fall in FVC >10% FIGURE 4 Change in forced vital capacity (FVC) by interval to lastfollow-up.40 20 0 –20 –40Change in FVC % Follow-up interval months01 0 2 0 3 0FVC change Line of best ﬁt https://doi.org/10.1183/23120541.00096-2016 7IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
Date last updated: June 2013. https://doi.org/10.1183/23120541.00096-2016 8IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
https://doi.org/10.1183/23120541.00096-2016 9IDIOPATHIC PULMONARY FIBROSIS | C. SHARP ET AL.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/00096-2016.PMC5349096.pdf
"@ERSpublications Acute changes following lung volume recruitment http://ow.ly/2dqE308g3oG Cite this article as: Molgat-Seon Y, Hannan LM, Dominelli PB, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
ERJ Open Res 2017; 3: 00135-2016 [https://doi.org/10.1183/23120541.00135-2016].,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 ERJ Open Res 2017; 3: 00135-2016 ORIGINAL ARTICLE RESPIRATORY MUSCLE WEAKNESS,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
"During each pulse, subjects were relaxed while air passively inflated their lungs, thereby causing a https://doi.org/10.1183/23120541.00135-2016 2RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.",Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 3RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 4RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 5RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 6RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 7RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 8RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 9RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
https://doi.org/10.1183/23120541.00135-2016 10RESPIRATORY MUSCLE WEAKNESS | Y. MOLGAT-SEON ET AL.,Non-OADS,/arxiv_data1/oa_pdf/d6/ec/00135-2016.PMC5349097.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF ENDOUROLOGY Volume 31, Number 3, March 2017Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/8a/5f/end.2016.0773.PMC5349221.pdf
Available from: http://www.who.int/mediacentre/fact- sheets/fs311/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/69/51/jphia-2016-1-515.PMC5349253.pdf
Available from: http://www.who.intl/ chp/steps/en27.,OADS,/arxiv_data1/oa_pdf/69/51/jphia-2016-1-515.PMC5349253.pdf
Available from: http://www.who.int/mediacentre/fact- sheets/fs311/en/ 30.,Non-OADS,/arxiv_data1/oa_pdf/69/51/jphia-2016-1-515.PMC5349253.pdf
Available from: http://www.who.int/cancer/ detection/en/  9.,Non-OADS,/arxiv_data1/oa_pdf/1a/7e/jphia-2016-1-528.PMC5349254.pdf
Available from: https://www.uspreventiveservicestaskforce.org /Page/Document/UpdateSummaryFinal/breast -cancer-screening 14.,Non-OADS,/arxiv_data1/oa_pdf/1a/7e/jphia-2016-1-528.PMC5349254.pdf
Available from: http://ispub.com/IJH/12/1/ 8251 21.,Non-OADS,/arxiv_data1/oa_pdf/1a/7e/jphia-2016-1-528.PMC5349254.pdf
Available from: http://www.nigeriamasterweb.com/Nigeria06C ensusFigs.html  24.,Non-OADS,/arxiv_data1/oa_pdf/1a/7e/jphia-2016-1-528.PMC5349254.pdf
Available from: http://www.avert.org/professionals/ hiv-around-world/sub-saharan-africa/zim- babwe.,Non-OADS,/arxiv_data1/oa_pdf/08/ae/jphia-2016-1-533.PMC5349255.pdf
Available from: http://who.int/ mediacentre/factsheets/fs360/en/.,Non-OADS,/arxiv_data1/oa_pdf/08/ae/jphia-2016-1-533.PMC5349255.pdf
Available from: http://www.who.int/mediacentre/fact- sheets/fs103/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.cdc.gov/vhf/ebola/outbreaks/hi story/chronology.html 4.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://apps.who.int/iris/bitstream/10665/13 1596/1/EbolaResponseRoadmap.pdf?ua=1 6.,OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://datatopics.worldbank.org/hnp/HNPDash.aspx 10.,OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/whr/2000/en/whr00_e n.pdf?ua=1 12.,OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.nih.gov/news/health/aug2014/od-29.htm 18.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.doctorswith- outborders.org/news-stories/voice- field/struggling-contain-ebola-epidemic- west-africa 19.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/mediacentre/news/sta tements/2014/ebola-20140808/en/ 21.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.vox.com/2014/8/ 6/5971675/where-ebola-outbreak-will-go- next-africa 22.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.the- guardian.com/society/2014/aug/23/ebola- outbreak-blamed-on-fruit-bats-africa 31.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.geohive.com/earth/his_histo- ry1.aspx                                                                                                                    Review,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/csr/disease/ebola/PAC E_outbreaks_ebola_marburg_en.pdf 35.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.rockefeller- foundation.org/uploads/files/05f03ea8- 0fcd-4a8b-9c6c-c2eaad3be607-monitor- ing.pdf 36.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.fao.org/docrep/016/i2727e/i272 7e01.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.ghanaweb.com/ GhanaHomePage/NewsArchive/artikel.php?ID=171426 41. International Business Times.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.ibtimes.com/million-dollar- fruit-bat-trade-could-be-spreading-ebola- un-warns-1634630 42.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.nytimes.com/video/world/africa/100000003019972/why-ebola-patients- are-rejecting-care.html 45.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.ibtimes.co.uk/mystery-illness- ebola-like-symptoms-kills-10-democratic-republic-congo-1461961 46.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/mediacentre/news/eb ola/25-august-2014/en/ 48.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.panapress.com/Nurses-strike- in-Sierra-Leone-for-better-conditions— 13-550776-17-lang1-index.html 50.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.world- b a n k .,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.independent.co.uk/news/world /africa/ebola-virus-spread-by-taxi-passen- gers-says-who-9719478.html 54.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.rockefeller- foundation.org/newsroom/lessons-from- previous-ebola-outbreaks 66.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.doctorswithoutborders.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
The New York Times.Available from: http://www.nytimes.com/2014/07/28/world /africa/ebola-epidemic-west-africa- guinea.html?_r=4  68.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.cidi.org/ebola-ngos/#.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.economist.com/news/interna- tional/21612158-epidemics-damage-economies-well-health-panicking-only- makes-it-worse                              Review,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://documents.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.law.georgetown.edu/oneillinst itute/resources/documents/Briefing10Ebola2inT emplate.pdf 75.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.timeslive.co.za/africa/2014/08/ 30/the-world-food-programme-needs- 70m-to-feed-1.3m-people-in-ebola-quar- antine 76.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://thecable.foreignpolicy.com/posts/20 14/08/19/ebola_wreaking_havoc_on_african_economy 78.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://online.wsj.com/articles/chinas-anti- ebola-plan-hits-youth-olympics- 1408182271 79.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.bbc.com/sport/0/football/26765 839 80.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://gulfbusiness.com/2014/08/saudi- arabia-bans-haj-pilgrims-ebola-hit-coun- tries/#.VDlcWU0tAdU 81.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.dailymail.co.uk/health/article- 2753832/Ebola-treatment-blood-sur- vivors-traded-new-black-market-emerg- ing-amid-outbreak.html#ixzz3G17G7Akw  86.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://apps.who.int/iris/bitstream/ 10665/135591/1/WHO_HIS_SDS_2014.8_ eng.pdf 87.,OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/media- centre/news/statements/2014/ebola-ethi- cal-review-summary/en/ 94.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from:https://www.enca.com/africa/french- nurse-cured-ebola-contracted-liberia 97.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://edition.cnn.com/ 2014/09/27/health/ebola-hiv-drug/ 98.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.chimerix.com/c/discovery-clin- ical-trials/brincidofovir-ebola.php.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://ir.chimerix.com /releasedetail.cfm?releaseid=874647 100.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.huffingtonpost.com/2014/10/0 6/experimental-drug-dallas-ebola- thomas-eric-duncan_n_5941104.html 101.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.forbes.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: https://www.niaid.nih.gov/sites/default/fil es/documents/jordanreport2012.pdf 103.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.the guardian.com/society/2014/sep/17/ruth- atkins-first-british-volunteer-injected- trial-ebola-vaccine-oxford 104.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.the- guardian.com/world/2014/oct/10/ebola- vaccine-mali-trialled-health-workers 105.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.theguardian.com/ world/2014/oct/13/canada-testing-ebola- vaccine-humans-in-the-us 106.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.crucell.com  107.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.scmp.com/news/china/ article/1573511/shenzhen-company-                                                                                                                    Review,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.chinadaily.com.cn/china/2014- 08/22/content_18467682.htm 111.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.niaid.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/healthsystems/ Assessment26African_countries.pdf 113.,Non-OADS,/arxiv_data1/oa_pdf/52/5f/jphia-2016-1-534.PMC5349256.pdf
Available from: http://www.who.int/malaria/media/world- malaria-report-2015/en/ Accessed: August 2016.,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
Available from: http://www.nationalplan- ningcycles.org/sites/default/files/coun- try_docs/Kenya/kenya_national_malar-ia_strategy_2009-2017.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
Available from: https://www.pmi.gov/docs/default- source/default-document-library/malaria- operational-plans/fy11/kenya_mop- fy11.pdf?sfvrsn=8 6.,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
Available from: http://pdf.usaid.,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
Availablefrom: http://www.healthyfutures.eu/ images/healthy/deliverables/D5.1/Kenya/k enya%20second%20national%20health%2 0sector%20strategic%20plan%202005%20- %202010.pdf                                                                                                                    Article,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
Available from: http://apps.who.int/ healthmetrics/library/countries/HMN_KE N_StrPlan_Final_2010_02_en.pdf 35.,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
Available from: http://www.uio.no/studier/emner/matnat/if i/INF5761/v12/undervisningsmateriale/He ywood%20and%20Rohde%20- %20Using%20information%20for%20actio n%20a%20manual%20for%20health%20.p df.,Non-OADS,/arxiv_data1/oa_pdf/8b/69/jphia-2016-1-549.PMC5349258.pdf
available frm: http://www.dhsprogram.,OADS,/arxiv_data1/oa_pdf/4a/ff/jphia-2015-1-357.PMC5349259.pdf
2005 Available from: http://www.kwenu.com/publications/orabu chi/poor_healthcare.htm  15.,Non-OADS,/arxiv_data1/oa_pdf/82/ef/jphia-2015-1-394.PMC5349260.pdf
Available from: http://www.population.,OADS,/arxiv_data1/oa_pdf/82/ef/jphia-2015-1-394.PMC5349260.pdf
Available from: http://www.unaids.org/sites/default/files/m edia_asset/20130625_progress_global_pla n_en_0.pdf 2.,OADS,/arxiv_data1/oa_pdf/da/86/jphia-2015-1-455.PMC5349261.pdf
Available frm: http://www.unaids.org/ sites/default/files/country/documents/NGA _narrative_report_2014.pdf 4.,OADS,/arxiv_data1/oa_pdf/da/86/jphia-2015-1-455.PMC5349261.pdf
Available from: http://amref.org/ amref/en/info-hub/amrefs-position-on-the-role-and-services-of-traditional-birth- attendants-/.,Non-OADS,/arxiv_data1/oa_pdf/da/86/jphia-2015-1-455.PMC5349261.pdf
Available from: http://pdf.usaid.gov/pdf_docs/Pnadh422.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/da/86/jphia-2015-1-455.PMC5349261.pdf
Available form: http://www.dhsprogram.,Non-OADS,/arxiv_data1/oa_pdf/43/43/jphia-2015-1-480.PMC5349262.pdf
Available from: http://www.statistics-cameroon.org/down- loads/Rapport_de_presentation_3_RGPH.pdf   9.,Non-OADS,/arxiv_data1/oa_pdf/fd/13/jphia-2015-1-491.PMC5349264.pdf
Availablefrom: http://www.statistics-cameroon.org/ downloads/EDS-MICS11/DHSMICS_ 2011_preliminary_report.pdf 10.,OADS,/arxiv_data1/oa_pdf/fd/13/jphia-2015-1-491.PMC5349264.pdf
Available from: https://www.utwente.nl/cw/theorieen- overzicht/Theory%20Clusters/Health%20Communication/Health_Belief_Model/  18.,Non-OADS,/arxiv_data1/oa_pdf/fd/13/jphia-2015-1-491.PMC5349264.pdf
Available from: http://paa2006.princeton.edu/papers/60050 19.,Non-OADS,/arxiv_data1/oa_pdf/fd/13/jphia-2015-1-491.PMC5349264.pdf
From: http://recapp.etr.org/recapp /index.cfm?fuseaction=pages.TheoriesHo me 20.,OADS,/arxiv_data1/oa_pdf/fd/13/jphia-2015-1-491.PMC5349264.pdf
Available from: http://recapp.etr.org/recapp/index.,OADS,/arxiv_data1/oa_pdf/fd/13/jphia-2015-1-491.PMC5349264.pdf
Available from: http://www.who.int/health-info/statistics/toolkit_hss/EN_PDF_Toolkit _HSS_Financing.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/jphia-2015-1-512.PMC5349265.pdf
Available from: http://data.worldbank.org/indicator/SI.POV.DDAY.,OADS,/arxiv_data1/oa_pdf/bc/a2/jphia-2015-1-512.PMC5349265.pdf
Available from: http://www.who.int/dg/ speeches/2012/wha_20120521/en/  13.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/jphia-2015-1-512.PMC5349265.pdf
Available from: http://www.nhis.gov.ng/ Accessed on: 21 November 2014.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/jphia-2015-1-512.PMC5349265.pdf
Available from: http://www.who.int/malar- ia/media/world_malaria_report_2013/en/ 21.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/jphia-2015-1-512.PMC5349265.pdf
Available from: http://www.who.int/health_financing/Health_Systems_Financing_Plan_Action.pdf 28.,Non-OADS,/arxiv_data1/oa_pdf/bc/a2/jphia-2015-1-512.PMC5349265.pdf
Available from: http://www.who.int/pbd/deaf- ness/WHO_GE_HL.pdf  2.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
[page 56]                                                 [Journal of Public Health in Africa 2015; 6:529]https://vula.uct.ac.za/access/content/group/27 b5cb1b-1b65-4280-9437-a9898ddd4c40/ School%20age%20hearing%20screening.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.jcih.org/JCIH1990.pdf  7.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.jcih.org/JCIH1994.pdf  8.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from:  http://www.unaids.org/sites/default/files/media_ asset/20131129_stocktaking_report_chil- dren_aids_en_0.pdf  13.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.unaids.org/sites/default /files/media_asset/UNAIDS_Global_Report _2013_en_1.pdf 14.,OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: https://www.phonakpro.com/content/dam/ph onak/b2b/Events/conference_proceedings/2 nd_pediatric_conference_2001/2001pro- ceedings_chapter14.pdf  21.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available form: http://www.who.int/school_youth_health/m edia/en/92.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.education.gov.za/Portals/0/Docu ments/Policies/INTEGRATED%20SCHOOL% 20HEALTH%20POLICYB-W_1.pdf?ver= 2014-06-14-172322-000 24.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://qa.saslha.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.section27.org.za /wp-content/uploads/2013/01 /IntSchoo lHealthProg.pdf 26.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.cdc.gov/ncbddd/hearingloss/doc- uments/AAA_Childhood%20Hearing%20Gui delines_2011.pdf 27.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.asha.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from:  http://www.ci.org.za/depts/ci/pubs /pdf/health/poldraft/schealthpol.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.raosoft.com/ samplesize.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.unicef.org/ sowc08/docs/sowc08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.statssa.gov.za/ publications/P0318/P03182012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7b/dc/jphia-2015-1-529.PMC5349266.pdf
Available from: http://www.who.int/neglected_diseases/ab out/en/ Accessed: January 2014.,Non-OADS,/arxiv_data1/oa_pdf/72/ec/jphia-2015-1-531.PMC5349267.pdf
Available from: http://siteresources.worldbank.org/INTCY/ Resources/395766-1186420121500/ YDNii1HIVAIDS.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/22/32/jphia-2015-2-454.PMC5349269.pdf
Available from: https://www.k4health.org/sites/default/files /2009-10%20Q2%20HCP%20 Report%20Jan%20to%20March.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/22/32/jphia-2015-2-454.PMC5349269.pdf
Available from: http://www.who.int/media- centre/factsheets/fs297/en/.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://www.cancerre- searchuk.org/about-cancer/type/cervical-                                                                                                                    Review,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://www.who.int/media- centre/factsheets/fs380/en/.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://www.cancerresearchuk.org/about- cancer/type/cervical-cancer/treatment/cer- vical-cancer-stages.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://screening.iarc.fr/viavilichap1.php?lang=1 15.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://globocan.iarc.fr/old/FactSheets/can- cers/cervix-new.asp.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://www.worldcancer- day.org/sites/wcd/files/private/Myth_Just_ a_Health_Issue_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Geneva: WHO; 2007.Available from: http://www.who.int/health- systems/strategy/en/ 32.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://nigerianhealthjour-nal.com/?p=777.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://www.dhsprogram.com/pubs/pdf/FR22 2/FR222.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://print.ispub.com/api/0/ispub- article/14024 38.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://data.worldbank.org/country/Nigeria.,OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://screening.iarc.fr/doc/RH_accp_improve_screening.pdf 44.,Non-OADS,/arxiv_data1/oa_pdf/48/97/jphia-2015-2-484.PMC5349270.pdf
Available from: http://apps.who.int/iris/bitstream/10665/76 700/1/9789241504393_eng.pdf 13. International Tobacco Control Project.,Non-OADS,/arxiv_data1/oa_pdf/0c/c2/jphia-2015-2-523.PMC5349271.pdf
Available from: http://www.unicef.org/pub-lications/index_57468.html.,Non-OADS,/arxiv_data1/oa_pdf/64/74/jphia-2015-2-566.PMC5349275.pdf
Available from: http://www.unicef.org/ publications/ index_30398.html.,Non-OADS,/arxiv_data1/oa_pdf/64/74/jphia-2015-2-566.PMC5349275.pdf
Avalable from: http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/64/74/jphia-2015-2-566.PMC5349275.pdf
Available from: http://www.unicef.org.,Non-OADS,/arxiv_data1/oa_pdf/64/74/jphia-2015-2-566.PMC5349275.pdf
Available from: http://data.world- bank.org/about/country-classifications.,OADS,/arxiv_data1/oa_pdf/64/74/jphia-2015-2-566.PMC5349275.pdf
Available from: http://www.unicef.org/evaldatabase/index_ 14411.html.,Non-OADS,/arxiv_data1/oa_pdf/64/74/jphia-2015-2-566.PMC5349275.pdf
"The CSDA range is obtained by integrating the reciprocal of the total stopping power with respect toenergy.”(NISTCSDA,http://physics.nist.gov/PhysRefData/Star/Text/appendix.html)Inthescopeofthispaperweextendedthiscomparisonupto50MeV,showninFigure1a.Additionally,Figure1cshowstherelativeerror (𝜈NIST−𝜈Simulation)∕𝜈Simulationindicatinggoodagreementbetweenthedataandthesimulationswitharelative error of≲0.2 except for a small deviation for very small and very large energies.",OADS,/arxiv_data1/oa_pdf/af/51/JGRD-122-1365.PMC5349290.pdf
"EPDLDatabase(1997),Photonandelectroninteractiondata.[Availableathttp://www-609nds.iaea.org/epdl97/.]",OADS,/arxiv_data1/oa_pdf/af/51/JGRD-122-1365.PMC5349290.pdf
"LXCatDatabase(2014),Electronscatteringdatabase.[Availableathttp://www.lxcat.laplace.univ-tlse.fr.]",OADS,/arxiv_data1/oa_pdf/af/51/JGRD-122-1365.PMC5349290.pdf
"Mendoza,E.,etal.(2012),IAEATech.Rep.INDC(NDS)-0612,Vienna.[Availableathttp://www-nds.iaea.org/geant4.]",Non-OADS,/arxiv_data1/oa_pdf/af/51/JGRD-122-1365.PMC5349290.pdf
"of Toulouse, LAPLACE, CNRS-UPS-INP,Toulouse,France.[Availableathttp://www.zdplaskin.laplace.univ-tlse.fr.]",Non-OADS,/arxiv_data1/oa_pdf/af/51/JGRD-122-1365.PMC5349290.pdf
"http://colorbrewer2.org/, October 2015.",Non-OADS,/arxiv_data1/oa_pdf/d6/eb/CGF-36-249.PMC5349295.pdf
"Thus, this dual-plane dissection fully separated the prior upper fold in- cision from the prior levator aponeurosis attachment site (see Video, Supplemental Digital Content 1, http://links.lww.com/SAP/A201).",Non-OADS,/arxiv_data1/oa_pdf/57/d0/spa-78-365.PMC5349302.pdf
"Methods Site of Study The catchment area of Etep Hospital includes Wasu local-level government area (around 20 000  inhabitants, part of Tewai/Siassi district) and Kabwum district (around 50 000 inhabitants) in  Morobe Province (see Figures 5 and 6 in the online appendix, available at http://aph.sagepub.",Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
"Villagers with these symptoms self-identified, and these people were further screened for a possible diagnosis of TB with a detailed history and examination (Figure 3, online appendix, available at http://aph.sagepub.com/content/by/supplemental-data).",Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
"The slides were examined after Ziehl-Neelsen staining for acid-fast bacilli (AFB) by an experienced laboratory technician from Etep Hospital (Figure 4, online appendix, available at http://aph.sagepub.com/content/by/supplemental-data).",OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
"Table 2 outlines the symptoms they presented with, and Figure 2 in the online appen-dix (available at http://aph.sagepub.com/content/by/supplemental-data) describes the different types of TB identified.",Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
"22 Asia Pacific Journal of Public Health 29(1) listed in Table 3 (online appendix, available at http://aph.sagepub.com/content/by/supplemental- data).",Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
The total cost was Kina 56 900 (approximately US$17 070); see Table 4 online appendix (available at http://aph.sagepub.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.who.int/mediacentre/factsheets/fs104/en/.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.who.int/tb/publications/global_report/high_tb_burdencountrylists2016-2020.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.stoptb.org/assets/docu- ments/events/world_tb_day/2002/1Therelationship.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.wpro.who.int/countries/png/25PNGpro2011_finaldraft.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.wpro.who.int/tb/data/rr12/en/index2.html.,OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
https://www.spc.int/frp/index2.php?option=com_docman&task=doc_view&gid=169&Itemid=33.,OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://sdd.spc.int/ en/resources/document-library?view=preview&format=raw&fileId=218.,OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.who.int/tb/publications/2006/tbhiv_recommendations.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.who.int/tb/challenges/ ChildhhoodTB_section2.pdf?ua=1&ua=1.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.adi.org.au/wp-content/uploads/2013/07/2011_NDOH_National-TB-Treatment-Protocol.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/6b/61/10.1177_1010539516683497.PMC5349312.pdf
"https://doi.org/10.1177/1363459315617311Health 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/dd/98/10.1177_1363459315617311.PMC5349313.pdf
NHS Choices Website (2015) http://www.nhs.uk/Conditions/pregnancy-and-baby/pages/how-to- make-birth-plan.aspx (accessed 13 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/dd/98/10.1177_1363459315617311.PMC5349313.pdf
"Retrieved from http://muse.jhu.edu/journals/pbm/summary/v046/46.3xmarmot.html Marmot, M. G., Stansfeld, S., Patel, C., North, F., Head, J., White, I., .",OADS,/arxiv_data1/oa_pdf/4c/7c/10.1177_0898264313492822.PMC5349315.pdf
Retrieved from http://www.regeringen.se/sb/d/108/a/2747 Swedish Work Environment Authority.,OADS,/arxiv_data1/oa_pdf/4c/7c/10.1177_0898264313492822.PMC5349315.pdf
It was undertaken as an intellectual project without pharmaceutical industry funding.Supplemental Material The online supplementary files are available at http://journals.sagepub .com/doi/suppl/10.1177/1076029615606531.,Non-OADS,/arxiv_data1/oa_pdf/ee/e3/10.1177_1076029615606531.PMC5349316.pdf
"CLINICAL REHABILITATION https://doi.org/10.1177/0269215516640320Clinical Rehabilitation 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/59/f9/10.1177_0269215516640320.PMC5349317.pdf
Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav Introduction Stroke is a significant worldwide health problem and is one of the leading causes of death among the elderly [Wang et  al.,Non-OADS,/arxiv_data1/oa_pdf/c6/b3/10.1177_1756285616681943.PMC5349374.pdf
Clinical trial registration: The study described here is registered at http://www.chictr.org/ (unique identifier: ChiCTR-OCH-14004724).,Non-OADS,/arxiv_data1/oa_pdf/c6/b3/10.1177_1756285616681943.PMC5349374.pdf
The study was registered at http://www.chictr.org/ with the unique identifier of ChiCTR-OCH-14004724.,Non-OADS,/arxiv_data1/oa_pdf/c6/b3/10.1177_1756285616681943.PMC5349374.pdf
"Genotyping In the present study, a total of 14 variants from six genes, including COX-1 (rs1236913, rs3842787), COX-2 (rs689466, rs20417), TXAS1 (rs194149, rs2267679, rs41708), P2Y1 (rs701265, rs1439010, and rs1371097), P2Y12 (rs16863323, rs9859538), and GPIIIa (rs2317676, rs11871251) were  selected from the NCBI database (http://www.ncbi.nlm.nih.gov/SNP), based on the following criteria: (i) SNPs that have been assessed in previ-ous studies [Goodman et al.",Non-OADS,/arxiv_data1/oa_pdf/c6/b3/10.1177_1756285616681943.PMC5349374.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d1/78/main.PMC5349450.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.009 113,OADS,/arxiv_data1/oa_pdf/d1/78/main.PMC5349450.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
"After  consultations  by  vascular  surgery, general  surgery,  infectious  diseases  and  interventional  radiology, http://dx.doi.org/10.1016/j.ijscr.2017.03.001 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
"246  (5)  (2007) 741–748,  http://dx.doi.org/10.1097/SLA.0b013e31811f3f9f .",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
"Liu,  A  common  disease  with  an  unusual  complication  of acute  abdomen,  Gastroenterology  142  (2)  (2012)  e16–e18,  http://dx.doi.org/ 10.1053/j.gastro.2011.03.064 .",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
"Case  Rep.  2  (5)  (2014)  188–190,  http://dx.doi.org/10.1002/ccr3.",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
"Morrow,  J.R.  Boyle,  Ruptured  infected  aneurysm  of  the  aorta  secondary  to appendicitis,  EJVES  Extra  9  (2)  (2005)  11–12,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
"Little,  et  al.,  Infected  (mycotic)  aneurysms: spectrum of  imaging  appearances  and  management,  Radiographics  28  (7) (2008)  1853–1868,  http://dx.doi.org/10.1148/rg.287085054 .",Non-OADS,/arxiv_data1/oa_pdf/ae/7e/main.PMC5349451.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/aa/06/main.PMC5349452.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.01.014 116,OADS,/arxiv_data1/oa_pdf/aa/06/main.PMC5349452.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2017) 8, 289–295 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2017.02.002 2090-1232 /C2112017 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/ff/97/main.PMC5349453.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/97/main.PMC5349453.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/97/main.PMC5349453.pdf
Mitochond DNA A DNA Mapp Seq Anal 2016. http://dx.doi.org/10.3109/ 24701394.2016.1160076 .,OADS,/arxiv_data1/oa_pdf/ff/97/main.PMC5349453.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/bd/main.PMC5349454.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/bd/main.PMC5349454.pdf
http://dx.doi.org/10.1016/j.eucr.2017.01.008Urology Case Reports 12 (2017) 42 e44,Non-OADS,/arxiv_data1/oa_pdf/c3/bd/main.PMC5349454.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/main.PMC5349456.pdf
An  ultrasound  of  the  thigh  was  also  carried http://dx.doi.org/10.1016/j.ijscr.2017.02.047 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e9/main.PMC5349456.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.008Urology Case Reports 12 (2017) 45 e46,Non-OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10443737 [cited 2016 Apr 17].,OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
Available from: http://linkinghub.elsevier.com/r etrieve/pii/S0022534705673612 [cited 2016 Apr 16].,Non-OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/6632099 [cited 2016 Apr 17].,OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 7123721 [cited 2016 Apr 17].,OADS,/arxiv_data1/oa_pdf/20/73/main.PMC5349459.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/0d/main.PMC5349460.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/0d/main.PMC5349460.pdf
http://dx.doi.org/10.1016/j.eucr.2016.12.009Urology Case Reports 12 (2017) 39 e41,Non-OADS,/arxiv_data1/oa_pdf/bd/0d/main.PMC5349460.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bd/0d/main.PMC5349460.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/20/main.PMC5349462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/20/main.PMC5349462.pdf
http://dx.doi.org/10.1016/j.eucr.2017.02.006Urology Case Reports 12 (2017) 37 e38,Non-OADS,/arxiv_data1/oa_pdf/7f/20/main.PMC5349462.pdf
"These parasites successfully withstand http://dx.doi.org/10.1016/j.redox.2017.03.004 Received 2 March 2017; Accepted 3 March 2017⁎Corresponding author at: Department of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna 800007, India.",Non-OADS,/arxiv_data1/oa_pdf/81/c9/main.PMC5349463.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/81/c9/main.PMC5349463.pdf
Densitometry analyses of the immuno- blots were performed using Image J software ( http://imagej.nih.gov/ij ) and relative band intensity was plotted.,OADS,/arxiv_data1/oa_pdf/81/c9/main.PMC5349463.pdf
Densitometry analysis of the immunoblots was performed using Image J software ( http://imagej.nih.gov/ij ) and relative band intensity was plotted.,OADS,/arxiv_data1/oa_pdf/81/c9/main.PMC5349463.pdf
"http://dx.doi.org/10.1016/j.redox.2017.02.019 Received 28 January 2017; Received in revised form 22 February 2017; Accepted 23 February 2017⁎Correspondence to: Department of Nursing, Division of Basic Medical Sciences, and Chronic Diseases and Health Promotion Research Center, Chang Gung University Of Science and Technology, Chia-Yi, Taiwan.",OADS,/arxiv_data1/oa_pdf/5e/f7/main.PMC5349464.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/5e/f7/main.PMC5349464.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c5/3e/lra-10-001.PMC5349500.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c5/3e/lra-10-001.PMC5349500.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Local and Regional Anesthesia 2017:10 1–7Local and Regional Anesthesia Dovepress submit your manuscript | www.dovepress.com Dovepress  1 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S101373Anesthesia for the patient undergoing total knee  replacement: current status and future prospects Zachary A T urnbull   Dahniel Sastow   Gregory P Giambrone   Tiffany T edore Department of Anesthesiology, Weill  Cornell Medical College, New Y ork,  NY, USAAbstract: Total knee arthroplasty (TKA) has become one of the most common orthopedic  surgical procedures performed nationally.",Non-OADS,/arxiv_data1/oa_pdf/c5/3e/lra-10-001.PMC5349500.pdf
"Presented here is a synopsis of the trends in TKA utilization and demographics, as well as a discussion of the current and future trends in TKA anesthesia and analgesia and the implications for patient outcomes.Correspondence: Zachary A Turnbull   Department of Anesthesiology,  Weill Cornell Medical College, 525 East 68th Street, Box 124, New York, NY 10065, USA Tel +1 212 746 5643   Email ZAT2002@med.cornell.eduJournal name: Local and Regional Anesthesia Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Turnbull et alRunning head recto: Ambulatory anesthesia for the patient undergoing total knee replacementDOI: http://dx.doi.org/10.2147/LRA.S101373",Non-OADS,/arxiv_data1/oa_pdf/c5/3e/lra-10-001.PMC5349500.pdf
"Local and Regional Anesthesia 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/local-and-regional-anesthesia-journalLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthetics and  analgesics.",Non-OADS,/arxiv_data1/oa_pdf/c5/3e/lra-10-001.PMC5349500.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 7 Ambulatory anesthesia for the patient undergoing total knee replacement  42.,Non-OADS,/arxiv_data1/oa_pdf/c5/3e/lra-10-001.PMC5349500.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2017:9 29–35Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 29 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S124975 Long-term safety and efficacy of biosimilar  infliximab among patients with inflammatory  arthritis switched from reference product Abuelmagd Abdalla Niamh Byrne Richard Conway Thomas WalshGeraldine MannionMichael Hanly Miriam O’Sullivan Ann Maria CurranJohn J Carey Department of Rheumatology, Galway  University Hospitals, Galway, IrelandPurpose: To evaluate the efficacy and safety of the biosimilar infliximab in adult patients with  inflammatory arthritis switched from reference product in our center.",Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
"Biosimilar medicine is a biological compound that is highly similar to the refer - ence (original) biological medicine that has already been authorized for use for at Correspondence: Abuelmagd Abdalla Unit-1, Merlin Park University Hospital, Old Dublin road, Galway, EC5, IrelandTel +353 87 676 5486Email abuelmagdaabdalla@physicians.ieJournal name: Open Access Rheumatology: Research and Reviews Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Abdalla et alRunning head recto: Switching to biosimilar infliximab in adults with inflammatory arthritisDOI: http://dx.doi.org/10.2147/OARRR.S124975",Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
"Open Access Rheumatology: Research and Reviews 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 35 Switching to biosimilar infliximab in adults with inflammatory arthritis Conclusion Our patients who were switched from the reference to the  biosimilar infliximab experienced comparable efficacy and safety profile over the follow-up period (15.8 months) with-out major safety issues in keeping with the other previous reports.,Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
Available from:  http://www.webmd.com/rheumatoid-arthritis/guide/biologics.,Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
Available from: http://www.researchandmarkets.com/research/xr7tsg/competitor.,OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
Available from: http://www.ema.europa.eu/ema/index.jsp?curl= pages/special_topics/document_listing/document_list- ing_000318.jsp.,Non-OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
Available from: http://acrabstracts.org/abstract/biosimilar-infliximab-ct-p13-is-not-inferior-to-originator-infliximab-results-from-a-52-week-randomized-switch-trial-in-norway/,OADS,/arxiv_data1/oa_pdf/d3/4d/oarrr-9-029.PMC5349501.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Emergency Medicine 2017:9 37–41Open Access Emergency Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 37 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAEM.S124149 Clinical experience and skills of physicians  in hospital cardiac arrest teams in Denmark:  a nationwide study Kasper G Lauridsen1–3 Anders  S Schmidt1–3 Philip Caap3,4 Rasmus Aagaard2,3,5 Bo Løfgren1,3,4 1Department of Internal Medicine,   2Clinical Research Unit, Regional  Hospital of Randers, Randers,   3Research Center for Emergency  Medicine, Aarhus University Hospital,   4Institute of Clinical Medicine, Aarhus  University, Aarhus, 5Department of  Anesthesiology, Randers Regional  Hospital, DenmarkBackground: The quality of in-hospital resuscitation is poor and may be affected by the clinical  experience and cardiopulmonary resuscitation (CPR) training.",Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
"Teams mostly  include physicians, nurses and orderlies from different departments.6 However, the Correspondence: Bo Løfgren Department of Internal Medicine, Randers Regional Hospital, Skovlyvej 1, 8930 Randers NE, DenmarkTel +45 7842 0000Email bl@clin.au.dkJournal name: Open Access Emergency Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Lauridsen et alRunning head recto: Experience and skills in cardiac arrest teamsDOI: http://dx.doi.org/10.2147/OAEM.S124149",Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
"Open Access Emergency Medicine 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Emergency Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-emergency-medicine-journalThe Open Access Emergency Medicine is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of emergency medicine.",Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 41 Experience and skills in cardiac arrest teams on the physicians’ self-perceived skills, and not their actual  skill performance.",Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
Available from: http://www.ncepod.org.uk/2012report1/downloads/CAP_fullreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
Available from: http://www.resus.org.uk/pages/QSCPR_Acute.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/21/oaem-9-037.PMC5349502.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/9b/ndt-13-733.PMC5349503.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 733–736Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  733Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13235 5 Bipolar disorder recurrence prevention using   self-monitoring daily mood charts: case reports  from a 5 year period Norio Yasui-Furukori Kazuhiko Nakamura Department of Neuropsychiatry,   Graduate school of Medicine,   Hirosaki University, Hirosaki, JapanAbstract:  Mood symptoms in bipolar disorders are significantly related to psychosocial events,  and the personalized identification of symptom triggers is important.",Non-OADS,/arxiv_data1/oa_pdf/ee/9b/ndt-13-733.PMC5349503.pdf
"The ecological momentary  assessments have been used in paper-and-pencil form to explore emotional reactivity to  daily life stress among participants with affective disorder including bipolar disorders.8  Frequent self-monitoring of symptomology associated with bipolar disorders including  prodromal symptoms would allow psychiatrists to personalize treatment approaches  in a more timely manner.8Correspondence: Norio Yasui-Furukori Department of Neuropsychiatry,  Graduate school of Medicine,  Hirosaki University, Zaifucho 5,  Hirosaki, aomori 036-8562, Japan Tel +81 172 39 5066 Fax +81 172 39 5067 email yasufuru@hirosaki-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case Series Y ear: 2017 Volume: 13 Running head verso: Y asui-Furukori and Nakamura Running head recto: Bipolar disorder recurrence prevention using self-monitoring DOI: http://dx.doi.org/10.2147/NDT.S132355",Non-OADS,/arxiv_data1/oa_pdf/ee/9b/ndt-13-733.PMC5349503.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ee/9b/ndt-13-733.PMC5349503.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/9b/ndt-13-733.PMC5349503.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/99/51/ndt-13-723.PMC5349504.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 723–732Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  723Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11399 8 The role of deep brain stimulation in Parkinson’s  disease: an overview and update on new  developments John Y Fang Christopher T olleson Department of Neurology, vanderbilt  University Medical Center, Nashville,   TN, USAAbstract:  Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized  by the loss of neuronal dopamine production in the brain.",Non-OADS,/arxiv_data1/oa_pdf/99/51/ndt-13-723.PMC5349504.pdf
"In addition, synthetic  dopamine receptor agonists have also become an important standard therapy for many  PD patients.Correspondence: John Y Fang Department of Neurology, Movement  Disorders, vanderbilt University Medical  Center, 1161, 21st Avenue South,  A-0118 Medical Center North, Nashville,  TN 37232, USA Tel +1 615 936 2025 Fax +1 616 936 1229 email john.y.fang@vanderbilt.ed uJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Fang and Tolleson Running head recto: Deep brain stimulation in Parkinson’s disease DOI: http://dx.doi.org/10.2147/NDT.S113998",Non-OADS,/arxiv_data1/oa_pdf/99/51/ndt-13-723.PMC5349504.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/99/51/ndt-13-723.PMC5349504.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/51/ndt-13-723.PMC5349504.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/0e/ott-10-1465.PMC5349505.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1465–1474OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1465Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12780 3 Pancreatic neuroendocrine neoplasms at magnetic  resonance imaging: comparison between grade 3  and grade 1/2 tumors chuangen guo1,* Xiao chen2,* Wenbo Xiao1 Qidong Wang1 Ke sun3 Zhongqiu Wang2 1Department of radiology,   The First affiliated hospital, college  of Medicine Zhejiang University,   hangzhou, 2Department of radiology,   The affiliated hospital of nanjing  University of chinese Medicine,   nanjing, 3Department of Pathology,   The First affiliated hospital, college  of Medicine Zhejiang University,   hangzhou, People’s republic of china *These authors contributed equally  to this workBackground:  The grading of pancreatic neuroendocrine neoplasms (PanNENs) is associated  with the choice of treatment strategy.",Non-OADS,/arxiv_data1/oa_pdf/5d/0e/ott-10-1465.PMC5349505.pdf
"Pancreatic NENs (PanNENs) are rare and correspond to  1%–2% of all pancreatic neoplasms.2 Many PanNENs are benign neoplasms, while  some are malignant.3,4 Treatment strategy and prognosis closely depend on the tumor  differentiation and clinical symptoms.correspondence: chuangen guo Department of radiology, The First  Affiliated Hospital, College of Medicine  Zhejiang University, hangzhou 310003,  People’s republic of china email zyyfy001@sina.c n  Zhongqiu Wang Department of Radiology, The Affiliated  hospital of nanjing University of chinese  Medicine, 155 hanzhong road, nanjing  2100029, People’s republic of china Tel +86 25 8661 7141 email zhqwang001@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Guo et al Running head recto: PanNENs at MRI DOI: http://dx.doi.org/10.2147/OTT.S127803",Non-OADS,/arxiv_data1/oa_pdf/5d/0e/ott-10-1465.PMC5349505.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets­and­therapy­journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5d/0e/ott-10-1465.PMC5349505.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/0e/ott-10-1465.PMC5349505.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1b/e9/nss-9-059.PMC5349506.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1b/e9/nss-9-059.PMC5349506.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 59–65Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  59 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S123319Smartphone viewing distance and sleep: an  experimental study utilizing motion capture  technology Michitaka Y oshimura1,*  Momoko Kitazawa1–3,*  Yasuhiro Maeda2  Masaru Mimura4  Kazuo Tsubota1  Taishiro Kishimoto4,5 1Department of Ophthalmology,   Keio University School of  Medicine, T okyo, 2RIKEN Center  for Advanced Photonics, Wako,  Saitama,  3Department of Nursing,   Aino University Junior College,   4Department of Neuropsychiatry,   Keio University School of Medicine,  T okyo, Japan;  5Department of  Psychiatry, Hofstra Northwell School of Medicine, NY, USA *These authors contributed equally to  this workAbstract:  There are studies reporting the negative impact of smartphone utilization on sleep.",Non-OADS,/arxiv_data1/oa_pdf/1b/e9/nss-9-059.PMC5349506.pdf
"They found that 84.4% of Japanese adolescents used smartphones Correspondence: Taishiro Kishimoto   Department of Psychiatry, Keio  University School of Medicine, 35 Shinanomachi, Shinjuku, 160-8582, Tokyo, Japan   Email taishiro-k@mti.biglobe.ne.jpJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Y oshimura et alRunning head recto: Smartphone viewing distance and sleepDOI: http://dx.doi.org/10.2147/NSS.S123319",OADS,/arxiv_data1/oa_pdf/1b/e9/nss-9-059.PMC5349506.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/1b/e9/nss-9-059.PMC5349506.pdf
"https://doi.org/10.1177/2333794X17694231Global Pediatric Health Volume 4: 1 –10  © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav  DOI: 10.1177/2333794X17694231 journals.sagepub.com/home/gph Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons  Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non- commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified  on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Original Article Introduction In the United States, approximately 21% of children  have at least one abnormal lipid measure.",Non-OADS,/arxiv_data1/oa_pdf/b5/23/10.1177_2333794X17694231.PMC5349558.pdf
Supplemental Figure 1 (avail-able at http://gph.sagepub.com/supplemental) illustrates the pilot study design overview.,Non-OADS,/arxiv_data1/oa_pdf/b5/23/10.1177_2333794X17694231.PMC5349558.pdf
Supplemental Material  Supplementary material for this paper can be found at http://jour-nals.sagepub.com/doi/suppl/10.1177/2050312117696436 References  1.,Non-OADS,/arxiv_data1/oa_pdf/6b/1b/10.1177_2050312117696436.PMC5349560.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/e5/main.PMC5349614.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.02.012 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/e5/main.PMC5349614.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 20 (2017) 205 e207,Non-OADS,/arxiv_data1/oa_pdf/04/e5/main.PMC5349614.pdf
"Published by Elsevier Inc. Thi s is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: DTIALSPhenotypesDiffusion tensor tractography/ NeuroImage: Clinical 14 (2017) 574 –579 Abbreviations: ALS, Amyotrophic lateral sclerosis; cMRI, Conventional MRI; CNS, Central nervous system; CP, Cerebral peduncle; CSoLV, Centrum semiovale at top of lateral ventricle; CST, Corticospinal tract; DTI, Diffusion tensor imaging; DTT, Diffusion tensor tractography; DW, Diffusion weighted; EMG, Electromyography; EPI , Echo planar imaging; FA, Fractional anisotropy; FLAIR, Fluid attenuated inversion recovery; FSE, Fast spin echo; LMN, Lower motor neuron; MD, Mean diffusivity; MR, Magnetic resonance ; MRI, Magnetic resonance imaging; PD, Proton density; PLIC, Posterior limb of the internal capsule; PMC, Primary motor cortex; PoG, Postcentral gyrus; PrG, Precentral gyrus ; PSC, Primary sensory cortex; ROI, Region of interest; SNR, Signal-to-noise ratio; SS-EPI, Single shot echo planar imaging; SubPMC, Subcortical to primary motor cortex; TE, Echo time ; TR, Repetition time; UMN, Upper motor neuron.",Non-OADS,/arxiv_data1/oa_pdf/2b/bd/main.PMC5349615.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.017 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/bd/main.PMC5349615.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/bd/main.PMC5349615.pdf
"These images were then processed using DTI Studio open software ( https://www.nitrc.org/projects/mri_studio/ ) and DTT of CST was performed in the following manner ( Jiang et al., 2006 ).",OADS,/arxiv_data1/oa_pdf/2b/bd/main.PMC5349615.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Frontotemporal dementia Amyotrophic lateral sclerosis Functional MRIDiffusion tensor imagingGeneticsNeuroImage: Clinical 14 (2017) 286 –297 Abbreviations: ALS, amyotrophic lateral sclerosis; bvFTD, behavioral variant frontotemporal dementia; FTD, frontotemporal dementia; CDR, Clinical Dementia Ra ting scale; DMN, default mode network; FA, fractional anisotropy; fMRI, functional MRI; FWE, familywise error; HC, healthy control; ICN, intrinsic connectivity ne twork; IRI, Interpersonal Reactivity Index; MMSE, Mini-Mental State Exam; MND, motor neuron disease; NPI, Neuropsychiatric Inventory; preSxC9, presymptomatic C9ORF72 expansion carriers; SMN, sensorimotor network; TIV, total intracranial volume; ROI, region of interest; VBM, voxel-based morphometry.",Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/j.nicl.2016.12.006 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
"Tract-Based Spatial Statistics analysis was performed in FSL ( http://www.fmrib.ox.ac.uk/fsl )(Smith et al., 2006 ) (see Supplementary Methods: DTI preprocessing for details).",OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1098/rstb.2005.1634 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1212/ WNL.0b013e31829c5eee .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1212/WNL.0000000000001276 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1093/brain/aws004 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/ j.biopsych.2010.01.020 .295 S.E.,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/S1474-4422(12)70014-5 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2006.09.011 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1037/ 0022-3514.44.1.113 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
71:11 –22.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
Neuron:1 –12http://dx.doi.org/10.1016/j.neuron.2011.09.011 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/j.cortex.2012.09.008 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1093/ schbul/sbu177 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1868-09.2009 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1136/jnnp-2012- 303507 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/ 10.1093/brain/awn234 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/ 10.1093/brain/awu248 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1093/brain/awr361 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
77:33 –46.http://dx.doi.org/10.1002/ana.24296 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/j.bbr.2010.07.009 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/S1474-4422(12)70043-1 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
Nature 508:199 – 206. http://dx.doi.org/10.1038/ nature13185 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1002/ cne.902270112 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1126/science.aaf1064 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1007/s00401-014-1245-7 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
Neuron:1 –12http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/S1474-4422(14)70324-2 .296 S.E.,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1001/ archneurol.2007.38 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
Neuron 62:42 –52.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5587-06.2007 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1212/WNL.0b013e318268452e .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1093/brain/awr353 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.02.024 .,OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
"http://dx.doi.org/10.1093/brain/awr355 .Van Dijk, K.R.A., Sabuncu, M.R., Buckner, R.L., 2012.",Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
Brain:3202 –3216 http://dx.doi.org/10.1093/brain/aww250 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
Neurology:1 –9http://dx.doi.org/10.1212/WNL.0000000000002135 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1212/WNL.0b013e31822c61f2 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1093/brain/aws001 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
http://dx.doi.org/10.1093/brain/awq075 .,Non-OADS,/arxiv_data1/oa_pdf/62/54/main.PMC5349617.pdf
"Our previous studies have identi ﬁed a series of autophagy inducers from natural products, such as glycyrrhetinic acid, platycodin D, baicalein, licochalcone A, cryptotanshinone, isocrypto- http://dx.doi.org/10.1016/j.redox.2017.03.009 Received 27 February 2017; Received in revised form 8 March 2017; Accepted 8 March 2017⁎Correspondence to: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, N7014, N22, Avenida da Universidade, Taipa, Macao, China.",Non-OADS,/arxiv_data1/oa_pdf/bd/04/main.PMC5349618.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/04/main.PMC5349618.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bb/90/jpr-10-535.PMC5349697.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bb/90/jpr-10-535.PMC5349697.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 535–544Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  535 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128871Individual and dyadic coping in chronic  pain patients Andrea Burri1–3  Michèle Blank Gebre4  Guy Bodenmann1 1Department of Psychology, University  of Zurich, Zurich, Switzerland; 2Health  and Rehabilitation Research Institute,   Auckland University of T echnology,   3Waitemata Pain Service, Department  of Anaesthesia and Perioperative Medicine, North Shore Hospital,  Auckland, New Zealand;  4Private  Practice, Zurich, SwitzerlandAbstract: The purpose of the current cross-sectional study was to test the associations between  individual coping responses to pain, dyadic coping, and perceived social support, with a number  of pain outcomes, including pain intensity, functional disability, and pain adjustment, in a sample  of N = 43 patients suffering from chronic pain in Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/bb/90/jpr-10-535.PMC5349697.pdf
"9–11 In terms of individual Correspondence: Andrea Burri Department of Psychology, University of Zurich, Binzmuehlestrasse 14, Box 9, 8050 Zurich, SwitzerlandTel +41 44 635 7457Fax +41 44 635 7552Email a.burri@psychologie.uzh.chJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Burri et alRunning head recto: Coping and chronic painDOI: http://dx.doi.org/10.2147/JPR.S128871",Non-OADS,/arxiv_data1/oa_pdf/bb/90/jpr-10-535.PMC5349697.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/bb/90/jpr-10-535.PMC5349697.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 544 Burri et al 46.,Non-OADS,/arxiv_data1/oa_pdf/bb/90/jpr-10-535.PMC5349697.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 47–56Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 47 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S121276Environmental triggers and avoidance in the  management of asthma Clarisse Gautier1  Denis Charpin1,2 1Department of Pulmonology and  Allergy, North Hospital, 2Faculty of  Medicine, Aix-Marseille University,   Marseille, FranceAbstract: Identifying asthma triggers forms the basis of environmental secondary prevention.",Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
"1 For each of these, after a short definition, we will review studies that  suggest or prove their involvement, and when appropriate, we will then evaluate the outcomes of avoidance procedures.Correspondence: Denis Charpin Clinique des bronches, allergie et sommeil, Hôpital Nord, Chemin des Bourrelly, 13015 Marseille, France Tel +33 4 91 96 86 31   Fax +33 4 91 96 89 02   Email denis-andre.charpin@ap-hm.frJournal name: Journal of Asthma and Allergy Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Gautier and CharpinRunning head recto: Avoidance of asthma triggersDOI: http://dx.doi.org/10.2147/JAA.S121276",Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: https://www.ncbi.nlm.nih.gov/books/NBK215643/.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: http://www.who.int/indoorair/publications/7989289041683/en/.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: https://www.avma.org/KB/Resources/Statistics/Pages/Market-research-statistics-US-pet-ownership.aspx.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: http://www.pfma.com/faq.html.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: http://www.fediaf.org/fileadmin/ user_upload/facts_and_figures_2010.pdf.,OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: https://www.cdc.gov/asthma/asthma_stats/asthma_stats_factsheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: http://oehha.ca.gov/air/report/health-effects-exposure-environmental-tobacco-smoke-final-report.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: https://www.airnow.gov.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
Available from: http://www.guidelines.co.uk/btssign/asthma-in-adult.,Non-OADS,/arxiv_data1/oa_pdf/7e/e7/jaa-10-047.PMC5349698.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2017:4 41–47Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 41 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S126308 A single institution report of 19 hepatocellular  carcinoma patients with bile duct tumor  thrombus Anon Chotirosniramit   Akkaphod Liwattanakun   Worakitti Lapisatepun   Wasana Ko-iam   Trichak Sandhu   Sunhawit Junrungsee Division of Hepatobiliary and  Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandBackground: Obstructive jaundice caused due to bile duct tumor thrombus (BDTT) in a  hepatocellular carcinoma (HCC) patient is an uncommon event.",Non-OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
"Materials and methods Population and clinical features From 2001 to 2015, a total of 407 HCC patients underwent hepatic resection at the  Hepatobiliary and Pancreas Unit, Department of Surgery, Chiang Mai University Correspondence: Sunhawit Junrungsee Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University, 110 Intavarorod, Sripoom, Chiang Mai, Thailand 50200Tel +66 5393 5531Fax +66 5393 5532Email sunhawit.j@cmu.ac.thJournal name: Journal of Hepatocellular Carcinoma Article Designation: CASE SERIESY ear: 2017V olume: 4Running head verso: Chotirosniramit et alRunning head recto: A single institution report of HCC patients with BDTTDOI: http://dx.doi.org/10.2147/JHC.S126308",Non-OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
"National Cancer Institute DoMS, Ministry of Public Health, Thailand  2016 [homepage on the Internet]; Available from: http://nci.go.th/.",Non-OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
"Journal of Hepatocellular Carcinoma 2017:4submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 47 A single institution report of HCC patients with BDTT  29.,Non-OADS,/arxiv_data1/oa_pdf/f1/57/jhc-4-041.PMC5349699.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ea/e9/amep-8-205.PMC5349700.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ea/e9/amep-8-205.PMC5349700.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 205–210Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 205 EXPERT OPINION open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S124004 Faculty development for the evaluation system:   a dual agenda Kellee L Oller   Cuc T Mai   Robert J Ledford   Kevin E O’Brien Department of Internal Medicine,   University of South Florida Morsani College of Medicine, Tampa, FL, USAAbstract:  Faculty development for the evaluation process serves two distinct goals.",Non-OADS,/arxiv_data1/oa_pdf/ea/e9/amep-8-205.PMC5349700.pdf
"3–7 Additionally, faculty can receive Correspondence: Kellee L Oller  Department of Internal Medicine, University of South Florida Morsani College of Medicine, 5 Tampa General Circle, HMT-750, Tampa, FL 33606, USA   Tel +1 813 844 4919   Fax +1 813 844 1934   Email koller@health.usf.eduJournal name: Advances in Medical Education and Practice Article Designation: EXPERT OPINIONY ear: 2017V olume: 8Running head verso: Oller et alRunning head recto: Faculty development for the evaluation systemDOI: http://dx.doi.org/10.2147/AMEP .S124004",Non-OADS,/arxiv_data1/oa_pdf/ea/e9/amep-8-205.PMC5349700.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/ea/e9/amep-8-205.PMC5349700.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 210 Oller et al 18.,Non-OADS,/arxiv_data1/oa_pdf/ea/e9/amep-8-205.PMC5349700.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3b/7d/jpr-10-545.PMC5349701.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3b/7d/jpr-10-545.PMC5349701.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 545–555Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  545 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S131482Effectiveness of ultrasound therapy for myofascial  pain syndrome: a systematic review and   meta-analysis Peng Xia*   Xiaoju Wang*  Qiang Lin   Kai Cheng   Xueping Li Department of Rehabilitation  Medicine, Nanjing First Hospital,  Nanjing Medical University, Nanjing,  People’s Republic of China *These authors contributed equally to  this workObjective: The objective of this review was to assess the therapeutic effect of ultrasound (US)  on myofascial pain syndrome (MPS).",Non-OADS,/arxiv_data1/oa_pdf/3b/7d/jpr-10-545.PMC5349701.pdf
"4,5 Therefore, MPS is refractory and the outcomes may Correspondence: Xueping Li Department of Rehabilitation Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, People’s Republic of ChinaTel +86 189 5167 0129Email lixueping6504@163.comJournal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Xia et alRunning head recto: Effectiveness of ultrasound therapy for myofascial pain syndromeDOI: http://dx.doi.org/10.2147/JPR.S131482",Non-OADS,/arxiv_data1/oa_pdf/3b/7d/jpr-10-545.PMC5349701.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/3b/7d/jpr-10-545.PMC5349701.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 555 Effectiveness of ultrasound therapy for myofascial pain syndrome Supplementary material Search strategies for PubMed, Embase  and the Cochrane Library database PubMed  1.",Non-OADS,/arxiv_data1/oa_pdf/3b/7d/jpr-10-545.PMC5349701.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 557–566Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  557 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S128184Pain behavior mediates the relationship between  perceived injustice and opioid prescription for  chronic pain: a Collaborative Health Outcomes  Information Registry study Junie S Carriere1 Marc-Olivier Martel2,3 Ming-Chih Kao4 Michael JL Sullivan5 Beth D Darnall4 1Department of Psychology, 2Faculty  of Dentistry, 3Department of  Anesthesia, Faculty of Medicine,   McGill University, Montreal, QC,  Canada;  4Division of Pain Medicine,   Stanford Systems Neuroscience and Pain Laboratory, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA;   5Faculty of Health and Behavioural  Sciences, University of Queensland,  Herston, QLD, AustraliaBackground and purpose: Perceived injustice has been defined as an appraisal regarding the  severity and irreparability of loss associated with pain, blame and a sense of unfairness.",Non-OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
"1 Accumulating evidence suggests that perceived injustice is a Correspondence: Junie S Carriere Department of Psychology, McGill University, 1205 Dr. Penfield Avenue, Montreal, QC H3A 1B1, Canada   Tel +1 514 398 6127   Fax +1 514 398 4896   Email junie.carriere@mail.mcgill.caJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Carriere et alRunning head recto: Perceived injustice, pain behavior and opioid prescriptionDOI: http://dx.doi.org/10.2147/JPR.S128184",Non-OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
The poster’ s abstract was published in “Poster Abstracts” in the Journal of Pain: DOI: http://dx.doi.org/10.1016/j.jpain.2016.01.425.Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 566 Carriere et al,Non-OADS,/arxiv_data1/oa_pdf/de/af/jpr-10-557.PMC5349702.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/6e/jaa-10-035.PMC5349703.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/6e/jaa-10-035.PMC5349703.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2017:10 35–46Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 35 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S111712Control of moderate-to-severe asthma with  randomized ciclesonide doses of 160, 320   and 640 μg/day Søren E Pedersen1  Niyati Prasad2  Udo-Michael Goehring3  Henrik Andersson4  Dirkje S Postma5 1Pediatric Research Unit, Kolding  Hospital, University of Southern  Denmark, Kolding, Denmark;   2Vertex, Phase IV & Global Strategy,   London, UK; 3Vifor Pharma Ltd,   Clinical Research & Biometrics,  Glattbrugg, Switzerland;  4Swedish  Social Insurance Agency, Government Offices of Sweden, Stockholm,  Sweden;  5Department of Pulmonology,   Griac Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsBackground: The inhaled corticosteroid (ICS) ciclesonide (Cic), controls asthma symptoms  in the majority of patients at the recommended dose of 160 µg/day.",Non-OADS,/arxiv_data1/oa_pdf/5e/6e/jaa-10-035.PMC5349703.pdf
"2 The score reflects the adequacy of asthma control and changes in Correspondence: Søren E Pedersen   Pediatric Research Unit, Kolding Hospital,  University of Southern Denmark, Universitetsparken 1, 6000 Kolding, Denmark Email sp@spconforsk.dkJournal name: Journal of Asthma and Allergy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Pedersen et alRunning head recto: CONTRAST study of Cic in asthmaDOI: http://dx.doi.org/10.2147/JAA.S111712",Non-OADS,/arxiv_data1/oa_pdf/5e/6e/jaa-10-035.PMC5349703.pdf
Available from: http://www.ginasthma.org/.,Non-OADS,/arxiv_data1/oa_pdf/5e/6e/jaa-10-035.PMC5349703.pdf
"Journal of Asthma and Allergy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/5e/6e/jaa-10-035.PMC5349703.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/04/75/imcrj-10-081.PMC5349704.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/04/75/imcrj-10-081.PMC5349704.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 81–85International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 81 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S129174Decrease of the foveal avascular zone area   after internal limiting membrane peeling:   single case study Kazuyuki Kumagai1 Akinori Uemura2 Mariko Furukawa1 T etsuyuki Suetsugu1 Nobuchika Ogino3 1Department of Ophthalmology,   Kami-iida Daiichi General Hospital,   Aichi, 2Department of Ophthalmology,   Kagoshima City Hospital, Kagoshima,   3Department of Ophthalmology,   Nishigaki Eye Clinic, Aichi, JapanPurpose: To report a patient whose foveal avascular zone (FAZ) decreased after vitrectomy  with internal limiting membrane (ILM) peeling.",Non-OADS,/arxiv_data1/oa_pdf/04/75/imcrj-10-081.PMC5349704.pdf
"Correspondence:  Kazuyuki Kumagai Department of Ophthalmology, Kami-iida  Daiichi General Hospital, 2-70 Kamiiida Kita-machi, Aichi 462-0802, JapanTel +81 52 991 3111Fax +81 52 991 3220Email ganka@kamiiida-hp.jpJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Kumagai et alRunning head recto: Decrease of FAZ area after ILM peelingDOI: http://dx.doi.org/10.2147/IMCRJ.S129174",Non-OADS,/arxiv_data1/oa_pdf/04/75/imcrj-10-081.PMC5349704.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/04/75/imcrj-10-081.PMC5349704.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 85 Decrease of FAZ area after ILM peeling 2.,Non-OADS,/arxiv_data1/oa_pdf/04/75/imcrj-10-081.PMC5349704.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/37/0e/693.PMC5349770.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a9/df/697.PMC5349772.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/74/c3/699.PMC5349773.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/75/72/701.PMC5349774.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f3/ae/703.PMC5349775.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3f/58/705.PMC5349776.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/12/1f/707.PMC5349777.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/af/ba/712.PMC5349778.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0f/6b/716.PMC5349779.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8c/4c/726.PMC5349780.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6e/ea/736.PMC5349781.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1d/72/746.PMC5349782.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8f/c8/760.PMC5349783.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/45/58/771.PMC5349784.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d4/86/783.PMC5349785.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ee/96/792.PMC5349786.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8c/2a/809.PMC5349787.pdf
Cell culture and reporters Experiments were done using the axenic  strain Ax2 (Kay laboratory strain; DBS0235521  at http://dictybase.org) of D. discoideum .,OADS,/arxiv_data1/oa_pdf/8c/2a/809.PMC5349787.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1c/f5/817.PMC5349788.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5d/58/825.PMC5349789.pdf
", 2015), because it  is specifically expressed in cells at the early conjugation stage, that  is, when meiosis takes place (TetraFGD; http://tfgd.ihb.ac.cn; Miao  et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/58/825.PMC5349789.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/fd/834.PMC5349790.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/jpr-10-567.PMC5349853.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b3/0c/jpr-10-567.PMC5349853.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 567–574Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  567 ORIGINAL RESEARCH   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121810Pregnancy suppresses neuropathic pain induced  by chronic constriction injury in rats through the  inhibition of TNF-α Y oshiko Onodera Megumi Kanao-Kanda Hirotsugu Kanda T omoki SasakawaHiroshi IwasakiTakayuki Kunisawa Department of Anesthesiology and  Critical Care Medicine, Asahikawa Medical University,  Hokkaido, JapanPurpose : Pregnancy-induced analgesia develops during late pregnancy, but it is unclear whether  this analgesia is effective against neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/jpr-10-567.PMC5349853.pdf
"A previous report revealed significant changes in the response of rats to several  forms of noxious stimulation, such as colorectal distention, on day 21 of gestation.8 Correspondence:  Hirotsugu Kanda Department of Anesthesiology and  Critical Care Medicine, Asahikawa Medical University, Midorigaoka-higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, JapanTel +81 166 68 2583Fax +81 166 68 2589Email h.kanda0629@nifty.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCH Y ear: 2017V olume: 10Running head verso: Onodera et alRunning head recto: Pregnancy suppresses neuropathic pain through the inhibition of TNF-αDOI: http://dx.doi.org/10.2147/JPR.S121810",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/jpr-10-567.PMC5349853.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/b3/0c/jpr-10-567.PMC5349853.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 574 Onodera et al  9.,Non-OADS,/arxiv_data1/oa_pdf/b3/0c/jpr-10-567.PMC5349853.pdf
Keywords: Adherence; Diabetes; Exenatide BID; Exenatide QW; GLP-1RA; Liraglutide QD; MedicareEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 7D47F0604CA496AA .,Non-OADS,/arxiv_data1/oa_pdf/22/61/12325_2016_Article_470.PMC5350190.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/22/61/12325_2016_Article_470.PMC5350190.pdf
2011. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/22/61/12325_2016_Article_470.PMC5350190.pdf
"Atlanta, GA:U.S. Department of Health and Humana Services; 2014. http://www.cdc.gov/diabetes/pubs/statsreport 14/national-diabetes-report-web.pdf .4.",Non-OADS,/arxiv_data1/oa_pdf/22/61/12325_2016_Article_470.PMC5350190.pdf
https://www.cms.gov/Medicare/Quality- Initiatives-Patient-Assessment-Instruments/QualityMeasures/index.html .,Non-OADS,/arxiv_data1/oa_pdf/22/61/12325_2016_Article_470.PMC5350190.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any med- ium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b8/98/12325_2017_Article_480.PMC5350191.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/73/78/12325_2017_Article_479.PMC5350192.pdf
Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2967F0607DC592C4 .,Non-OADS,/arxiv_data1/oa_pdf/c5/50/12325_2017_Article_476.PMC5350193.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c5/50/12325_2017_Article_476.PMC5350193.pdf
ThisEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ F587F06006221056 .,Non-OADS,/arxiv_data1/oa_pdf/82/6d/12325_2017_Article_484.PMC5350194.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/82/6d/12325_2017_Article_484.PMC5350194.pdf
http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf .,Non-OADS,/arxiv_data1/oa_pdf/82/6d/12325_2017_Article_484.PMC5350194.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/82/6d/12325_2017_Article_484.PMC5350194.pdf
Given theEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ FE47F06046AED88D .,Non-OADS,/arxiv_data1/oa_pdf/90/df/12325_2016_Article_471.PMC5350196.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/90/df/12325_2016_Article_471.PMC5350196.pdf
http://www.euroqol.org/ about-eq-5d.html .,Non-OADS,/arxiv_data1/oa_pdf/90/df/12325_2016_Article_471.PMC5350196.pdf
British Heart Foundation: morbidity 2010. https://www.bhf.org.uk/research/heart-statistics .,Non-OADS,/arxiv_data1/oa_pdf/90/df/12325_2016_Article_471.PMC5350196.pdf
Heart health conditions: heart failure 2013. https://www.bhf.,Non-OADS,/arxiv_data1/oa_pdf/90/df/12325_2016_Article_471.PMC5350196.pdf
"Methods : A group of experts in functional digestive disorders was convened to review the efﬁcacy and safety of linaclotide and to develop an updated consensus report for the treatment of patients with IBS-C. A search was performed for English, French and Spanish languageEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 4057F0605F054AE7 .",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/12325_2016_Article_473.PMC5350198.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/12325_2016_Article_473.PMC5350198.pdf
http://www.allergan.com/ assets/pdf/linzess_pi .,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/12325_2016_Article_473.PMC5350198.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/12325_2016_Article_473.PMC5350198.pdf
https://www.accessdata.fda.Adv Ther (2017) 34:587–598 597,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/12325_2016_Article_473.PMC5350198.pdf
2(1S):556. https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4212306/pdf/10.1177_205064061454 8980.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/9f/12325_2016_Article_473.PMC5350198.pdf
Keywords: Atrial ﬁbrillation; Edoxaban; Non-vitamin K antagonist oral anticoagulants; Oral anticoagulants; Venous thromboembolism; Vitamin K antagonistsEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0987F0607ED0B3A4 .,Non-OADS,/arxiv_data1/oa_pdf/4d/2f/12325_2017_Article_488.PMC5350200.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/4d/2f/12325_2017_Article_488.PMC5350200.pdf
2016. https://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/4d/2f/12325_2017_Article_488.PMC5350200.pdf
http://circ.ahajournals.org/content/ 132/Suppl_3/A11748 .,Non-OADS,/arxiv_data1/oa_pdf/4d/2f/12325_2017_Article_488.PMC5350200.pdf
"Six months ago, after excruciating pain from scrubbing tile ﬂoors on hands and knees, X-rays and MRIs revealed that my knees had a bone spur, advanced arthritis, and tornEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8967F0602107005F .",Non-OADS,/arxiv_data1/oa_pdf/af/ed/12325_2017_Article_475.PMC5350202.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/af/ed/12325_2017_Article_475.PMC5350202.pdf
2012. https://www.hop kinsarthritis.org/patient-corner/disease-management/role-of-body-weight-in-osteoarthritis/ .,Non-OADS,/arxiv_data1/oa_pdf/af/ed/12325_2017_Article_475.PMC5350202.pdf
"Aside from the burden of a chronic wound, even simple wounds created after minor procedures such as outpatient surgeries requireEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ A287F06016A19FA2 .",Non-OADS,/arxiv_data1/oa_pdf/00/d9/12325_2017_Article_478.PMC5350204.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/00/d9/12325_2017_Article_478.PMC5350204.pdf
"Funding : AbbVie GK and Eisai Co., Ltd. Trial Registration : ClinicalTrials.gov identiﬁer, NCT01346488.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 3D77F0604E017A74 .",Non-OADS,/arxiv_data1/oa_pdf/0f/9a/12325_2017_Article_477.PMC5350205.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.Adv Ther (2017) 34:686–702 699",Non-OADS,/arxiv_data1/oa_pdf/0f/9a/12325_2017_Article_477.PMC5350205.pdf
2016. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/0f/9a/12325_2017_Article_477.PMC5350205.pdf
http://www.pmda.go.jp/ PmdaSearch/iyakuDetail/ResultDataSetPDF/112130_3999426G1024_2_10 .,OADS,/arxiv_data1/oa_pdf/0f/9a/12325_2017_Article_477.PMC5350205.pdf
"Over the 12-month follow-up, T&E-treated eyes received a higher mean [ ±standard deviation (SD)] number of injections (9.29 ±2.43) than PRN-treated eyes (6.04 ±2.19) ( p\0.0001).Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D587F06056571C3C .",Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproductionin any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
Global data on visual impairments 2010. http://www.who.int/blindness/GLOBALDATAFINALforweb.pdf .,OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
https://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
https://www.ebs.tga.gov.au/ ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00271-3&d=2016050916114622483 .,Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
http://newsroom.novartis.co.uk/UK/ novartis-announce-licence-change-for-leading-sight-loss-treatment-lucentis-ranibizumab/s/b60c8753-51 a4-4d9d-8aed-7c0c5bbfd972 .,Non-OADS,/arxiv_data1/oa_pdf/ae/73/12325_2017_Article_483.PMC5350206.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/2b/main.PMC5350495.pdf
Transvaginal  ultrasound http://dx.doi.org/10.1016/j.ijscr.2017.02.045 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5a/2b/main.PMC5350495.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/52/main.PMC5350496.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.044 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/e4/52/main.PMC5350496.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/3d/main.PMC5350497.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.02.046 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/46/3d/main.PMC5350497.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/00/main.PMC5350498.pdf
Laboratory  values  drawn  at  the  time  were  signiﬁcant  for  an http://dx.doi.org/10.1016/j.ijscr.2017.02.040 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/2b/00/main.PMC5350498.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2017.02.040 .",OADS,/arxiv_data1/oa_pdf/2b/00/main.PMC5350498.pdf
"(2016),  http://dx.doi.org/10.1016/j.ijsu.2016.08.014 .",OADS,/arxiv_data1/oa_pdf/2b/00/main.PMC5350498.pdf
"[4] J.-H. Chen,  Q.  Zhang,  Y.  Yu,  K.  Li,  H.  Liao,  L.  Jiang,  et  al.,  Neurogenic  and myogenic  properties  of  pan-Colonic  motor  patterns  and  their  spatiotemporal organization  in  rats,  PLoS  One  8  (4)  (2013)  e60474,  http://dx.doi.org/10.1371/ journal.pone.0060474 .",Non-OADS,/arxiv_data1/oa_pdf/2b/00/main.PMC5350498.pdf
"Giorgio,  G.  Sarnelli,  R.  Corinaldesi,  V.  Stanghellini,  Advances  in  our understanding of the  pathology  of  chronic  intestinal  pseudo-obstruction,  Gut 53  (2004)  1549–1552,  http://dx.doi.org/10.1136/gut.2004.043968 .",Non-OADS,/arxiv_data1/oa_pdf/2b/00/main.PMC5350498.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/bd/main.PMC5350499.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com/locate/ijpddr http://dx.doi.org/10.1016/j.ijpddr.2017.02.002 2211-3207/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/bd/main.PMC5350499.pdf
"3 657–674 https://doi.org/10.1083/jcb.201507113Introduction A hallmark of cell polarity in many migratory cell types is the  orientation of the centrosome to a position between the nucleus  and leading edge (Luxton and Gundersen, 2011; Gundersen and  Worman, 2013).",OADS,/arxiv_data1/oa_pdf/0b/d2/JCB_201507113.PMC5350507.pdf
"3 641–656 https://doi.org/10.1083/jcb.201604025Introduction The phosphoinositide 3-kinase (PI3K) pathway is among the  most frequently altered growth-control mechanisms in all  of cancer, and defects in phosphatase and tensin homologue  (PTEN) tumor-suppressor activity are very often the cause (Van- haesebroeck et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/22/82/JCB_201604025.PMC5350510.pdf
"3 709–721 https://doi.org/10.1083/jcb.201605002Introduction Peroxisomes are single membrane–bound organelles that partic- ipate in many metabolic pathways, including β oxidation of fatty  acids (Wanders and Waterham, 2006).",Non-OADS,/arxiv_data1/oa_pdf/41/cb/JCB_201605002.PMC5350511.pdf
3 675–693 https://doi.org/10.1083/jcb.201607019Introduction Mitochondria are complex organelles involved in ATP production  and in several crucial biosynthetic and catabolic pathways.,Non-OADS,/arxiv_data1/oa_pdf/c1/d5/JCB_201607019.PMC5350512.pdf
"3 623–639 https://doi.org/10.1083/jcb.201607031Introduction The proper repair of double-strand breaks (DSBs) that occur  during DNA replication is heavily dependent on error-free  homologous recombination (HR; Schwartz and Heyer, 2011;  Heyer, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8a/05/JCB_201607031.PMC5350513.pdf
"3 723–741 https://doi.org/10.1083/jcb.201607091Introduction Changes in global bioenergetics and metabolic state, particu- larly starvation or nutrient overload, place a high demand on  energy sources and protein quality-control mechanisms of the  cell and have profound effects on organismal health.",Non-OADS,/arxiv_data1/oa_pdf/66/ea/JCB_201607091.PMC5350514.pdf
"3 595–605 https://doi.org/10.1083/jcb.201607093Introduction The most common known monogenic cause of intellectual dis- ability and autism in humans is Fragile X syndrome (Kelleher  and Bear, 2008).",Non-OADS,/arxiv_data1/oa_pdf/39/80/JCB_201607093.PMC5350515.pdf
3 743–760 https://doi.org/10.1083/jcb.201607095Introduction The primary cilium is a tiny subcellular compartment com- prised of a microtubular axoneme enveloped by a membrane  contiguous with the plasma membrane.,Non-OADS,/arxiv_data1/oa_pdf/89/d3/JCB_201607095.PMC5350516.pdf
3 761–778 https://doi.org/10.1083/jcb.201608002Introduction Bone homeostasis depends on the functional balance of osteo- blasts (OBs) and osteoclasts (OCs).,Non-OADS,/arxiv_data1/oa_pdf/d4/1a/JCB_201608002.PMC5350517.pdf
3 835–847 https://doi.org/10.1083/jcb.201608024Introduction Kidney cancer is among the top 10 most common cancers in  the world.,Non-OADS,/arxiv_data1/oa_pdf/67/10/JCB_201608024.PMC5350518.pdf
3 607–621 https://doi.org/10.1083/jcb.201608083Introduction The ability of cells to properly segregate a complete set of chro- mosomes to each daughter cell during mitosis is dependent on  a unique chromatin domain known as the centromere.,Non-OADS,/arxiv_data1/oa_pdf/85/4c/JCB_201608083.PMC5350519.pdf
"3 559–570 https://doi.org/10.1083/jcb.201610048Introduction: Overview of branching  morphogenesis During embryonic development, simple bud-like organ pre- cursors undergo dramatic branching to generate the complex  branched architectures of many organs.",Non-OADS,/arxiv_data1/oa_pdf/bb/89/JCB_201610048.PMC5350520.pdf
"3 571–581 https://doi.org/10.1083/jcb.201610093Introduction Although proteins mediating cell–cell fusion in tissues have  been demonstrated in the placenta of mammals (Syncytins)  and in organs of invertebrates (e.g., Epithelial Fusion Failure 1  [EFF-1] in Caenorhabditis elegans), the machinery mediating  sperm–egg fusion remains unknown (Aguilar et al., 2013; Bi- anchi et al., 2014; Maruyama et al., 2016).",OADS,/arxiv_data1/oa_pdf/23/e1/JCB_201610093.PMC5350521.pdf
3 539–541 https://doi.org/10.1083/jcb.201612014It has been clear for some time that the tumor suppressor PTEN  shuttles in and out of the nucleus.,Non-OADS,/arxiv_data1/oa_pdf/e1/6c/JCB_201612014.PMC5350522.pdf
3 535–537 https://doi.org/10.1083/jcb.201701038Double strand breaks (DSBs) are the most deleterious type of  DNA damage because they can cause the loss or rearrangement  of genomic sequences.,Non-OADS,/arxiv_data1/oa_pdf/47/99/JCB_201701038.PMC5350523.pdf
"3 543–545 https://doi.org/10.1083/jcb.201701054Nuclear migration is central to several cellular and develop- mental processes including fertilization, muscle development,  neuronal development, and cellular polarization (Bone and  Starr, 2016).",OADS,/arxiv_data1/oa_pdf/bf/cf/JCB_201701054.PMC5350524.pdf
3 555–557 https://doi.org/10.1083/jcb.201701062Type-specific dendrite morphology is a hallmark of the neuron  and has important functional implications required for neuro- nal circuit formation.,Non-OADS,/arxiv_data1/oa_pdf/54/cc/JCB_201701062.PMC5350525.pdf
3 551–553 https://doi.org/10.1083/jcb.201701093The ability to respond and adapt to environmental and cellu- lar challenges is a key evolutionary driver for organisms across  all biological domains.,OADS,/arxiv_data1/oa_pdf/09/8c/JCB_201701093.PMC5350526.pdf
"3 547–549 https://doi.org/10.1083/jcb.201701187Thousands of proteins, hundreds of posttranslational modifica- tions, different dynamic membranes, and myriad environmental  cues orchestrate organelle biology.",OADS,/arxiv_data1/oa_pdf/ef/94/JCB_201701187.PMC5350527.pdf
"3 531–533 https://doi.org/10.1083/jcb.201702034Fragile X syndrome is the most common heritable cause of au- tism spectrum disorder (Estes and McAllister, 2015).",Non-OADS,/arxiv_data1/oa_pdf/d3/ec/JCB_201702034.PMC5350528.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/      © Th e Author(s) 2017       1   Epidemiology and Public Health, Institute of  Biomedical and Clinical Science, University of Exeter Medical School ,  Exeter ,  UK   .",Non-OADS,/arxiv_data1/oa_pdf/0f/a9/ajg2016584a.PMC5350542.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2017; 112:447–457; doi: 10.1038/ajg.2016.500; published online 6 December 2016          INTRODUCTION   Obesity is a major public health problem in the United States  and throughout most of the world due to its high prevalence and adverse eff  ects on health, quality of life, and health-care  costs ( 1 ).",Non-OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/      © Th e Author(s) 2017                                    2 .",Non-OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
2001.Accessible at:     http://www.acces sdata.fda.gov/cdrh_docs/pdf/P000008b.pdf  .,OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
Accessible at:     http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvis oryCommittee/Gastroenterology- UrologyDevicesPanel/UCM302775.pdf  .,Non-OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
Accessible at:     http://www.accessdata.fda.gov/cdrh_docs/pdf13/P130019b.pdf  .,Non-OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
Accessible at     http://www.accessdata.fda.gov/cdrh_docs/pdf14/P140012b.pdf  .,Non-OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
Accessible at     http://www.accessdata.fda.gov/cdrh_docs/pdf14/P140008b.pdf  .,Non-OADS,/arxiv_data1/oa_pdf/9d/99/ajg2016500a.PMC5350543.pdf
Published by Elsevier Inc. Thi s is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Aphasia StrokeWhite matterLanguageMRI 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
http://dx.doi.org/10.1016/j.nicl.2017.02.019 2213-1582/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
"This procedure consisted of thresholding probabilistic atlas labels (ICBM-DTI atlas –available at http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases (Oishi et al., 2008 )) for the left UF, IFOF, and ATR at a 20% tract probability threshold, and intersecting the thresholded labels.",OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
"To identify these regions, up to three SVR- LSM peaks located in/near the WM (de ﬁned as voxels having a WM tis- sue probability of at least 20% as determined by the WM TPM included in SPM12) were de ﬁned as ROIs using the default ROI creation (12 mm spherical ROIs masked to exclude non-signi ﬁcant voxels) and peak reporting (top 3 peaks with minimum distances of 30 mm) settings in the bspmview toolbox for SPM12 ( http://www.bobspunt.com/ bspmview/ ).",OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
"We further emphasize that like previous post-hoc tract analyses described in the In- troduction ( Mirman et al., 2015a; Turken and Dronkers, 2011 ), these analyses cannot be used to directly infer that damage to the identi ﬁed tracts predicts task performance, and are provided only to characterize the potentially affected tracts so as to assess whether they are consistent with what is expected based on our ap r i o r i analyses and to inform fu- ture hypothesis-driven studies.Deterministic ﬁber tracking utilized a publicly available group-aver- aged tractography atlas (WU-Minn HCP Consortium; HCP-842 atlas - http://dsi-studio.labsolver.org/download-images/hcp-842-template ) from 842 healthy individuals' diffusion MRI data from the Human Connectome Project (2015 Q4, 900 subject release).",Non-OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
http://dx.doi.org/10.1016/j.neuroimage.2015.09.025 .,OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
http://dx.doi.org/10.1007/s00429-015-1001-3 .,Non-OADS,/arxiv_data1/oa_pdf/1e/5b/main.PMC5350568.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2017.01.012,Non-OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
The sequence was annotated using Rapid Annotation using Subsys- tem Technology (RAST) pipeline [20–22](http://rast.nmpdr.,OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
"org/); PATRIC, the bacterial bioinformatics database and anal- ysis resource [23] (http://www.patricbrc.org ); and the National Center for Biotechnology Information Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP; http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
"Downstream analysis was performed using the CGE server ( http://www.cbs.dtu.dk/ services ), RAST and PATRIC.",OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,6 5–68 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,6 5–68 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,17,6 5–68 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/6a/85/main.PMC5350569.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.021 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://activelivingresearch.org/sites/default/ ﬁles/ALR_Brief_ SedentaryBehavior_Jan2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://www.pewinternet.,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://www.nikproject.org/About_Us.htm .,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://www.seattlechildrens.org/research/ child-health-behavior-and-development/saelens-lab/measures-and-protocols/ .,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://futureofchildren.org/futureofchildren/publications/docs/ 18_01_FullJournal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://www.census.gov/newsroom/ releases/pdf/paper_mega_commuters_us.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://www.walkscore.com/methodology.shtml .,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
https://www.census.gov/geo/ reference/gtc/gtc_bg.html .,OADS,/arxiv_data1/oa_pdf/4b/a9/main.PMC5350570.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.02.018 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
U.S. Smartphone Use in 2015. http://www.pewinternet.org/2015/04/01/ us-smartphone-use-in-2015/ Retrieved from.,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
http://www.pewinternet.org/2015/ 04/01/us-smartphone-use-in-2015/ .,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
11 (7):709 –715http://doi.org/10.5664/jcsm.,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
33 (1):19 –31.http://dx.doi.org/10.1007/s10935-012-0263-2 .,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
(Retrieved from https://www.sleep.med.harvard.edu/ ﬁle_ download/100/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
(Retrieved from http://www.pewglobal.org/2016/02/22/smartphone- ownership-and-internet-usage-continues-to-climb-in-emerging-economies/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
3:406. http://dx.doi.org/10.1007/s13142-013-0222-3 .,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
(Retrieved fromhttp://medicaleconomics.modernmedicine.com/medical-economics/news/ prescribing-mobile-apps-what-consider?page=full ).,Non-OADS,/arxiv_data1/oa_pdf/0d/1c/main.PMC5350571.pdf
Several speci ﬁc miRNAs have been shown to act as tumor suppressors or as oncogenes in http://dx.doi.org/10.1016/j.redox.2017.03.006 Received 3 February 2017; Received in revised form 6 March 2017; Accepted 6 March 2017⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1194/jlr.R036012 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
12 (2014) 661– 672. http://dx.doi.org/ 10.1038/nrmicro3344 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/ 10.1200/JCO.2009.22.1291 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
Epigenetics 4 (2012) 4.http://dx.doi.org/10.1186/1868-7083-4-4 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1038/ sj.bjc.6600574 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1245/s10434-011-2159-4 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1371/jour- nal.pone.0079162 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
Markers 17 (2016) 155– 163. http://dx.doi.org/ 10.3233/CBM-160626.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
Lung Cancer 19 (2016) 57 –63.http://dx.doi.org/10.3779/ j.issn.1009-3419.2016.02.01 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
15 (2014) 509– 524. http://dx.doi.org/10.1038/nrm3838 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1016/j.molonc.2012.09.006 .,OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
34 (2016) 505– 510. http://dx.doi.org/10.1002/cbf.3223 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1002/elps.200410402 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
CBP 140 (2005) 47 –52.http://dx.doi.org/ 10.1016/j.cca.2005.01.005.,OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
193 (2011) 409– 424. http://dx.doi.org/10.1083/jcb.201010100.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
"Bissada, A. Weinberg, J. Karn, F. Ye, Short chain fatty acids potently induce latent HIV-1 inT-cells by activating P-TEFb and multiple histone modi ﬁcations, Virology 474 (2015) 65 –81.http://dx.doi.org/10.1016/j.virol.2014.10.033 .",Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
269 (2014) 38 –43.http://dx.doi.org/10.1016/j.jneur- oim.2014.02.001 .,OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
5 (2006) 769– 784. http://dx.doi.org/ 10.1038/nrd2133 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
"Singh, Sodium butyrate induces DRP1-mediated mitochondrial fusion and apoptosis in human colorectal cancercells, Mitochondrion 16 (2014) 55 –64.http://dx.doi.org/10.1016/ Fig.",Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
18 (2011) 602– 618. http://dx.doi.org/10.1038/cdd.2010.117 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/ 10.1073/pnas.0801613105 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1038/cddis.2013.46 .,OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
"[32] L. Zhang, X. Wang, P. Chen, MiR-204 down regulates SIRT1 and reverts SIRT1- induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells, BMC Cancer 13 (2013) 290. http://dx.doi.org/10.1186/1471- 2407-13-290.",Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1038/sj.bjc.6605895 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1111/j.1742- 4658.2010.07594.x.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1016/j.ygyno.2010.08.034 .,OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1021/pr1011125 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
17 (2007) 708– 719. http://dx.doi.org/10.1101/gr.5540007 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1038/ sj.onc.1210616 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
"[39] Z. Wang, W. Chen, Emerging roles of SIRT1 in cancer drug resistance, GenesCancer 4 (2013) 82 –90.http://dx.doi.org/10.1177/1947601912473826.",Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/ 10.1371/journal.pone.0073875 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1126/science.1094637 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
12 (2013) 499– 508. http://dx.doi.org/10.1158/1535-7163.MCT-12-0700.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/ 10.3892/or.2015.3830.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1074/jbc.M114.615948 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1371/journal.pone.0038698.,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1371/ journal.pone.0149865 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/10.1038/ sj.onc.1209085 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
http://dx.doi.org/ 10.1158/1535-7163.MCT-07-0120 .,Non-OADS,/arxiv_data1/oa_pdf/34/6b/main.PMC5350572.pdf
"In the few regulatory systems where both peroxidation and persul ﬁdation have http://dx.doi.org/10.1016/j.redox.2017.02.021 Received 23 January 2017; Received in revised form 11 February 2017; Accepted 24 February 2017⁎Correspondence to: Indiana University School of Medicine -South Bend, Raclin Carmichael Hall, 1234 Notre Dame Avenue, South Bend, IN 46617, USA.",Non-OADS,/arxiv_data1/oa_pdf/0c/fc/main.PMC5350573.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0c/fc/main.PMC5350573.pdf
"Disclosures No con ﬂicts of interest, ﬁnancial or otherwise, are declared by the authors ( http://Www.Nature.Com/Nature ).",Non-OADS,/arxiv_data1/oa_pdf/0c/fc/main.PMC5350573.pdf
All the publication in this project is opened to the public through the project website ( https://biobankjp.org/work/public.html ).,Non-OADS,/arxiv_data1/oa_pdf/51/ec/main.PMC5350585.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ Journal of Epidemiology 27 (2017) S1 http://dx.doi.org/10.1016/j.je.2016.11.001 0917-5040/ ©2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/51/ec/main.PMC5350585.pdf
This is an open access article under the CC B Y-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/ec/main.PMC5350585.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
Peer review under the responsibility of The Japan Epidemiological Association Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.009 0917-5040/ ©2017 Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological Association.,Non-OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S58 eS64,Non-OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
National Health and Nutrition Survey in Japan ; 2014. http://www.e-stat.go.jp/SG1/estat/GL08020103.do?,Non-OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
National Vital Statistics in 2014. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei14/index.html .,OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
http://ganjoho.jp/reg_stat/statistics/qa_words/ cohort01.html .,OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
http://www.mhlw.go.jp/toukei/saikin/hw/seimei/list54-57-02.html .,OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
http://www.gunma-cc.jp/sarukihan/ seizonritu/seizonritu2007.html#10 .,Non-OADS,/arxiv_data1/oa_pdf/03/30/main.PMC5350586.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/30/d7/main.PMC5350587.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.013 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/d7/main.PMC5350587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Journal of Epidemiology 27 (2017) S92 eS97,Non-OADS,/arxiv_data1/oa_pdf/30/d7/main.PMC5350587.pdf
Data of Japanese Dia- betic Patients in 2013 ; 2015. http://jddm.jp/data/index-2013.html .,OADS,/arxiv_data1/oa_pdf/30/d7/main.PMC5350587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/aa/92/main.PMC5350588.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.10.0070917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/92/main.PMC5350588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S71 eS76,Non-OADS,/arxiv_data1/oa_pdf/aa/92/main.PMC5350588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.010 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S49 eS57,Non-OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
National Vital Statistics in 2014. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei14/index.htmlAccessed 25 July 2016 [in Japanese].,OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
http://ganjoho.jp/reg_stat/statistics/qa_words/ cohort01.html Accessed 25 July 2016 [in Japanese].,OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
http://www.mhlw.go.jp/toukei/saikin/hw/seimei/list54-57-02.html Accessed 25 July 2016 [in Japanese].,OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
National Health and Nutrition Survey in 2005. http://www.mhlw.go.jp/bunya/kenkou/eiyou07/01.html Accessed 25 July 2016 [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
http://www.gunma-cc.jp/sarukihan/seizonritu/ seizonritu2007.html#10 Accessed 25 July 2016 [in Japanese].K.,Non-OADS,/arxiv_data1/oa_pdf/12/3e/main.PMC5350589.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.005 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S2 eS8,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
Detailed informationabout the distribution of the samples is available at the project website ( https://biobankjp.org/index.html ; Japanese only).8 Baseline survey We collected baseline clinical information through interviews and reviews of medical records using a standardized questionnaire (Table 1 ); full details of the questionnaire are available at the project website ( https://biobankjp.org/sample/pdf/list7.1.4.pdf ; Japanese only).,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
https://biobankjp.org/ work/public.html .,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
https://biobankjp.org/ sample/pdf/panf_v2.0.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
https://www.nih.gov/precision-medicine-initiative-cohort-program .,Non-OADS,/arxiv_data1/oa_pdf/0a/a2/main.PMC5350590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2b/59/main.PMC5350591.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.014 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/59/main.PMC5350591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S77 eS83,Non-OADS,/arxiv_data1/oa_pdf/2b/59/main.PMC5350591.pdf
Accessed 9 December 2016 http://www.japaneselawtranslation.go.jp/law/ detail/?vm ¼04 &re¼01&id¼148.,Non-OADS,/arxiv_data1/oa_pdf/2b/59/main.PMC5350591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/36/main.PMC5350592.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.002 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/36/main.PMC5350592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S29 eS35,Non-OADS,/arxiv_data1/oa_pdf/9a/36/main.PMC5350592.pdf
Available from: http://www.mhlw.go.,Non-OADS,/arxiv_data1/oa_pdf/9a/36/main.PMC5350592.pdf
Available from: http://ganjoho.jp/reg_stat/statistics/qa_words/cohort01.,OADS,/arxiv_data1/oa_pdf/9a/36/main.PMC5350592.pdf
Available from: http://www.gunma-cc.jp/sarukihan/seizonritu/ seizonritu2007.html [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/9a/36/main.PMC5350592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.008 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S65 eS70,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
http://www.ganjoho.jp/reg_stat/ statistics/dl/index.html#mortality Accessed 29 July 16.,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
Available at: http://www.seer.cancer.gov/archive/ publications/survival/seer_survival_mono_lowres.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
https://www.biobankjp.org/ sample/pdf/list7.1.4.pdf Accessed 26 July 16.,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
Patient Surv ; 2005. http://www.mhlw.go.jp/toukei/saikin/hw/kanja/05/ .,OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
http://www.ganjoho.jp/reg_stat/statistics/qa_ words/cohort01.html Accessed 26 July 16.,OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
http://www.mhlw.go.jp/toukei/saikin/hw/seimei/list54-57-02.html Accessed 26 July 16.,OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
Available from: http://www.ncbi.nlm.nih.gov/ books/NBK1247/ .,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
http://www.gunma-cc.jp/sarukihan/ seizonritu/seizonritu2007.html#10 Accessed 26 July 16.,Non-OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
2016. http://dx.doi.org/10.1016/j.sxmr.2016.06.005 .S.,OADS,/arxiv_data1/oa_pdf/47/6d/main.PMC5350593.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.007 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S43 eS48,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
9.Shinryo Jyouhou Nyuryoku Sheet Ver.7.1.4 ; 2015. https://biobankjp.org/sample/ pdf/list7.1.4.pdf .,OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
"Patient Survey, 2005 ; 2005. http://www.mhlw.go.jp/toukei/saikin/hw/kanja/05/ .",OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
Cohort Life Table ; 2016. http://ganjoho.jp/reg_stat/statistics/qa_ words/cohort01.html .,OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
"The Japan Society of Hepatology, 2003 ; 2016. http://www.jsh.or.jp/medical/ guidelines/jsh_guidlines/examination_jp .",Non-OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
Avail- able at: http://idsc.nih.go.jp/disease/hepatitisC/2011week21.html .,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
Five- and Ten-year Relative Survival Rate in All Cases in 2004 e2007 ; 2007. http://www.gunma-cc.jp/ sarukihan/seizonritu/seizonritu2007.html#10 .,Non-OADS,/arxiv_data1/oa_pdf/e8/a8/main.PMC5350594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/21/main.PMC5350595.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.011 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/21/main.PMC5350595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S84 eS91,Non-OADS,/arxiv_data1/oa_pdf/04/21/main.PMC5350595.pdf
Accessed 10 December 2016 http://www.japaneselawtranslation.go.jp/law/ detail/?vm ¼04&re¼01&id¼148.,Non-OADS,/arxiv_data1/oa_pdf/04/21/main.PMC5350595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.004 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S36 eS42,Non-OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
Available from: http://ganjoho.jp/reg_ stat/statistics/stat/summary.html [in Japanese].,OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
Accessed 25 July 2016 http://ganjoho.jp/reg_ stat/statistics/qa_words/cohort01.html [in Japanese].,OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
Accessed 25 July 2016 http://www.mhlw.go.jp/toukei/saikin/hw/seimei/list54- 57-02.html [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
Accessed 8 September 2016 http://www.mhlw.go.jp/bunya/ kenkou/eiyou07/01.html [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
Five-year relative survival rate in all cases in 2004-2007. http://www.gunma-cc.jp/sarukihan/seizonritu/ seizonritu2007.html#10 Accessed 25 July 2016 [in Japanese].,Non-OADS,/arxiv_data1/oa_pdf/22/27/main.PMC5350596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/de/main.PMC5350597.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.12.012 0917-5040/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/de/main.PMC5350597.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) S98 eS106,Non-OADS,/arxiv_data1/oa_pdf/58/de/main.PMC5350597.pdf
Statistics Act ; 2007. http://www.japaneselawtranslation.go.jp/law/detail/?,Non-OADS,/arxiv_data1/oa_pdf/58/de/main.PMC5350597.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC5350616.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.10.004 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC5350616.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 107 e111,Non-OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC5350616.pdf
[cited 2015 Jul 16] Available from: http://www.soumu.go.jp/johotsusintokei/tsusin_riyou/data/ eng_tsusin_riyou02.pdf .,OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC5350616.pdf
[cited 2015 Jul 16] Available from: http://www.soumu.go.jp/johotsusintokei/tsusin_riyou/data/ .,OADS,/arxiv_data1/oa_pdf/a0/c2/main.PMC5350616.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/28/main.PMC5350617.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.10.006 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/28/main.PMC5350617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 130 e134,Non-OADS,/arxiv_data1/oa_pdf/eb/28/main.PMC5350617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/db/main.PMC5350618.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.04.001 0917-5040/ ©2016 Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological Association.,Non-OADS,/arxiv_data1/oa_pdf/98/db/main.PMC5350618.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 123 e129,Non-OADS,/arxiv_data1/oa_pdf/98/db/main.PMC5350618.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ Journal of Epidemiology 27 (2017) 87 e88 http://dx.doi.org/10.1016/j.je.2017.01.001 0917-5040/ ©2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
This is an open access article under the CC B Y-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
https://scholarlyoa.com/publishers/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
Archived versions are listed here http://retractionwatch.com/2017/01/17/ bealls-list-potential-predatory-publishers-go-dark/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
Anderson R. https://scholarlykitchen.sspnet.org/2015/05/11/should-we-retire- the-term-predatory-publishing/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
"Berger M, Cirasella J. http://blogs.lse.ac.uk/impactofsocialsciences/2015/03/18/ beyond-bealls-list-predatory-publishers/ .",Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
http://publicationethics.org/ ﬁles/Principles_of_Transparency_ and_Best_Practice_in_Scholarly_Publishingv2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
http://thinkchecksubmit.org/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/94/main.PMC5350619.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/08/main.PMC5350620.pdf
Contents lists available at ScienceDirect Journal of Epidemiology journal homepage: http://www.journals.elsevier.c om/journal-of-epidemiology/ http://dx.doi.org/10.1016/j.je.2016.04.002 0917-5040/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/28/08/main.PMC5350620.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Epidemiology 27 (2017) 117 e122,Non-OADS,/arxiv_data1/oa_pdf/28/08/main.PMC5350620.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/86/94/CTS-9-267.PMC5350992.pdf
<http://www.accessdata.fda.,Non-OADS,/arxiv_data1/oa_pdf/b4/c0/CTS-9-260.PMC5350995.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/b4/c0/CTS-9-260.PMC5350995.pdf
Available from: http://www.fda.gov/forconsumers/consumerupdates/ucm350570.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/a7/CTS-9-246.PMC5350996.pdf
Available from: http://www.fda.gov/Food/IngredientsPackagingLabeling/ GRAS/ucm083022.htm.,Non-OADS,/arxiv_data1/oa_pdf/58/a7/CTS-9-246.PMC5350996.pdf
Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDeve lopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics /UCM154838.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/a7/CTS-9-246.PMC5350996.pdf
Available from: https://cran.r-project.org/bin/windows/base/old/3.1.2/ 15.,Non-OADS,/arxiv_data1/oa_pdf/58/a7/CTS-9-246.PMC5350996.pdf
Available from: http://www.fda.gov/downloads/Drugs/.../Guidances/ ucm070244.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/a7/CTS-9-246.PMC5350996.pdf
"SYLLABUS: Drug Development in a New Era: NYU GSAS, MSCI Program, Sackler, SOM 2014. https://www.med.nyu.edu/ research/sites/default/ﬁles/research2/DrugDevelopmentInANewEra2014%5B1%5D.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f1/ce/CTS-9-274.PMC5350998.pdf
https://www.med.nyu.edu/postdoc/sites/ www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/f1/ce/CTS-9-274.PMC5350998.pdf
http://www.fda.gov/AboutFDA/CentersOfﬁces/ OfﬁceofMedicalProductsandTobacco/CDER/.,Non-OADS,/arxiv_data1/oa_pdf/f1/ce/CTS-9-274.PMC5350998.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/f1/ce/CTS-9-274.PMC5350998.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/e4/59/CTS-9-321.PMC5351000.pdf
http://www.acceleronpharma.com/wp-content/uploads/ 2011/09/October-13-2010-Acceleron-Press-Release.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/2a/CTS-9-302.PMC5351001.pdf
http://quest.mda.org/ news/update-ace-031-clinical-trials-duchenne-md.,Non-OADS,/arxiv_data1/oa_pdf/54/2a/CTS-9-302.PMC5351001.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/54/2a/CTS-9-302.PMC5351001.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/97/26/CTS-9-337.PMC5351003.pdf
"Given the lim- ited number of genes identified, pathway analysis using DAVID (https://david.ncifcrf.gov/home.jsp) was uninforma- tive.",OADS,/arxiv_data1/oa_pdf/c9/53/CTS-9-293.PMC5351005.pdf
The Cancer Genome Atlas (TCGA: https://tcga-data.nci.,Non-OADS,/arxiv_data1/oa_pdf/c9/53/CTS-9-293.PMC5351005.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/c9/53/CTS-9-293.PMC5351005.pdf
Study 747-103 ClinicalTrials.gov Identiﬁer: NCT01904539 https://clinicaltrials.gov/ct2/show/NCT01904539 Study 757-105 Clini- calTrials.gov Identiﬁer: NCT01933503 https://clinicaltrials.gov/ct2/show/ NCT01933503 Study 747-204 EudraCT Number: 2010-023241- 29 https://www.clinicaltrialsregister.eu/ctr-search/trial/2010-023241- 29/GB Author Contributions.,Non-OADS,/arxiv_data1/oa_pdf/5f/09/CTS-9-328.PMC5351006.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/5f/09/CTS-9-328.PMC5351006.pdf
http://www.cancer.org/cancer/ esophaguscancer/detailedguide/esophagus-cancer-key-statistics.,Non-OADS,/arxiv_data1/oa_pdf/01/93/CTS-10-35.PMC5351007.pdf
https://clinicaltrials.gov/ct2/show/NCT01748838.,Non-OADS,/arxiv_data1/oa_pdf/1e/c4/CTS-10-20.PMC5351008.pdf
https://clinicaltrials.gov/ct2/show/NCT01944735 27.,Non-OADS,/arxiv_data1/oa_pdf/1e/c4/CTS-10-20.PMC5351008.pdf
https://clinicaltrials.gov/ct2/show/NCT02233244 28.,Non-OADS,/arxiv_data1/oa_pdf/1e/c4/CTS-10-20.PMC5351008.pdf
https://clinicaltrials.gov/ct2/show/NCT02443688.,Non-OADS,/arxiv_data1/oa_pdf/1e/c4/CTS-10-20.PMC5351008.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/1e/c4/CTS-10-20.PMC5351008.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/b8/0a/CTS-10-42.PMC5351010.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/05/44/CTS-10-03.PMC5351011.pdf
https://clinicaltrials.gov/ct2/show/NCT01944735 .,Non-OADS,/arxiv_data1/oa_pdf/fb/7d/CTS-10-28.PMC5351012.pdf
<https://clinicaltrials.gov/show/NCT02443688 >.,Non-OADS,/arxiv_data1/oa_pdf/fb/7d/CTS-10-28.PMC5351012.pdf
"Medscape, Jun 2011. http://emedicine.medscape.com/ article/847428-overview.",Non-OADS,/arxiv_data1/oa_pdf/9c/50/ol-13-02-0629.PMC5351039.pdf
"The following online miRNA target  prediction algorithms were used to evaluate the potential  target genes of miR -93-5p: PicTar ( http: //www.pictar.org /),  TargetScan ( http://www.targetscan.org /vert_71 /) and miRanda  (http://www.microrna.org /microrna /home.do ).",OADS,/arxiv_data1/oa_pdf/e8/41/ol-13-02-0722.PMC5351191.pdf
"We predicted the  interactions between target genes and miRNAs based on the  TarBase ( http://microrna.gr /tarbase ) (20), TargetScan ( www.",OADS,/arxiv_data1/oa_pdf/75/8e/ol-13-02-0777.PMC5351205.pdf
"Studies to  be considered for inclusion were identified by searching  through multiple databases, including Cochrane  Library ( http://www.cochranelibrary.com ), Embase  (https://www.embase.com ), LILACS ( http://lilacs.bvsalud.org ),  MEDLINE ( http://ovidsp.txovid.ez54.periodicos.capes.gov.br/sp )  and PubMed ( https://www.ncbi.nlm.nih.gov/pubmed/ ).",OADS,/arxiv_data1/oa_pdf/7b/db/ol-13-02-0554.PMC5351305.pdf
The transmembrane structure of Ag5 protein was predicted  by TMHMM Server v. 2.0 (http://www.cbs.dtu.dk/services/ TMHMM/) (22).,OADS,/arxiv_data1/oa_pdf/4e/85/br-06-02-0181.PMC5351307.pdf
The B cell  epitopes of the Ag5 protein were predicted using the online  prediction software Immune Epitope Database (IEDB;  http://tools.immuneepitope.org /bcell /) (25).,OADS,/arxiv_data1/oa_pdf/4e/85/br-06-02-0181.PMC5351307.pdf
"FDA News Release http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm465444.htm (October 2, 2015).",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/CTS-9-089.PMC5351311.pdf
"January 2015. http://www.goldcopd.org/uploads/users/ﬁles/GOLD_Report_2015_Feb18.pdf (accessed September 15, 2015).",OADS,/arxiv_data1/oa_pdf/a4/17/CTS-9-105.PMC5351312.pdf
August 2012. http://docs.boehringer- ingelheim.com/Prescribing%20Information/PIs/Atrovent%20HFA/10003001_US_1.pdf?,Non-OADS,/arxiv_data1/oa_pdf/a4/17/CTS-9-105.PMC5351312.pdf
April 2015. http://www.ginasthma.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/CTS-9-105.PMC5351312.pdf
"24 August 2006. http://trials.boehringer- ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/215/215.1364_U 06-1771_DR.pdf (accessed September 15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/a4/17/CTS-9-105.PMC5351312.pdf
"http://ozone.unep.org/en /handbook-montreal-protocol-substances-deplete-ozone-layer (accessed September 15, 2015).",OADS,/arxiv_data1/oa_pdf/a4/17/CTS-9-105.PMC5351312.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/a4/17/CTS-9-105.PMC5351312.pdf
<http://www.cancerresearchuk.org/about-cancer/cancers-in-general/cancer- questions/how-long-does-it-take-for-a-new-drug-to-go-through-clinical-trials > (accessed 9 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/f9/c4/CTS-9-063.PMC5351315.pdf
<http://www.roche.com/media/ store/releases/med-cor-2014-07-04.htm >(accessed 25 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/f9/c4/CTS-9-063.PMC5351315.pdf
<http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.,Non-OADS,/arxiv_data1/oa_pdf/f9/c4/CTS-9-063.PMC5351315.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/f9/c4/CTS-9-063.PMC5351315.pdf
https://www.gilotrif.com/content/dam/internet/pm/gilotrif4/com_EN/ documents/Gilotrif.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/f2/dd/CTS-9-09.PMC5351319.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/201292Orig1s000StatR.pdf (2013).,OADS,/arxiv_data1/oa_pdf/f2/dd/CTS-9-09.PMC5351319.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/ nda/2013/201292Orig1s000ClinPharmR.pdf (2013).,OADS,/arxiv_data1/oa_pdf/f2/dd/CTS-9-09.PMC5351319.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021366s016lbl.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/f2/dd/CTS-9-09.PMC5351319.pdf
http://www.accessdata.fda.gov//drugsatfda_docs/ nda/2011/202570Orig1s000ClinPharmR.pdf (2011).,OADS,/arxiv_data1/oa_pdf/f2/dd/CTS-9-09.PMC5351319.pdf
"ASCPT History, ASCPT Website: http://www.ascpt.org/About-ASCPT/ASCPT-History.",Non-OADS,/arxiv_data1/oa_pdf/0c/bc/CTS-9-06.PMC5351324.pdf
"ASCPT Strategic Plan: Transforming Translation, 2015. http://www.ascpt.org/Portals/8/docs/About%20ASCPT/ ASCPT_5-Year_Plan-WEB_FINAL.pdf.",Non-OADS,/arxiv_data1/oa_pdf/0c/bc/CTS-9-06.PMC5351324.pdf
http://www.mdguidelines.com/ paralysis-paraplegia-and-quadriplegia.,Non-OADS,/arxiv_data1/oa_pdf/03/7a/CTS-9-168.PMC5351327.pdf
http://www.parliament.uk/documents /lords-committees/science-technology/RegenerativeMedicine/RegenMed.pdf.,Non-OADS,/arxiv_data1/oa_pdf/03/7a/CTS-9-168.PMC5351327.pdf
https://clinicaltrials.gov/ct2/show/NCT01072370?term = stem+cells+and+cerebral +palsy&rank =5&submit_ﬂd_opt =.,Non-OADS,/arxiv_data1/oa_pdf/03/7a/CTS-9-168.PMC5351327.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/03/7a/CTS-9-168.PMC5351327.pdf
http://www.fda.gov/downloads/drugs/guida ncecomplianceregulatoryinformation/guidances/ucm072123.pdf (2003).,Non-OADS,/arxiv_data1/oa_pdf/3d/12/CTS-9-139.PMC5351328.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/3d/12/CTS-9-139.PMC5351328.pdf
New molecular entity approvals for 2015. http:// www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm430302.htm 3. http://www.ﬁercebiotech.com/press-releases/astrazeneca-acquire-ardea-biosciences- 126-billion-including-lead-product-le 4. http://investors.amgen.com/phoenix.zhtml?c =61656&p =irol-newsArticle&ID =1653062 5. http://www.gilead.com/news/press-releases/2011/2/gilead-sciences-to-acquire- calistoga-pharmaceuticals-for-375-million 6.,Non-OADS,/arxiv_data1/oa_pdf/49/6a/CTS-9-125.PMC5351330.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/cf/72/CTS-9-128.PMC5351331.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/05/a5/CTS-9-183.PMC5351336.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) www.wileyonlinelibrary/cts,Non-OADS,/arxiv_data1/oa_pdf/45/87/CTS-9-207.PMC5351338.pdf
Available at http://aidsinfo.nih.gov/contentﬁles/lvguidelines /adultandadolescentgl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/4f/CTS-9-192.PMC5351339.pdf
Available at http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM355128.,Non-OADS,/arxiv_data1/oa_pdf/48/4f/CTS-9-192.PMC5351339.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label /2011/020972s038lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/4f/CTS-9-192.PMC5351339.pdf
(http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062) Clinical and T ranslational Science,Non-OADS,/arxiv_data1/oa_pdf/48/4f/CTS-9-192.PMC5351339.pdf
"For the primary purpose of this study, lack of significant interaction with AJ was to be concluded when at least one volume was associated with the lower bound of 90%CIofGMRforAUC AJ/AUCwaterbeingabove0.5.Allsta- tisticalanalyseswereperformedbythestatisticalsoftwareR (https://www.r-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/d0/36/CTS-9-201.PMC5351340.pdf
"Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/ 2003/20872se8-003,20625se8-010_allegra_lbl.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/d0/36/CTS-9-201.PMC5351340.pdf
Available from: http://www.goldcopd.org.,OADS,/arxiv_data1/oa_pdf/58/76/LI-34-117.PMC5351350.pdf
Available from: http://www.ipaqt.org.,Non-OADS,/arxiv_data1/oa_pdf/20/c6/LI-34-120.PMC5351351.pdf
Available from: https://www.osha.gov/SLTC/ cottondust.,Non-OADS,/arxiv_data1/oa_pdf/70/b1/LI-34-144.PMC5351356.pdf
Available from:  https://www.law.cornell.edu/cfr/text/29/1910.1043.,Non-OADS,/arxiv_data1/oa_pdf/70/b1/LI-34-144.PMC5351356.pdf
Available from:  http://www.uptodate.com.,Non-OADS,/arxiv_data1/oa_pdf/17/2d/LI-34-189.PMC5351367.pdf
The CHODL  and GAPDH sequences were obtained from PubMed GenB ank  (https://www.ncbi.nlm.nih.gov/nuccore/BC009418.1 and  https://www.ncbi.nlm.nih.gov/nuccore/NM_00204 6).,OADS,/arxiv_data1/oa_pdf/70/dd/ol-13-02-0715.PMC5351393.pdf
Statistical analyses were  performed with Student's t-test using SigmaPlot 10.0 soft - ware (http://www.126xiazai.com/fileview_1619971.html) .,OADS,/arxiv_data1/oa_pdf/b4/d6/ol-13-02-0599.PMC5351397.pdf
Target  sequences were obtained from the NCBI GenBank database  (https://www.ncbi.nlm.nih.gov/genbank/ ).,OADS,/arxiv_data1/oa_pdf/ae/4e/ol-13-02-0661.PMC5351400.pdf
"For example, the Clinical Pharmacogenetics Implementa- tion Consortium (CPIC) has published 17 guidelines that describe the interactions between 14 genes and 36 drugs.3 The guidelines for the selective serotonin reuptake inhibitor(SSRI) class of antidepressants provide recommendations based only on a patient’s cytochrome P-450 genotype, butthe recommendation also states “drug interactions and other clinical factors can have a major influence for prescribing decisions for SSRIs and should be taken into considerationbefore initiating drug therapy” (http://cpicpgx.org/g/25974703).",Non-OADS,/arxiv_data1/oa_pdf/27/9b/PSP4-6-153.PMC5351408.pdf
An encouraging example is the collaboration between the Observational Healthcare Data and Informatics (OHDSI) program (www.ohdsi.org) and the Electronic MedicalRecords and Genomics (eMERGE) Network (https://emerge.mc.vanderbilt.edu/).,Non-OADS,/arxiv_data1/oa_pdf/27/9b/PSP4-6-153.PMC5351408.pdf
"Researchers used a common data model and the OHDSI clinical cohort discovery tool to represent patient phenotype definitions from the PhenotypeKnowledgeBase (https://phekb.org/), which have been used for a variety of genomic medicine studies using EHR data including genome-wide association studies.",OADS,/arxiv_data1/oa_pdf/27/9b/PSP4-6-153.PMC5351408.pdf
"Infobuttons, which provide information on-demand,are an example of noninterruptive CDS that is being testedby eMERGE and ClinGen (https://www.clinicalgenome.org/)for PGx.",Non-OADS,/arxiv_data1/oa_pdf/27/9b/PSP4-6-153.PMC5351408.pdf
<https://healthit.ahrq.gov/ahrq- funded-projects/clinical-decision-support-initiative/chapter-1-approaching-clinical-deci-sion/section-2-overview-cds-five-rights >.,Non-OADS,/arxiv_data1/oa_pdf/27/9b/PSP4-6-153.PMC5351408.pdf
We retrieved the FDA-approved cancer drugs from the FDA online label repository (http://labels.fda.gov/).,OADS,/arxiv_data1/oa_pdf/13/42/PSP4-6-188.PMC5351410.pdf
We also generated structure information using third-party tools such as NCI/CADD online tool (http://cactus.nci.nih.gov/gifcreator/) or SWISS-MODEL (http://swissmodel.expasy.org/).,OADS,/arxiv_data1/oa_pdf/13/42/PSP4-6-188.PMC5351410.pdf
Data visualization A website was developed (http://www.drugkb.org) to display all the integrated information collected from different knowl- edge bases summarized in Table 1.,OADS,/arxiv_data1/oa_pdf/13/42/PSP4-6-188.PMC5351410.pdf
"To dis-play results in the “literature” subpage, we search PubMedTable 1 Data sources used in the CATTLE (CAncer Treatment Treasury with Linked Evidence) database Resource Link Contribution # of Records FDA drug label http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/Description, Indication 6,825 drugs NCIT http://ncit.nci.nih.gov/ Description, Synonyms, External IDs121,794 Records PubChem https://pubchem.ncbi.nlm.nih.gov/ Structure, Synonyms, External IDs, Bioassay1.1 million bioassays, 90 million compounds, 220 million substance ChEMBL https://www.ebi.ac.uk/chembl/ Structure, External IDs 1,3 million ChemicalsTTD http://bidd.nus.edu.sg/group/TTD/ttd.asp Structure, External IDs, Indication, Drug Targets2,025 Targets, 17,816 Drugs MeSH http://www.ncbi.nlm.nih.gov/mesh Synonyms, External IDs 822,268 Concepts DrugBank http://www.drugbank.ca/ External IDs, Indication, Drug interaction8,246 Drugs, 4,170 Targets, 15,438 Drug-Target associations KEGG http://www.genome.jp/kegg/ Pathway, Indication, Drug interaction, Drug Targets10 thousand Drugs, 20 million Genes, 501 Pathways ChEBI https://www.ebi.ac.uk/chebi/ Synonyms, External IDs 50 thousand CompoundsRxNorm http://www.nlm.nih.gov/research/umls/rxnorm/ Synonyms, External IDs 630 thousand RecordsUMLS http://www.nlm.nih.gov/research/umls/ Synonyms, External IDs 7.4 million ConceptATC http://www.whocc.no/atc_ddd_index/ External IDs, drug class 6,601 DrugsMATADOR http://matador.embl.de/ Drug targets 15 thousand Drug-Target AssociationSIDER http://sideeffects.embl.de/ Side effects 5,868 Side Effects of 1,430 Drugs with 139 thousand Associations.",Non-OADS,/arxiv_data1/oa_pdf/13/42/PSP4-6-188.PMC5351410.pdf
"FAERS http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/Pharmacovigilance 4,070,067 Reports PharmGKB https://www.pharmgkb.org/ Pharmacogenetic variation/genes 24,784,816 Records CCLE http://www.broadinstitute.org/ccle/home Pharmacogenetic variation/genes 23,390 RecordsGDSC http://www.cancerrxgene.org/ Drug sensitivity/resistance genes Total number of IC50 values 224,510cMAP https://www.broadinstitute.org/cmap/ Drug-induced gene expression 1.5M gene expression profiles from /C245,000 small-molecule compounds, and/C243,000 genetic reagents PubMed http://www.ncbi.nlm.nih.gov/pubmed Literature 24.6 million ClinicalTrials.gov https://clinicaltrials.gov/ Clinical trials, Indications 231,860 TrialsUSPTO http://www.uspto.gov/ Patents 326,032 Patents FDA, Food and Drug Administration; NCIT, National Cancer Institute Thesaurus; ChEMBL, Chemical Database of Bioactive Molecules by European Bioinf or- matics Institute-European Molecular Biology Laboratory; TTD, Theurapeutic Target Database; MeSH, Medical Subject Headings; KEGG, Kyoto Encyclo pedia of Genes and Genomes; ChEBI, Chemical Entities of Biological Interest; RxNorm, Normalized naming system for generic and branded drugs; UMLS, UnifiedMedical Language System; ATC, Anatomical Therapeutic Chemical Classification System; MATADOR, Manually Annotated Targets and Drugs Online Resource; SIDER, Side Effect Resource; CCLE, Cancer Cell Line Encyclopedia; GDCS, Genomics of Drug Sensitivity in Cancer; cMAP , Connectivity Map O2 ; USPTO, United States Patent and Trademark Office.CATTLE an Integrated Knowledge Base for Personalized Oncology Research and Practice Soysal et al.",Non-OADS,/arxiv_data1/oa_pdf/13/42/PSP4-6-188.PMC5351410.pdf
<https://pct.mdanderson.org >.,Non-OADS,/arxiv_data1/oa_pdf/13/42/PSP4-6-188.PMC5351410.pdf
<http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/e0/86/PSP4-6-197.PMC5351411.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://psp-journal.com)Aztreonam-Avibactam Pharmacodynamic Model Syet al .,OADS,/arxiv_data1/oa_pdf/e0/86/PSP4-6-197.PMC5351411.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://psp-journal.com)Mathematical Modeling of the Effects of CK2.3 Lisberg et al .,OADS,/arxiv_data1/oa_pdf/f8/77/PSP4-6-208.PMC5351412.pdf
"Pathway Commons 7is a comprehen- sive public pathway database (http://www.pathwaycommons.org/), integrating Human IntAct,8BioGrid,9human protein reference database,10Kyoto Encyclopedia of Genes and Genomes,11and 10 more famous PPI datasets.",OADS,/arxiv_data1/oa_pdf/4c/84/PSP4-6-168.PMC5351413.pdf
"Pathway Commons 2 (version 7) 10(http://www.pathwaycommons.org) is a well-known col- lection of biological pathways and PPI network knowledge.Pathway Commons consists of 31,698 pathways, 1,912,848 edges (PPI), and 14,863 nodes (genes), which were used for this analysis.",OADS,/arxiv_data1/oa_pdf/4c/84/PSP4-6-168.PMC5351413.pdf
Drug-targeted genes were annotated byDrugBank database version 4.0 32(http://www.drugbank.ca/ drugs).,OADS,/arxiv_data1/oa_pdf/4c/84/PSP4-6-168.PMC5351413.pdf
The original pro- gram is accessible to: https://drive.google.com/open?id 50B9- cfjp2iWgONjU4a3hwQ2RKcW8.,Non-OADS,/arxiv_data1/oa_pdf/4c/84/PSP4-6-168.PMC5351413.pdf
Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website (http://psp-journal.com)IODNE: An Integrated Optimization Method Mounika Inavolu et al .,OADS,/arxiv_data1/oa_pdf/4c/84/PSP4-6-168.PMC5351413.pdf
Source code is publicly hosted at http://github.com/bioasp/caspo.,OADS,/arxiv_data1/oa_pdf/4e/1b/btw738.PMC5351548.pdf
"947 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/1b/btw738.PMC5351548.pdf
"Next, we provide abrief description of the CLI and refer the reader to the online docu-mentation for an in-depth description of installation and usage (http://caspo.readthedocs.io).",Non-OADS,/arxiv_data1/oa_pdf/4e/1b/btw738.PMC5351548.pdf
Availability and Implementation: the source code is freely available at http://last.cbrc.jp/ Contact: mhamada@waseda.jp or mcfrith@edu.k.u-tokyo.ac.jp Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/0a/91/btw742.PMC5351549.pdf
"926 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/91/btw742.PMC5351549.pdf
"Furthermore, when the coverage of the read set is at least 75 /C2, the throughput of the new method is at least 20% higher.Availability and Implementation: LoRMA is freely available at http://www.cs.helsinki.ﬁ/u/lmsalmel/ LoRMA/.",OADS,/arxiv_data1/oa_pdf/fb/1b/btw321.PMC5351550.pdf
"799 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/1b/btw321.PMC5351550.pdf
SKUJA  et al:  CHROMOTHRIPSIS AND PFS IN METASTATIC COLORECTAL CANCER 185 using the DNA copy package ( http://bioconductor.org/pack - ages/release/bioc/html/DNAcopy.html ).,OADS,/arxiv_data1/oa_pdf/26/cb/mco-06-02-0182.PMC5351707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
"2, e1276687 (3 pages)http://dx.doi.org/10.1080/15592324.2016.1276687",Non-OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant Cell Environ2017; 40:150-64; PMID: 27676158; http://dx.doi.org/10.1111/ pce.12837 2.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
"Hu R, Zhu Y, Shen G, Zhang H. TAP46 plays a positive role in the abscisic acid insensitive5-regulated gene expression in Arabidopsis.Plant Physiol 2014; 164:721-34; PMID:24357600; http://dx.doi.org/ 10.1104/pp.113.233684 3.",OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant J 2004; 38:563-77; PMID:15125764; http://dx.doi.org/10.1111/j.1365- 313X.2004.02073.x 5.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant Cell 2002; 14:833-45; PMID:11971138;http://dx.doi.org/10.1105/tpc.010402 6.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant Cell 2004; 16:709-22; PMID:14973165; http://dx.doi.org/10.1105/tpc.018994 7.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant Phys- iol 2014; 166:1519-34; PMID:25281708; http://dx.doi.org/10.1104/ pp.114.250563 8.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Biochem J 2001; 353:417-39; PMID:11171037; http://dx.doi.org/ 10.1042/bj3530417 9.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Trend Plant Sci 2007; 12:169-76; PMID:23790269; http://dx.doi.org/10.1016/j.tplants.2007.03.003 10.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant J 2007; 51:763- 78; PMID:17617176; http://dx.doi.org/10.1111/j.1365-313X.2007.03179.x 11.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Ann Rev Plant Physiol Plant Mol Biol 2002; 53:247-73; PMID:12221975;http://dx.doi.org/10.1146/annurev.arplant.53.091401.143329 12.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
Plant J 2010; 64:563-76; PMID:20822503; http://dx.doi.org/10.1111/ j.1365-313X.2010.04352.x 13.,OADS,/arxiv_data1/oa_pdf/a2/f0/kpsb-12-02-1276687.PMC5351730.pdf
"2, 124 –126 http://dx.doi.org/10.1080/19336918.2016.1225632",Non-OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Trends Pharmacol Sci 2016; 37(7):606-17; PMID:27157716; http://dx.doi.org/10.1016/j.tips.2016.04.006 [2] Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Br €u g g e rB ,S i m o n sM .C e r a m i d et r i g - gers budding of exosome vesicles into multivesicular endo-somes.",OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
Science 2008; 319(5867):1244-7; PMID:18309083; http://dx.doi.org/10.1126/science.1153124 [3] Hurley JH.,OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"EMBO J 2015; 34 (19):2398-407; PMID: 26311197; http://dx.doi.org/ 10.15252/embj.201592484 [ 4 ]F r i a n dV ,D a v i dG ,Z i m m e r m a n nP .S y n t e n i na n d syndecan in the biogenesis of exosomes.",OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
Biol Cell2015; 107(10):331-41; PMID:26032692; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Cell Res 2015; 25(5):531-2; PMID:25828531; http://dx.doi.org/10.1038/cr.2015.39 [6] Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, et al.",OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Nat Cell Biol 2012; 14(7):677-85; PMID:22660413; http://dx.doi.org/10.1038/ncb2502 [7] Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, Slav /C19ık J, Machala M, Zimmermann P. Synte- nin-ALIX exosome biogenesis and budding into multive- sicular bodies are controlled by ARF6 and PLD2.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Nat Commun 2014; 5:3477; PMID:24637612; http://dx.doi.org/10.1038/ncomms4477 [8] Roucourt B, Meeussen S, Bao J, Zimmermann P, David G. Heparanase activates the syndecan-syntenin-ALIX exosome pathway.",OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Cell Res 2015; 25(4):412-28;PMID:25732677; http://dx.do i.org/10.1038/ cr.2015.29 [9] Thompson CA, Purushothaman A, Ramani VC, Vlodavsky I, Sanderson RD.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"J Biol Chem 2013; 288(14):10093-9; PMID:23430739; http://dx.doi.org/10.1074/jbc.C112.444562 [10] Ramani VC, Purushothaman A, Stewart MD, Thompson CA, Vlodavsky I, Au JL, Sanderson RD.",OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Expert Opin TherTargets 2014; 19(1):97-112; http://dx.doi.org/ 10.1517/14728222.2014.959495 [12] Kashyap R, Roucourt B, Lembo F, Fares J, Carcavilla A M ,R e s t o u i nA ,Z i m m e r m a n nP ,G h o s s o u bR .S y n t e - nin controls migration, growth, proliferation, and cell cycle progression in can cer cells.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"Front Pharmacol 2015; 6:241; PMID:26539120; http://dx.doi.org/10.3389/fphar.2015.00241 [13] Zimmermann P, Zhang Z, Degeest G, Mortier E, Lee- naerts I, Coomans C, Schulz J, N ’Kuli F, Courtoy PJ, David G. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.",Non-OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
PNAS 2013; 110 (43):17380-5; PMID:2410152 4; http://dx.doi.org/ 10.1073/pnas.1304266110126 J.,OADS,/arxiv_data1/oa_pdf/0c/22/kcam-11-02-1225632.PMC5351732.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"2, 135 –150 http://dx.doi.org/10.1080/19336918.2016.1236899",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Beer http://orcid.org/0000-0003-1340-0305 Ann Marie Wehman http://orcid.org/0000-0001-9826-4132CELL ADHESION & MIGRATION 145,Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Cell Mol Immunol 2014; 11:548-63; PMID:24954226; http://dx.doi.org/10.1038/cmi.2014.42 [2] Deatherage BL, Cookson BT.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Infect Immun2012; 80:1948-57; PMID:22409932; http://dx.doi.org/10.1128/IAI.06014-11 [3] Schwechheimer C, Kuehn MJ.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions.Nat Rev Microbiol 2015; 13:605-19; PMID:26373371; http://dx.doi.org/10.1038/nrmicro3525 [4] Budnik V, Ruiz-Ca ~nada C, Wendler F. Extracellular vesicles round off communication in the nervous sys- tem.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nat Rev Neurosci 2016; 17:160-72; PMID:26891626; http://dx.doi.org/10.1038/nrn.2015.29 [5] Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Annu Rev Cell Dev Biol 2014;30:255-89; PMID:25288114; http://dx.doi.org/10.1146/annurev-cellbio-101512-122326 [6] Cocucci E, Meldolesi J. Ectosomes and exosomes: shed- ding the confusion between extracellular vesicles.Trends Cell Biol 2015; 25:364-72; PMID:25683921; http://dx.doi.org/10.1016/j.tcb.2015.01.004 [7] McGough IJ, Vincent JP.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Dev 2016; 143:2482-93; PMID:27436038; http://dx.doi.org/10.1242/dev.126516 [8] Robbins PD, Morelli AE.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nat Rev Immunol 2014; 14:195-208; PMID:24566916; http://dx.doi.org/ 10.1038/nri3622 [9] Desrochers LM, Antonyak MA, Cerione RA.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Curr Opin Microbiol 2016; 32:77-81; PMID:27232382; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Semin Cell DevBiol 2015; 40:35-40; PMID:25843775; http://dx.doi.org/ 10.1016/j.semcdb.2015.03.009 [13] Torrano V, Royo F, Peinado H, Loizaga-Iriarte A, Unda M, Falc /C19on-P /C19erez JM, Carracedo A. Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Opin Pharmacol 2016; 29:47-53; PMID:27366992;http://dx.doi.org/10.1016/j.coph.2016.06.003 [14] De Palma G, Sallustio F, Schena FP.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Int J Mol Sci 2016; 17:1043; PMID:27376269; http://dx.doi.org/10.3390/ijms17071043 [15] Wehman AM, Poggioli C, Schweinsberg P, Grant BD, Nance J.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Biol 2011; 21:1951-9; PMID:22100064; http://dx.doi.org/10.1016/j.cub.2011.10.040 [16] Li R, Albertini DF.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nat Rev Mol Cell Biol 2013; 14:141-52;PMID:23429793; http://dx.doi.org/10.1038/nrm3531 [17] Dionne LK, Wang X-J, Prekeris R. Midbody: from cellu- lar junk to regulator of cell polarity and cell fate.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Int J Mol Sci 2016; 17:170; PMID:26861301; http://dx.doi.org/10.3390/ijms17020170 [19] Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borr /C18as FE, Breake ﬁeld X, Budnik V, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nature 2015; 527:329-35; PMID:26524530; http://dx.doi.org/10.1038/nature15756 [21] Desrochers LM, Bordeleau F, Reinhart-King CA, Cerione RA, Antonyak MA.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nat Com- mun 2016; 7:11958; PMID:27302045; http://dx.doi.org/ 10.1038/ncomms11958 [22] N €usslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nature 1980; 287:795-801; PMID:6776413; http://dx.doi.org/10.1038/287795a0 [23] Wang X, Yang C. Programmed cell death and clearance of cell corpses in Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Cell Mol LifeSci 2016; 73:2221-36; PMID:27048817; http://dx.doi.org/10.1007/s00018-016-2196-z [24] Pan /C19akov/C19a D, Sprong H, Marois E, Thiele C, Eaton S. Lipoprotein particles are required for Hedgehog and Wingless signalling.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nature 2005; 435:58-65; PMID: Can ’t; http://dx.doi.org/10.1038/nature03504 [25] Zugasti O, Rajan J, Kuwabara PE.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Genome Res 2005; 15:1402-10; PMID:16204193; http://dx.doi.org/10.1101/gr.3935405 [26] Kolotuev I, Apaydin A, Labouesse M. Secretion of Hedgehog-related peptides and WNT during Caeno- rhabditis elegans development.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Traf ﬁc 2009; 10:803-10; PMID:19210682; http://dx.doi.org/10.1111/j.1600-0854.2009.00871.x [27] Li /C19egeois S, Benedetto A, Garnier J-M, Schwab Y, Labouesse M. The V0-ATPase mediates apical secre-tion of exosomes containing Hedgehog-related pro- teins in Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"61; PMID:16785323; http://dx.doi.org/10.1083/jcb.2 00511072 [28] Korkut C, Ataman B, Ramachandran P, Ashley J, Barria R, Gherbesi N, Budnik V. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Cell 2009; 139:393-404; PMID:19837038; http://dx.doi.org/10.1016/j.cell.2009.07.051 [29] Koles K, Nunnari J, Korkut C, Barria R, Brewer C, Li Y, Leszyk J, Zhang B, Budnik V. Mechanism of evennessinterrupted (Evi)-exosome release at synaptic boutons.JBC 2012; 287:16820-34; PMID:22437826; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Nat Cell Biol 2012; 14:1036-45; PMID:22983114; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"The ESCRT machinery regu- lates the secretion and long-range activity of Hedgehog.Nature 2014; 516:99-103; PMID:25471885; http://dx.doi.org/10.1038/nature13847 [32] Gradilla A-C, Gonz /C19alez E, Seijo I, Andr /C19es G, Bischoff M, Gonz /C19alez-Mendez L, S /C19anchez V, Callejo A, Ib /C19a~nez C, Guerra M, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Nat Commun 2014; 5:5649; PMID:25472772; http://dx.doi.org/10.1038/ncomms6649 [33] Cadigan KM.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Semin Cell Dev Biol 2002; 13:83-90;PMID:12127140; http://dx.doi.org/10.1016/S1084-9521 (02)00014-9 [34] Ram /C19ırez-Weber FA, Kornberg TB.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Cell 1999; 97:599-607; PMID:Can ’t; http://dx.doi.org/10.1016/S0092-8674(00) 80771-0 [35] Danilchik M, Williams M, Brown E. Blastocoel-span- ning ﬁlopodia in cleavage-stage Xenopus laevis: Poten- tial roles in morphogen distribution and detection.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
DevBiol 2013; 382:70-81; PMID:23916849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Trends Cell Biol 2015; 25:276-85; PMID:25618328; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Elife2015; 4:183; PMID:25688564; http://dx.doi.org/10.7554/ eLife.05242 [38] Wang J, Silva M, Haas LA, Morsci NS, Nguyen KCQ, Hall DH, Barr MM.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Biol 2014; 24:519-25;PMID:24530063; http://dx.doi.org/10.1016/j.cub.2014.01.002 [39] Maguire JE, Silva M, Nguyen KCQ, Hellen E, Kern AD, Hall DH, Barr MM.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Mol Biol Cell 2015; 26:2823-32; PMID:26041936; http://dx.doi.org/10.1091/ mbc.E15-01-0009[40] Barr MM, Sternberg PW.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Biol 2001; 11:1341-6; PMID:11553327; http://dx.doi.org/10.1016/ S0960-9822(01)00423-7 [42] Corrigan L, Redhai S, Leiblich A, Fan S-J, Perera SMW, Patel R, Gandy C, Wainwright SM, Morris JF, Hamdy F, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
JCB2014; 206:671-88; PMID:25154396; http://dx.doi.org/ 10.1083/jcb.201401072 [43] Hurley JH.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"EMBO J 2015; 34:2398-407; PMID:26311197; http://dx.doi.org/ 10.15252/embj.201592484 [44] Henne WM, Stenmark H, Emr SD.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"CSHPerspect Biol 2013; 5(9); pii: a016766; PMID:24003212; http://dx.doi.org/10.1 101/cshperspect.a016766 [45] Hyenne V, Apaydin A, Rodriguez D, Spiegelhalter C, Hoff- Yoessle S, Diem M, Tak S, Lefebvre O, Schwab Y, Goetz JG, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCB 2015; 211:27-37; PMID:26459596;http://dx.doi.org/10.1083/jcb.201504136 [46] Abels ER, Breake ﬁeld XO.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Cell Mol Neurobiol 2016; 36:301- 12; PMID:27053351; http://dx.doi.org/10.1007/s10571- 016-0366-z [47] Nabhan JF, Hu R, Oh RS, Cohen SN, Lu Q.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"PNAS 2012;109:4146-51; PMID:22315426; http://dx.doi.org/10.1073 /pnas.1200448109 [48] Gradilla A-C, Guerrero I. Hedgehog on the move: a precise spatial control of Hedgehog dispersion shapes the gradient.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Opin Genet Dev 2013; 23:363-73; PMID:23747033; http://dx.doi.org/10.1016/j.gde.2013.04.011 [49] Beckett K, Monier S, Palmer L, Alexandre C, Green H, Bonneil E, Raposo G, Thibault P, Le Borgne R, Vincent JP.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Traf ﬁc 2013; 14:82-96; PMID:23035643; http://dx.doi.org/10.1111/tra.12016 [50] Utley TJ, Ducharme NA, Varthakavi V, Shepherd BE, Santangelo PJ, Lindquist ME, Goldenring JR, Crowe JE.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"PNAS2008; 105:10209-14; PMID:18621683; http://dx.doi.org/ 10.1073/pnas.0712144105 [51] Campsteijn C, Vietri M, Stenmark H. Novel ESCRT functions in cell biology: spiraling out of control?",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
JCS 2014; 127:3840-51; PMID:25002399; http://dx.doi.org/10.1242/jcs.154732CELL ADHESION & MIGRATION 147,Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Sci Rep 2016; 6:27629; PMID:27282220; http://dx.doi.org/10.1038/srep27629 [54] Stenmark H. Rab GTPases as coordinators of vesicle trafﬁc.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nat Rev Mol Cell Biol 2009; 10:513-25; PMID:19603039; http://dx.doi.org/10.1038/nrm2728 [55] Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, FreitasRP, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Nat Cell Biol 2010; 12:19-30 –suppp1 –13; PMID:19966785; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Lysosome-related organ- elles: driving post-Golgi compartments into specialisation.Curr Opin Cell Biol 2007; 19:394-401; PMID:17628466; http://dx.doi.org/10.1016/j.ceb.2007.05.001 [57] Gerber PP, Cabrini M, Jancic C, Paoletti L, Banchio C, Bilderling von C, Sigaut L, Pietrasanta LI, Duette G, FreedEO, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCB 2015; 209:435-52; PMID:25940347;http://dx.doi.org/10.1083/jcb.201409082 [58] Zhang M, Chen L, Wang S, Wang T. Rab7: roles in membrane traf ﬁcking and disease.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Biosci Rep 2009; 29:193-209; PMID:19392663; http://dx.doi.org/10.1042/ BSR20090032 [59] Ja /C19e N, McEwan DG, Manavski Y, Boon RA, Dimmeler S. Rab7a and Rab27b control secretion of endothelial microRNA through extracellular vesicles.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"FEBS Lett 2015; 589:3182-8; PMID:Can ’t; http://dx.doi.org/ 10.1016/j.febslet.2015.08.040 [60] Sato M, Grant BD, Harada A, Sato K. Rab11 is required for synchronous secretion of chondroitin proteoglycans after fertilization in Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCS 2008;121:3177-86; PMID:18765566; http://dx.doi.org/ 10.1242/jcs.034678 [61] Takahashi S, Kubo K, Waguri S, Yabashi A, Shin H-W, Katoh Y, Nakayama K. Rab11 regulates exocytosis of recycling vesicles at the plasma membrane.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCS 2012; 125:4049-57; PMID:22685325; http://dx.doi.org/10.1242/jcs.102913 [62] Savina A, Vidal M, Colombo MI.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Traf ﬁc 2005; 6:131-43; PMID:15634213; http://dx.doi.org/10.1111/j.1600- 0854.2004.00257.x [64] Klinkert K, Echard A. Rab35 GTPase: A Central Regulator of Phosphoinositides and F-actin in Endo- cytic Recycling and Beyond.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Traf ﬁc 2016; 17 (10):1063-77; PMID:27329675; http://dx.doi.org/10.1111/tra.12422 [65] Hsu C, Morohashi Y, Yoshimura S-I, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Grønborg M, M€obius W, Rhee J, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Regulation of exosome secre- tion by Rab35 and its GTPase-activating proteins TBC1D10A-C. JCB 2010; 189:223-32; PMID:20404108; http://dx.doi.org/10.1083/jcb.200911018[66] Bombardier JP, Munson M. Three steps forward, two steps back: mechanistic insights into the assembly and disassembly of the SNARE complex.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Opin ChemBiol 2015; 29:66-71; PMID:26498108; http://dx.doi.org/ 10.1016/j.cbpa.2015.10.003 [67] Fader CM, S /C19anchez DG, Mestre MB, Colombo MI.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Biochim BiophysActa 2009; 1793:1901-16; PMID:19781582; http://dx.doi.org/10.1016/j.bbamcr.2009.09.011 [68] Jahn R, Lang T, S €udhof TC.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Cell 2003; 112:519-33; PMID:12600315; http://dx.doi.org/10.1016/S0092-8674(03)00112-0 [69] Schulze KL, Broadie K, Perin MS, Bellen HJ.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Biochim Biophys Acta 2014; 1837:857-79; PMID:24508215; http://dx.doi.org/10.101 6/j.bbabio.2014.01.018 [71] Maxson ME, Grinstein S. The vacuolar-type HC- ATPase at a glance - more than a proton pump.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCS 2014; 127:4987-93; PMID:25453113; http://dx.doi.org/10.1242/jcs.158550 [72] Wang D, Epstein D, Khalaf O, Srinivasan S, Williamson WR, Fayyazuddin A, Quiocho FA, Hiesinger PR.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCB 2014; 205:21-31; PMID:24733584; http://dx.doi.org/10.1083/jcb.201312109 [73] Wu B, Guo W. The exocyst at a glance.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCS 2015; 128:2957- 64; PMID:26240175; http://dx.doi.org/10.1242/jcs.156398 [74] Armenti ST, Chan E, Nance J. Polarized exocyst-medi- ated vesicle fusion directs intracellular lumenogenesis within the C. elegans excretory cell.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Dev Biol 2014; 394:110-21; PMID:25102190; http://dx.doi.org/10.1016/j.ydbio.2014.07.019 [75] Wang J, Kaletsky R, Silva M, Williams A, Haas LA, Androwski RJ, Landis JN, Patrick C, Rashid A,Santiago-Martinez D, et al.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Biol 2015; 25:3232-8; PMID:26687621; http://dx.doi.org/10.1016/j.cub.2015.10.057 [76] Graham TR, Kozlov MM.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Curr Opin CellBiol 2010; 22:430-6; PMID:20605711; http://dx.doi.org/ 10.1016/j.ceb.2010.05.002 [77] McMahon HT, Boucrot E. Membrane curvature at a glance.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Chem Phys Lipids 2016; 194:58-71; PMID:26319805; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Biochemistry 1993; 32:2337- 44; PMID:Can ’t; http://dx.doi.org/10.1021/bi00060a027 [81] Larson MC, Woodliff JE, Hillery CA, Kearl TJ, Zhao M. Phosphatidylethanolamine is externalized at the surface of microparticles.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Biochim Biophys Acta 2012; 1821:1501-7; PMID:22960380; http://dx.doi.org/10.1016/j.bbalip.2012.08.017 [82] Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"J Thromb Haemost 2014; 12:614-27; PMID:24618123; http://dx.doi.org/10.1111/jth.12554 [84] van Meer G, Voelker DR, Feigenson GW.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Biochim Bio- phys Acta 2016; 1861:767-83; PMID:26747647; http://dx.doi.org/10.1016/j.bbalip.2015.12.020 [86] Andersen JP, Vestergaard AL, Mikkelsen SA, Mogensen LS, Chalat M, Molday RS.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"FrontPhysiol 2016; 7:275; PMID:27458383; http://dx.doi.org/ 10.3389/fphys.2016.00275 [87] Hankins HM, Baldridge RD, Xu P, Graham TR.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Traf ﬁc 2015; 16:35-47; PMID:25284293; http://dx.doi.org/10.1111/tra.12233 [88] Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-depen- dent phospholipid scrambling by TMEM16F.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Nature 2010; 468:834-8; PMID:21107324; http://dx.doi.org/10.1038/nature09583 [89] Castoldi E, Collins PW, Williamson PL, Bevers EM.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Blood 2011;117:4399-400; PMID:21511967; http://dx.doi.org/ 10.1182/blood-2011-01-332502 [90] Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"BiochimBiophys Acta 2002; 1585:53-63; PMID:12531537; http://dx.doi.org/10.1016/S1388-1981(02)00324-4 [92] Kay JG, Grinstein S. Phosphatidylserine-mediated cellu- lar signaling.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Adv Exp Med Biol 2013; 991:177-93;PMID:23775696; http://dx.doi.org/10.1007/978-94-007- 6331-9_10[93] Zhou X, Platt JL.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Adv Exp Med Biol 2011; 713:33-64; PMID:21432013; http://dx.doi.org/10.1007/978-94-007-0763-4_4 [94] Xu P, Baldridge RD, Chi RJ, Burd CG, Graham TR.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Science 2008; 320:528-31; PMID:18436785;http://dx.doi.org/10.1126/science.1155847 [96] Ruaud A-F, Nilsson L, Richard F, Larsen MK, Bessereau J-L, Tuck S. The C. elegans P4-ATPase TAT-1 regulateslysosome biogenesis and endocytosis.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Traf ﬁc 2009; 10:88-100; PMID:18939953; http://dx.doi.org/10.1111/ j.1600-0854.2008.00844.x [97] Li Z, Venegas V, Nagaoka Y, Morino E, Raghavan P, Audhya A, Nakanishi Y, Zhou Z. Necrotic cells actively attract phagocytes through the collaborative action of two distinct ps-exposure mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"PLoS Genet2015; 11:e1005285; PMID:26061275; http://dx.doi.org/ 10.1371/journal.pgen.1005285 [98] Emoto K, Kobayashi T, Yamaji A, Aizawa H, Yahara I, Inoue K, Umeda M. Redistribution of phosphatidyletha- nolamine at the cleavage furrow of dividing cells during cytokinesis.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"FEBS Lett 2010; 584:1665-9; PMID:19913542;http://dx.doi.org/10.1016/j.febslet.2009.11.017 [100] Lee I-H, Kai H, Carlson L-A, Groves JT, Hurley JH.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JCB 2006;172:923-35; PMID:16533950; http://dx.doi.org/10.1083/jcb.200508014 [102] Posor Y, Eichhorn-Gr €unig M, Haucke V. Phosphoinosi- tides in endocytosis.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Biochim Biophys Acta 2015;1851:794-804; PMID:25264171; http://dx.doi.org/ 10.1016/j.bbalip.2014.09.014 [103] Lemmon MA.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Nat Rev Mol Cell Biol 2008; 9:99-111; PMID:18216767; http://dx.doi.org/10.1038/nrm2328 [104] BallaT.Phosphoinositides:tinylipidswithgiantimpactoncell regulation.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Physiol Rev 2013; 93:1019-137; PMID:23899561; http://dx.doi.org/10.1152/physrev.00028.2012 [105] Hurley JH, Hanson PI.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"1999; 18:871-81; PMID:10022830; http://dx.doi.org/ 10.1093/emboj/18.4.871 [107] Khuong TM, Habets RLP, Kuenen S, Witkowska A, Kasprowicz J, Swerts J, Jahn R, van den Bogaart G, Ver- streken P. Synaptic PI(3,4,5)P3 is required for Syntax- in1A clustering and neurotransmitter release.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Neuron2013; 77:1097-108; PMID:23522045; http://dx.doi.org/ 10.1016/j.neuron.2013.01.025 [108] Murate M, Abe M, Kasahara K, Iwabuchi K, Umeda M, Kobayashi T. Transbilayer distribution of lipids at nanoscale.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Microbiology (Reading, Engl) 1996; 142(Pt 12):3407-14; PMID:9004503; http://dx.doi.org/10.1099/13500872-142-12-3407 [110] Arbuzova A, Martushova K, Hangy /C19as-Mih /C19alyn/C19eG , Morris AJ, Ozaki S, Prestwich GD, McLaughlin S. Fluo-rescently labeled neomycin as a probe of phosphatidyli-nositol-4, 5-bisphosphate in membranes.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"JBC2016; 291:15727-39; PMID:27235400; http://dx.doi.org/ 10.1074/jbc.M115.686253 [112] Wicky S, Schwarz H, Singer-Kr €uger B. Molecular inter- actions of yeast Neo1p, an essential member of the Drs2family of aminophospholipid translocases, and its role in membrane traf ﬁcking within the endomembrane sys- tem.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Mol Cell Biol 2004; 24:7402-18; PMID:15314152;http://dx.doi.org/10.1128/MCB.24.17.7402-7418.2004 [113] Yamagami K, Yamamoto T, Sakai S, Mioka T, Sano T, Igarashi Y, Tanaka K. Inositol depletion restores vesicletransport in yeast phospholipid ﬂippase mutants.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
PLoS One 2015; 10:e0120108; PMID:25781026; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"org/10.1371/journal.pone.0120108 [114] Kowal J, Tkach M, Thery C. Biogenesis and secretion of exo- somes.CurrOpinCellBiol20 14;29:116-25;PMID:24959705; http://dx.doi.org/10.1 016/j.ceb.2014.05.004 [115] Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Br €ugger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Science 2008; 319:1244-7; PMID:18309083;http://dx.doi.org/10.1126/science.1153124 [116] Jimenez AJ, Maiuri P, Lafaurie-Janvore J, Divoux S, Piel M, Perez F. ESCRT machinery is required for plasma mem-brane repair.",Non-OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Science 2014; 343:1247136; PMID:24482116;http://dx.doi.org/10.1126/science.1247136 [117] Sato K, Sato M, Audhya A, Oegema K, Schweinsberg PJ, Grant BD.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Mol Biol Cell 2006; 17:3085-94; PMID:16672374; http://dx.doi.org/10.1091/mbc.E06-03-0211 [118] Maddox AS, Azoury J, Dumont J. Polar body cytokine- sis.",OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
Cytoskeleton (Hoboken) 2012; 69:855-68;PMID:22927361; http://dx.doi.org/10.1002/cm.21064150 K. B.,OADS,/arxiv_data1/oa_pdf/86/d4/kcam-11-02-1236899.PMC5351733.pdf
"Published wit license by Taylor & Francis Group, LLC © Vincent P. Klink, Keshav Sharma, Shankar R. Pant, Brant McNeece, Prakash Niraula, and Gary W. Law rence This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.PLANT SIGNALING & BEHAVIOR 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"2, e1274481 (19 pages)http://dx.doi.org/10.1080/15592324.2016.1274481",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1980; 21:205-15; PMID:6996832; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1990; 61:709-21; PMID:2111733; http://dx.doi.org/ 10.1016/0092-8674(90)90482-T 3.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Front Cell Dev Biol 2016; 4:46;PMID:27243010; http://doi.org/10.3389/fcell.2016.00046 5.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2003; 425:973-7; PMID:14586469; http://dx.doi.org/ 10.1038/nature02076Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Proc Natl Acad Sci U S A 2010; 107:21896-901; PMID:21098265; http://dx.doi.org/10.1073/ pnas.1003619107 7.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PlantMol Bio 2014; 85:107-21; http://dx.doi.org/10.1007/s11103-014-0172-2 8.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2014; 79:466-76; PMID:24889055; http://dx.doi.org/10.1111/tpj.12571 9.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Plant Interactions 2016; 11:74-93; http://dx.doi.org/10.1080/17429145.2016.1195891 10.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Heredity 1991; 66:105-15; http://dx.doi.org/10.1038/hdy.1991.13 13.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 1985; 166:156-60; PMID:24241426; http://dx.doi.org/10.1007/BF00397342 14.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"ABCC1, an ATP binding cassette protein from grape berry, transports anthocyanidin3-O-Glucosides.Plant Cell 2013; 25:1840-54; PMID:23723325; http://dx.doi.org/10.1105/tpc.112.102152 15.",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Sci-ence 2005; 310:1180-3; PMID:16293760; http://dx.doi.org/10.1126/ science.1119409 16.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Stein M, Dittgen J, Sanchez-Rodriguez C, Hou B-H, Molina A, Schulze-Lefert P, Lipka V, Somerville S. Arabidopsis PEN3/PDR8, an ATP Binding Cassette Transporter, contributes to nonhost resis- tance to inappropriate pathogens that enter by direct penetration.Plant Cell 2006; 18:731-46; PMID:16473969; http://dx.doi.org/10.1105/tpc.105.038372 17.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Mol Biol 2009; 71:525-67; PMID:19787434; http://dx.doi.org/10.1007/s11103-009-9539-1 19.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"J Biomed Biotechnol 2010b; 1-30; http://dx.doi.org/10.1155/2010/491217 21 Klink VP, Hosseini P, Matsye PD, Alkharouf NW, Matthews BF.",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Mol Biol 2011; 75:141-65; PMID:21153862; http://dx.doi.org/10.1007/s11103-010-9715-3 22.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Mol Bio 2011; 77:513-28; http://dx.doi.org/10.1007/s11103-011-9828-3 24.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Mol Bio 2012; 80:131-5; http://dx.doi.org/ 10.1007/s11103-012-9932-z 25.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1982; 30:439-48; PMID:6754086; http://dx.doi.org/10.1016/0092-8674(82)90241-0 26.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Crop Sci 2004; 44:1121-31; http://dx.doi.org/10.2135/cropsci2004.1121 27.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nucl Acids Res 2010; 38:D843-6; PMID:20008513; http://dx.doi.org/10.1093/ nar/gkp798 28.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Genome 2010; 3:81-9; http://dx.doi.org/10.3835/plantgenome2010.02.0001 29.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2010; 463:178-83; PMID:20075913; http://dx.doi.org/10.1038/nature08670 30.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Science 2012; 338:1206-9; PMID:23065905; http://dx.doi.org/10.1126/science.1228746 31.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
ProcNatl Acad Sci U S A 1979; 76:1858-62; PMID:377286; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1981; 25:461-69; PMID:7026045; http://dx.doi.org/10.1016/0092-8674(81)90064-7 34.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1981;25:451-60; PMID:7026044; http://dx.doi.org/10.1016/0092-8674(81) 90063-5 35.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell1990; 61:723-33; PMID:2188733; http://dx.doi.org/10.1016/0092- 8674(90)90483-U 36.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2001a; 124:1558-69; http://dx.doi.org/10.1104/pp.124.4.1558 39.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell2001b; 12:3733-43; PMID:11739776; http://dx.doi.org/10.1091/mbc.12.12.3733 40.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Yeast 2000; 16:979-93; PMID:10923020; http://dx.doi.org/10.1002/1097-0061(200008)16:11 <979::AID-YEA594 >3.0.CO;2-C 41.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Proc Natl Acad Sci U S A2004; 101:1748-53; PMID:14755058; http://dx.doi.org/10.1073/ pnas.0308268100 42.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Neurosci 2004; 24:3964-73; PMID:15102912; http://dx.doi.org/10.1523/JNEUROSCI.5259-03.2004 43.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PLoS One2011; 6:e21925; http://dx.doi.org/10.1371/journal.pone.0021925 44.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones.Science 1992; 257:255-9; PMID:1321498; http://dx.doi.org/10.1126/ science.1321498 47.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1994; 78:937-48; PMID:7923363; http://dx.doi.org/10.1016/0092-8674(94)90270-4 49.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem1997; 272:17776-83; PMID:9211930; http://dx.doi.org/10.1074/jbc.272.28.17776 50.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
2008; 27:923-33; PMID:18337752; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Science 2009; 323:474-7; PMID:19164740; http://dx.doi.org/10.1126/science.1161748 52.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 1993a; 362:318-24;PMID:8455717; http://dx.doi.org/10.1038/362318a0 53.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"A protein assembly-disassembly pathway in vitro that may correspondto sequential steps of synaptic vesicle docking, activation, and fusion.Cell 1993b; 75:409-18; PMID:8221884; http://dx.doi.org/10.1016/ 0092-8674(93)90376-2 54.",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 1992b; 359:832-5; PMID:1331807; http://dx.doi.org/10.1038/359832a0 56.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2006; 444:1096-100;PMID:17167418; http://dx.doi.org/10.1038/nature05411 59.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2006; 444:1092-5; PMID:17167421; http://dx.doi.org/10.1038/nature05387 60.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
FEBS Lett 2012;586:310-3; PMID:22265973; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PLoS One 2013; 82:e56798; http://dx.doi.org/10.1371/journal.pone.0056798 62.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 2008; 19:776-84; PMID:18094056; http://dx.doi.org/10.1091/mbc.E07-05-0498 63.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PLoS One 2015; 10:e0145601; PMID:26714307;http://dx.doi.org/10.1371/journal.pone.0145601 64.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 2009; 185:535-49;PMID:19414611; http://dx.doi.org/10.1083/jcb.200811082 65.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Elife 2014; 3:e02272;PMID:24837546; http://dx.doi.org/10.7554/eLife.02272.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Elife 2014; 3:e01879;PMID:24596153; http://dx.doi.org/10.7554/eLife.01879 68.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Elife2015b; 4:e08843; http://dx.doi.org/10.7554/eLife.08843 69.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1988;54:221-7; http://dx.doi.org/10.1016/0092-8674(88)90554-5 72.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2013; 288:24984-91; PMID:23836889; http://dx.doi.org/10.1074/jbc.M113.489807 73.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2015; 518:61-7; PMID:25581794; http://dx.doi.org/10.1038/nature14148 74.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Yeast 1995; 11:901-11; PMID:8533466; http://dx.doi.org/10.1002/yea.320111002 75.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PLoSOne 2012; 7: e49628; PMID:23166732; http://dx.doi.org/10.1371/ journal.pone.0049628 76.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 1998; 17:985-95; PMID:9463377; http://dx.doi.org/10.1093/ emboj/17.4.985 77.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 2002; 21:6095-104; PMID:12426381; http://dx.doi.org/ 10.1093/emboj/cdf598 78.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 2014; 157:1473-87; PMID:24906158; http://dx.doi.org/10.1016/j.cell.2014.04.029 79.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2004; 135:71-84; PMID:15122013; http://dx.doi.org/10.1104/pp.103.038059 80.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2008; 147:1072-91;PMID:18467457; http://dx.doi.org/10.1104/pp.107.109512 81.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Biochim Biophys Acta 2005;1735:1-19; PMID:15922656; http://dx.doi.org/10.1016/j.bbalip.2005.04.004 82.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Lipid Res 2008; 49:169-82; PMID:17916878;http://dx.doi.org/10.1194/jlr.M700364-JLR200 83.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2013; 25:4640-57; PMID:24285789; http://dx.doi.org/10.1105/tpc.113.117382 84.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Virology 1970; 40:820-7; PMID:5432280; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Annu Rev Phytopathol 1976; 14:145-63; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 1987; 172:101- 5; PMID:24225793; http://dx.doi.org/10.1007/BF00403034 87.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Jahnen W, Hahlbrock K. Cellular localization of nonhost resistance reactions of parsley (Petroselinum crispum) to fungal infection.Planta 1988; 173:197-204; PMID:24226400; http://dx.doi.org/ 10.1007/BF00403011 88.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 1991; 183:484-90; http://dx.doi.org/10.1007/BF00194268 89.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Theor Appl Genet 1992; 84:123-8; PMID:24203038; http://dx.doi.org/10.1007/BF00223991 90.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plan t Cell 1996; 8:1001-11; PMID:12239410; http://dx.doi.org/10.1105/tpc.8.6.1001 92.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 1995; 197:535-45; http://dx.doi.org/10.1007/BF00196676 93.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 1995; 108:503-16; PMID:12228488; http://dx.doi.org/ 10.1104/pp.108.2.503 94.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
radicis-lycopersici.Phytopathology 1997; 87:108-22; PMID:18945162; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 1996; 112:919-29; PMID:12226427; http://dx.doi.org/10.1104/pp.112.3.919 9 6 .,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 1996; 8:793- 803; PMID:12239401; http://dx.doi.org/10.1105/tpc.8.5.793 97.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 1999; 11:15-29; PMID:9878629; http://dx.doi.org/10.1105/ tpc.11.2.177 98.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 1997; 203:196-203; PMID:9362565; http://dx.doi.org/10.1007/s004250050182 99.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 1999; 17:535-45; PMID:10205906;http://dx.doi.org/10.1046/j.1365-313X.1999.00405.x 100.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 2000; 210:853-64; PMID:10872215; http://dx.doi.org/10.1007/s004250050690 101.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2000; 12:1811-22; PMID:11041878; http://dx.doi.org/10.1105/tpc.12.10.1811 103.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Plant Microbe Interact 2001; 14:439-50;PMID:11310731; http://dx.doi.org/10.1094/MPMI.2001.14.4.439 104.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2001; 13:413-24; PMID:11226194; http://dx.doi.org/10.1105/tpc.13.2.413 105.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
The Arabidopsis aberrant growth and death2 mutant shows resistance to Pseudomonas syringae andreveals a role for NPR1 in suppressing hypersensitive cell death.Plant J 2001; 27:203-11; PMID:11532166; http://dx.doi.org/10.1046/ j.0960-7412.2001.1075umedoc.x 106.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Plant Pathol 2002; 3:1-8; PMID:20569303; http://dx.doi.org/10.1046/j.1464-6722.2001.00087.x 107.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2001; 127:832-41; PMID:11706166; http://dx.doi.org/10.1104/pp.010350 108.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Plant Pathol 2002; 3:163-166;PMID:20569322; http://dx.doi.org/10.1046/j.1364-3703.2002.00109.x 109.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Fridborg I, Grainger J, Page A, Coleman M, Findlay K, Angell S. TIP, a novel host factor linking callose degradation with the cell- to-cell movement of Potato virus X. Mol Plant Microbe Interact2003; 16:132-40; PMID:12575747; http://dx.doi.org/10.1094/ MPMI.2003.16.2.132 111.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2000; 21:157-66; PMID:10743656; http://dx.doi.org/10.1046/j.1365- 313x.2000.00658.x 112.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2001; 28:361-69; PMID:11722778; http://dx.doi.org/10.1046/j.1365-313X.2001.01181.x 113.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2003;15:2503-13; PMID:14555698; http://dx.doi.org/10.1105/tpc.016097 114.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2010; 22:3831-44; PMID:21057060; http://dx.doi.org/10.1105/tpc.110.078063 115.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PLoSPathog 2014; 10:e1004496; PMID:25393742; http://dx.doi.org/ 10.1371/journal.ppat.1004496 118.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2000; 24:205-18; PMID:11069695;http://dx.doi.org/10.1046/j.1365-313x.2000.00870.x 119.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Science 2003; 301:969-72; PMID:12920300; http://dx.doi.org/10.1126/science.1086716 120.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell Microbiol2006; 8:1009-19; PMID:16681841; http://dx.doi.org/10.1111/j.1462- 5822.2006.00683.x 121.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 1989; 1:37-52;PMID:2535466; http://dx.doi.org/10.1105/tpc.1.1.37 122.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 1994; 6:1211-25; PMID:7919989; http://dx.doi.org/10.1105/tpc.6.9.1211 123.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 1996; 8:659-71; PMID:8624440; http://dx.doi.org/10.1105/tpc.8.4.659 124.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell Biol 1989; 108:1271-81; PMID:2466847; http://dx.doi.org/10.1083/ jcb.108.4.1271 126.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 1990; 347:561-2; PMID:2215682; http://dx.doi.org/ 10.1038/347561a0 127.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 1999; 18:1071-80; PMID:10022848; http://dx.doi.org/10.1093/emboj/18.4.1071 129.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Annu Rev Biochem 2012; 81:637-59; PMID:22463690; http://dx.doi.org/10.1146/annurev-biochem-052810-093700 130.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nat Rev Mol Cell Biol 2006; 7:631-43; PMID:16912714; http://dx.doi.org/ 10.1038/nrm2002 131.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1994; 77:895-907; PMID:8004676;http://dx.doi.org/10.1016/0092-8674(94)90138-4 132.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cold Spring Harb Perspect Biol 2013; 5:a013367;PMID:23378591; http://dx.doi.org/10.1101/cshperspect.a013367 133.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Trends Plant Sci 2016; 21:758-69;PMID:27317568; http://dx.doi.org/10.1016/j.tplants.2016.05.010 134.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Sci 2003; 116: 1893-903;PMID:12668726; http://dx.doi.org/10.1242/jcs.00395e1274481-14 V. P. KLINK ET AL.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
DevCell 2005; 8:937-47; PMID:15935782; http://dx.doi.org/10.1016/j.devcel.2005.04.001 136.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 2001; 106:145-55; PMID:11511343; http://dx.doi.org/10.1016/S0092-8674 (01)00434-2 137.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Dev Cell 2002a; 3:271-82; PMID:12194857; http://dx.doi.org/10.1016/S1534-5807(02)00220-4 138.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Dev Cell 2002b; 3:283-9; PMID:12194858; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 2004; 15:5528-37; PMID:15371534; http://dx.doi.org/10.1091/mbc.E04-08-0666 140.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Curr Biol 2014; 24:2556-63;PMID:25438943; http://dx.doi.org/10.1016/j.cub.2014.09.014 141.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2015; 27:2560-81; PMID:26342016; http://dx.doi.org/10.1105/tpc.15.00393 143.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Shen J, Gao C, Zhao Q, Lin Y, Wang X, Zhuang X Jiang L. AtBRO1 functions in ESCRT-I complex to regulate multivesicular body pro-tein sorting molecular plant 2016; 9:760-3; http://dx.doi.org/10.1016/j.molp.2016.02.005 144.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem1996; 271:17961-5; PMID:8663448; http://dx.doi.org/10.1074/ jbc.271.30.17961 145.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 1997; 8:1261-71; PMID:9243506; http://dx.doi.org/10.1091/mbc.8.7.1261 146.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 1998a;17:113-26; PMID:9427746; http://dx.doi.org/10.1093/emboj/17.1.113 147.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 1998b; 9:3383-97; PMID:9843576; http://dx.doi.org/10.1091/mbc.9.12.3383 148.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 1999; 10:2407-23; PMID:10397773; http://dx.doi.org/10.1091/mbc.10.7.2407 149.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2000; 275:1261-8; PMID:10625671; http://dx.doi.org/ 10.1074/jbc.275.2.1261 150.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 2002; 21:3620-31; PMID:12110575; http://dx.doi.org/10.1093/ emboj/cdf381 151.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nat Cell Biol 2006; 8:317- 28; PMID:16565709; http://dx.doi.org/10.1038/ncb1380 152.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 2008; 27:923-33; PMID:18337752; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
NewPhytol 2016; 211:1338-51; PMID:27110912; http://dx.doi.org/10.1111/nph.13973 154.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nat Plants 2016; 2:15197; PMID:27249189;http://dx.doi.org/10.1038/nplants.2015.197 155.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Suwastika IN, Uemura T, Shiina T, Sato MH, Takeyasu K. SYP71, a plant-speci ﬁc Qc-SNARE protein, reveals dual localization to the plasma membrane and the endoplasmic reticulum in Arabidopsis.Cell Struct Funct 2008; 33:185-92; PMID:18827404; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 2013; 24:1593-601;PMID:23515225; http://dx.doi.org/10.1091/mbc.E13-02-0074 157.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plos Pathogens2013; 9:e1003378; PMID:23696741; http://dx.doi.org/10.1371/journal.ppat.1003378 158.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Plant 2013; 6:916-30; PMID:23087325; http://dx.doi.org/10.1093/ mp/sss117 159.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 1996; 271:5671-9; PMID:8621431; http://dx.doi.org/ 10.1074/jbc.271.10.5671 161.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1997; 89:149-58; PMID:9094723;http://dx.doi.org/10.1016/S0092-8674(00)80191-9 162.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 1997; 139:1157-68; PMID:9382863; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 1997; 8:1175-81; PMID:9243499; http://dx.doi.org/10.1091/mbc.8.7.1175 164.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Sci- ence 1998; 281:698-700; PMID:9685263; http://dx.doi.org/ 10.1126/science.281.5377.698 165.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
EMBO J 1998; 17:2494-503; PMID:9564032;http://dx.doi.org/10.1093/emboj/17.9.2494 166.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Science 1998; 279:696-700; PMID:9445473; http://dx.doi.org/10.1126/science.279.5351.696PLANT SIGNALING & BEHAVIOR e1274481-15,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature1998; 391:187-90; PMID:9428766; http://dx.doi.org/10.1038/34438 168.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 1998; 141:1107-19; PMID:9606204;http://dx.doi.org/10.1083/jcb.141.5.1107 169.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 2016; 27:2697-707; PMID:27413010; http://dx.doi.org/10.1091/mbc.E16-04-0229 170.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol BiolCell 1999; 10:3317-29; PMID:10512869; http://dx.doi.org/10.1091/ mbc.10.10.3317 171.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 1993; 123:1727-34; PMID:8276893; http://dx.doi.org/10.1083/jcb.123.6.1727 172.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 2009; 185:305-21; PMID:19364919; http://dx.doi.org/10.1083/jcb.200810098 174.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
FEBS Lett 2009; 583:2701-9;PMID:19631211; http://dx.doi.org/10.1016/j.febslet.2009.07.032 175.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2002; 417:187-93; PMID:12000962; http://dx.doi.org/10.1038/417187a 177.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell2012; 148:530-42; PMID:22304919; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Cells 2015; 38:866- 75; PMID:26434491; http://dx.doi.org/10.14348/molcells.2015.0115 179.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 1992; 360:603-5; PMID:1461285; http://dx.doi.org/ 10.1038/360603a0 180.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cell 1994; 79:1199-207; PMID:8001155; http://dx.doi.org/10.1016/0092-8674 (94)90011-6 181.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nat Cell Biol 1999; 1:330-4; PMID:10559958; http://dx.doi.org/10.1038/14020 183.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Sci2006; 119:2173-83; PMID:16723730; http://dx.doi.org/10.1242/ jcs.03019 184.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2004; 279:47242-53; PMID:15308636; http://dx.doi.org/10.1074/jbc.M406644200185.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Sci 2005; 118:357-67; PMID:15632110; http://dx.doi.org/10.1242/jcs.01615 186.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
JCell Sci 2006; 119:4730-40; PMID:17077122; http://dx.doi.org/ 10.1242/jcs.03250 187.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Cold Spring Harb Perspect Biol 2011;3:a005207; PMID:21482742; http://dx.doi.org/10.1101/cshperspect.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Traf ﬁc 2013; 14:551-67; PMID:23369235; http://dx.doi.org/10.1111/tra.12052 189.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
BMC Cancer 2013; 13:44; PMID:23374247; http://dx.doi.org/10.1186/1471-2407-13-44 190.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 2015; 208:197-209; PMID:25583996; http://dx.doi.org/10.1083/jcb.201408024 191.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Oncotarget 2016; 7(40):65335-47; http://dx.doi.org/10.18632/oncotarget.11678 192.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2001; 277:10555-61; PMID:11748215; http://dx.doi.org/10.1074/jbc.M104863200 193.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Phytopathology 1970; 60:1493-8; http://dx.doi.org/10.1094/Phyto-60-1493 197.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Biochem J 1993; 294:231-8; PMID:8363577; http://dx.doi.org/10.1042/bj2940231 198.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 1994; 5:185-95; http://dx.doi.org/10.1046/j.1365-313X.1994.05020185.x 199.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Front Plant Sci 2012; 3:79; PMID:22639665; http://dx.doi.org/ 10.3389/fpls.2012.00079 200.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Biochem J 1992; 282:821-8; PMID:1554366; http://dx.doi.org/10.1042/bj2820821 201.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2008; 55:240-52; PMID:18397375; http://dx.doi.org/10.1111/j.1365-313X.2008.03504.x 202.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Biol (Stuttg) 2007; 9:142-6; PMID:17099842; http://dx.doi.org/10.1055/s-2006-924661 204.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PlantPhysiol 2010; 153:456-66; PMID:20421457; http://dx.doi.org/10.1104/pp.110.156844 205. de Vries H. Plasmalytische studien die wand der vakuolen.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 1963; 17:216-21; PMID:14000199; http://dx.doi.org/10.1083/jcb.17.1.216 207.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Cell Biol 1963; 17:222-5; PMID:13935874;http://dx.doi.org/10.1083/jcb.17.1.222 208.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 1968; 80:159-75; http://dx.doi.org/10.1007/BF00385592 209.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant CellPhysiol 2002; 43:1421-35; PMID:12514239; http://dx.doi.org/ 10.1093/pcp/pcf171 210.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 1993; 103:235-41; PMID:8208849; http://dx.doi.org/10.1104/pp.103.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Exp Bot 1993; 265:1281-9; http://dx.doi.org/10.1093/jxb/44.8.1281 213.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Int Rev Cytol 1997; 173:157-206; PMID:9127953; http://dx.doi.org/10.1016/S0074-7696(08)62477-8 214.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 1998; 15:553-61; PMID:9753780; http://dx.doi.org/10.1046/j.1365-313X.1998.00239.x 215.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell Physiol 2001; 42:292-300; PMID:11266580; http://dx.doi.org/10.1093/pcp/pce034 216.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Bio- chem J 2003; 375:61-73; PMID:12826015; http://dx.doi.org/10.1042/ bj20030485 217.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Biol (Stuttg) 2004; 6:402-7; PMID:15248122; http://dx.doi.org/10.1055/s-2004-817959 218.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Biochem J 2005; 390:105-13; PMID:15804235; http://dx.doi.org/10.1042/ BJ20041749 219.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
JExp Bot 2008; 59:875-89; PMID:18316315; http://dx.doi.org/ 10.1093/jxb/ern013 220.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Exp Bot 2009; 60:3959-72;PMID:19635745; http://dx.doi.org/10.1093/jxb/erp229 221.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2011; 155:399-413; PMID:21057113; http://dx.doi.org/10.1104/pp.110.166934 222.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Wiley 2011:464; http://dx.doi.org/10.1002/9781444320503.ch1 223.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Alkaloid biosynthesis in plants: biochemistry, cell biol- ogy, molecular regulation, and metabolic engineering applications.Annu Rev Plant Physiol Plant Mol Biol 2001; 52:29-66;PMID:11337391; http://dx.doi.org/10.1146/annurev.arplant.52.1.29 224.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 2014; 240:19-32; PMID:24671624; http://dx.doi.org/10.1007/s00425-014-2056-8 225.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Rink E, Bohm H. Conversion of reticuline into scoulerine by a cell free preparation from Macleaya microcarpa cell suspension cultures.FEBS Lett 1973; 49:396-9; http://dx.doi.org/10.1016/0014-5793(75)80794-0 228.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Phytochemistry 1985; 24:2577-83; http://dx.doi.org/10.1016/ S0031-9422(00)80672-X 229.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Phytochemistry1990; 29:3499-503; http://dx.doi.org/10.1016/0031-9422(90)85264-G 230.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 1995; 270:24475-81; PMID:7592663; http://dx.doi.org/10.1074/jbc.270.41.24475 232.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Mol Biol 1998; 36:473-8; PMID:9484487; http://dx.doi.org/10.1023/A:1005917808232 233.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 1998; 13:793-801; PMID:9681018;http://dx.doi.org/10.1046/j.1365-313X.1998.00085.x 234.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2000; 275:23398-405; PMID:10811648; http://dx.doi.org/10.1074/jbc.M002439200 235.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2002; 277:33878-83; PMID:12107162; http://dx.doi.org/10.1074/jbc.M203051200 236.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2002; 277:830-5; PMID:11682473; http://dx.doi.org/10.1074/jbc.M106405200PLANT SIGNALING & BEHAVIOR e1274481-17,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Phytochemistry 2009; 70:1092-7;PMID:19570558; http://dx.doi.org/10.1016/j.phytochem.2009.06.005 238.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Proc Natl Acad Sci U SA 2004; 101:14091-6; PMID:15383669; http://dx.doi.org/10.1073/ pnas.0405430101 239.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Proc Natl Acad Sci U SA 2005; 102:8495-500; PMID:15937106; http://dx.doi.org/10.1073/ pnas.0503244102 240.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Am Chem Soc 1988; 110:7878-80; http://dx.doi.org/ 10.1021/ja00231a050 241.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Intracellular compartmenta- tion of 2 enzymes of berberine biosynthesis in plant cell cultures.Planta 1986; 167:310-20; PMID:24240298; http://dx.doi.org/ 10.1007/BF00391333 242.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell 2003; 15:2626-35; PMID:14508000; http://dx.doi.org/10.1105/ tpc.015396 243.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 2001; 213:888-97; PMID:11722125; http://dx.doi.org/10.1007/s004250100582 244.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2005; 138:173-83; PMID:15849302; http://dx.doi.org/10.1104/pp.105.059287 245.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Cell Rep 1988; 7:1-4; PMID:24241402; http://dx.doi.org/10.1007/BF00272964 246.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 2002; 216:57-63;PMID:12430014; http://dx.doi.org/10.1007/s00425-002-0867-5 247.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PlantPhysiol 1987; 83:185-9; PMID:16665199; http://dx.doi.org/10.1104/ pp.83.1.185 250.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Plant Microbe Interact 2008; 21:1643-53; PMID:18986260; http://dx.doi.org/10.1094/MPMI-21-12-1643 251.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Bachmann M, Matile P, Keller F. Metabolism of the raf ﬁnose family oligo- saccharides in leaves of Ajuga reptans L. Cold acclimation, translocation,and sink to source transition: discovery of a chain elongation enzyme.Plant Physiol 1994; 105:1335-45; PMID:12232288; http://dx.doi.org/ 10.1104/pp.105.4.1335 252.",OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Arch Biochem Biophys 1999; 366:75-81; PMID:10334866; http://dx.doi.org/10.1006/abbi.1999.1212 253.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Planta 2002; 215:839-46; PMID:12244450; http://dx.doi.org/10.1007/s00425-002-0804-7 254.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2009; 57:986-99;PMID:19000165; http://dx.doi.org/10.1111/j.1365-313X.2008.03743.x 255.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Dev Cell 2011; 21:1144-55; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Scienti ﬁc Reports 2014; 4:4159; PMID:24561766; http://dx.doi.org/10.1038/srep04159 258.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Biol Cell 2004; 15:5118-29; PMID:15342780; http://dx.doi.org/10.1091/mbc.E04-02-0140 261.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Annu Rev Cell Dev Biol 2007;23:147-74; PMID:17506694; http://dx.doi.org/10.1146/annurev.cellbio.23.090506.123529 262.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Mol Plant Microbe Interact 2007; 20: 966-76; PMID:17722700; http://dx.doi.org/10.1094/MPMI-20-8- 0966 264.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Nature 2008; 451:835-40; PMID:18273019; http://dx.doi.org/10.1038/nature06545 265.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2008; 283:26974-84; PMID:18678865; http://dx.doi.org/10.1074/jbc.M805236200 266.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant J 2014; 79:835-47;PMID:24941879; http://dx.doi.org/10.1111/tpj.12591 267.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Science 1999; 284:1976-9; PMID:10373113; http://dx.doi.org/10.1126/science.284.5422.1976 268.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Natl Acad Sci U S A 2002; 99:3340-5; PMID:11854459; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
J Biol Chem 2006; 281:34197-207; PMID:16982611; http://dx.doi.org/ 10.1074/jbc.M606379200 271.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PlantCell 2005; 17:1764-76; PMID:15863516; http://dx.doi.org/10.1105/ tpc.105.031930 273.,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
"Zabotina OA, Avci U, Cavalier D, Pattathil S, Chou YH, Eberhard S, Danhof L, Keegstra K, Hahn MG. Mutations in multiple XXT genesof Arabidopsis reveal the complexity of xyloglucan biosynthesis.Plant Physiol 2012; 159:1367-84; PMID:22696020; http://dx.doi.org/ 10.1104/pp.112.198119 274.",Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Plant Physiol 2012; 159:1355-6; PMID:22665445; http://dx.doi.org/10.1104/pp.112.199356 275.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
PlantCell Physiol 2015; 56:255-67; PMID:25392066; http://dx.doi.org/10.1093/pcp/pcu161 276.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Annals Mathe-matical Statistics 1947; 18:50-60; http://dx.doi.org/10.1214/aoms/1177730491 277.,Non-OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
NatMethods 2011; 8:785-6; PMID:21959131; http://dx.doi.org/10.1038/nmeth.1701PLANT SIGNALING & BEHAVIOR e1274481-19,OADS,/arxiv_data1/oa_pdf/b8/9c/kpsb-12-02-1274481.PMC5351740.pdf
Available at: http://www.who.int/reproductivehealth/publications/ rtis/9789241505888/en/.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Available at: http://www.un aids.org/sites/default/ ﬁles/media_asset/ UNAIDS_Global_Report _2013_en_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Available at: http://www.info.gov.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
"Pretoria, South Africa: Department of Health; 2009: Available at:http://www.health-e.org.za/doc uments/85d3dad6136e8ca9d02cceb7f4a36145.",Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Available at: http://www.gov.za/provi ncial-budgets-and-e xpenditure-review.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Available at: http://www.hst.org.za/publications/south- African-health-review-2012/2013.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Available at: http://www.gov.za/sites/www.gov.za/ ﬁles/ DoH_draftHRstrategy_Consultation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Available at SSRN: http://ssrn.com/abstract=2322088.,Non-OADS,/arxiv_data1/oa_pdf/2f/20/qai-74-0523.PMC5351751.pdf
Other antiretroviral drugs were excluded because of insuf ﬁcient representation in the EuResist Integrated Database (EIDB20) or lack of a model for genotypic drug-resistance interpretation in geno2pheno [resistance] (g2p; http://www.geno2pheno.org; see Ref.,Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"Data Sources A total of 36,744 protease and reverse-transcriptase sequences from treatment-naive patients were obtained from the Los Alamos National Laboratory Sequence Database (LANLSD21; http://www.hiv.lanl.gov/; downloaded on March 31, 2015).",OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"HIV data from routine clinical practice were obtained from 2 sources: the EIDB (http:// www.euresist.org; downloaded April 11, 2014) and the HIVdb treatment-change episode (TCE)repository 22(http://hivdb.stanford.edu; downloaded November 21, 2013).",OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"The number ofgenotype-phenotype pairs per drug on which g2p v. 3.4 is trained is given in Table 1, Supplemental Digital Content, http://links.lww.com/QAI/A934.",Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"The resulting data set was used for estimating RF-conditionalprobabilities of success for each drug (see Methods, Supple- mental Digital Content, http://links.lww.com/QAI/A934).",OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"RF percentiles for the resulting RF distributions for therapy-naive patients, along with the corresponding POS, can be found in Table 2, SupplementalDigital Content, http://links.lww.com/QAI/A934.",Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"On average (SD), follow-up VLs used forlabeling TEs were obtained 7.04 (2.48) weeks after treatment initiation, with a median time of 7 weeks after treatment initiation (interquartile range: 9 –5 (Figure 1, Supplemental Digital Content, http://links.lww.com/QAI/A934)).",Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"12Nevertheless, cutoffs can be chosen manually based on other geometric features of the sigmoid function (see Figure 2 and Table 3, Supplemental DigitalContent, http://links.lww.com/QAI/A934) or at speci ﬁcp r o b a - bilities of success.",Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"Thisartifact results from the use of the probability density functions of the normal distribution for estimating success and failure densities (see Methods, Supplemental Digital Content,http://links.lww.com/QAI/A934).",Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
"We exemplify the computation of RF weights for an antiretroviral therapy with 3 drug compounds (see Table 4, Supplemental Digital Content, http://links.lww.com/QAI/ A934).",Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
Available at: http://www.hiv.lanl.gov/.,Non-OADS,/arxiv_data1/oa_pdf/df/49/qai-74-e129.PMC5351752.pdf
In the figure  the Pairwise Alignment Scores and evolutionary distances have been  reported (http://www.ncbi.nlm.nih.gov/gene/).,OADS,/arxiv_data1/oa_pdf/c5/3d/mco-06-02-0139.PMC5351761.pdf
The WordCloud representation shows the majority information about the PRDX family (see http://www.maayanlab.net/G2W/ help.php).,OADS,/arxiv_data1/oa_pdf/c5/3d/mco-06-02-0139.PMC5351761.pdf
"6, 810 –817, http://dx.doi.org/10.1080/00071668.2016.1222604 © 2016 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4c/f5/cbps-57-810.PMC5351789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any med- ium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/4c/f5/cbps-57-810.PMC5351789.pdf
"2, 237 –246 http://dx.doi.org/10.1080/02699052.2016.1231343 Published with license by Taylor & Francis Group, LLC © A. Reches, J. Kutcher, R. J. Elbin, H. Or-Ly, B. Sadeh, J. Greer, D. J. McAllister, A. Geva, A. P. Kontos This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/60/98/ibij-31-237.PMC5351793.pdf
"10, 1294 –1301 http://dx.doi.org/10.3109/02713683.2015.1122812 This article not subject to US copyright law.",Non-OADS,/arxiv_data1/oa_pdf/c7/92/icey-41-1294.PMC5351794.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/c7/92/icey-41-1294.PMC5351794.pdf
"1, 60–67 http://dx.doi.org/10.1080/01973533.2016.1255947  Imagining Success: Multiple Achievement Goals and the Effectiveness   of Imagery  Tim Blankert and Melvyn R. W. Hamstra  Maastricht University School of Business and Economics   ABSTRACT  Imagery (richly imagining carrying out a task successfully) is a popular performance-enhancement  tool in many domains.",Non-OADS,/arxiv_data1/oa_pdf/6f/86/hbas-39-060.PMC5351796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/6f/86/hbas-39-060.PMC5351796.pdf
"© 2017 Michael J. Kangas, Raychelle M. Burks, Jordyn Atwater, Rachel M. Lukowicz, Pat Williams, Andrea E. Holmes This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"2, 138 –153 http://dx.doi.org/10.1080/10408347.2016.1233805",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"ORCID Michael J. Kangas http://orcid.org/0000-0001-6558-6928 Andrea E. Holmes http://orcid.org/0000-0002-2963-1952 References Afkhami, A.; Sarlak, N. A Novel Cyanide Sensing Phase Based on Immobi- lization of Methyl Violet on A Triacetylcellulose Membrane.",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
http://shop.arrayit.com/ Accessed on 06.17.,Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"Mobile Field Kit (MFK) http://www.asynchrony.com/ products/mobile-Field-Kit/ Accessed on 01.08.16Bang, J. H.; Lim, S. H.; Park, E.; Suslick, K. S. Chemically Responsive Nano- porous Pigments: Colorimetric Sensor Arrays and the Identi ﬁcation of Aliphatic Amines.",OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
https://jacks.jpeocbd.army.mil/Jacks/Public/FactSheetProvider.,Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
http://www.army.mil/ article/125449/Explosives_detection_kit_ready_to_enter_new_acquisi tion_phase/ Accessed on 01.11.,OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"http://www.pcmag.com/article2/0,2817,2386386,00.asp Accessed on 03.02.16, PC Mag, 2011 .",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"http://www.acq.osd.mil/osbp/sbir/solicita-tions/sbir20151/army151.htm Accessed 04.08.16, 2015 .",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
https://www.army.mil/article/131773/DRSKO_project_ramping_up_quickly_to_production/ Accessed on 06.17.16.,Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"https://www.yahoo.com/news/bomb-dogs-shortage-us-homeland-secu rity-airport-195929824.html Accessed on 03.25.16, 2016 .",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"http://iabs.com/dry- explosive-test-kits/ Accessed on 01.12.16, 2015 .",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"http://www.gul ﬂink.osd.mil/fox_vehi cle_ii/index.html Accessed on 06.21.16, 2001 .",Non-OADS,/arxiv_data1/oa_pdf/53/37/batc-47-138.PMC5351797.pdf
"4, 216 –261 http://dx.doi.org/10.1080/10407413.2016.1230372",Non-OADS,/arxiv_data1/oa_pdf/0e/2e/heco-28-216.PMC5351798.pdf
"Retrieved from https://www.internationalphoneticassocia tion.org/icphs-proceedings/ICPhS2011/Online Proceedings/RegularSession/Moisik/Moisik.pdf Moran, G., Krupka, A., Tutton, A., & Symons, D. (1987).",Non-OADS,/arxiv_data1/oa_pdf/0e/2e/heco-28-216.PMC5351798.pdf
"Published with license by Taylor & Francis.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.CELL CYCLE 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"5, 457 –467 http://dx.doi.org/10.1080/15384101.2017.1281480",Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"ORCID Chandra Shekhar Verma http://orcid.org/0000-0003-0733-9798 Birgit Eisenhaber http://orcid.org/0000-0002-2910-7384 Frank Eisenhaber http://orcid.org/0000-0002-9599-5420 Samuel Ken-En Gan http://orcid.org/0000-0001-9936-5090 References [1] Herr A, White C, Milburn C, Wu C, Bjorkman P. Bivalent binding of IgA1 to Fc aRI suggests mechanism for cytokine activation of IgA phagocytosis.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"J Mol Biol 2003; 327:645-57; PMID:12634059; http://dx.doi.org/10.1016/S0022-2836(03)00149-9 [2] Maliszewski C, Vanden Bos T, Shen L, Schoenborn M, Kubagawa H, Beckmann M, Monteiro R. Recombinant soluble IgA Fc receptor: generation, biochemical characterization, and functional analysis ofthe recombinant protein.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"J Exp Med 1990;172:1665-72; PMID:2258698; http://dx.doi.org/10.1084/jem.172.6.1665 [4] Van Dijk T, Bracke M, Caldenhoven E, Raaijmakers J, Cammers J, Koenderman L, de Groot R. Cloning and characterization of Fc alphaRb, a novel Fc alpha receptor (CD89) isoform expressed in eosino- phils and neutrophils.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Gene 1996; 175:279-80; PMID:8917112;http://dx.doi.org/10.1016/0378-1119(96)00152-7 [6] Pleass R, Andrews P, Kerr M, Woof J.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"BiochemJ 1996; 318:771-7; PMID:8836118; http://dx.doi.org/10.1042/bj3180771 [7] Patry C, Sibille Y, Lehuen A, Monteiro R. Indenti ﬁcation of Fc a Receptor (CD89) isoforms generated by alternative splicing that aredifferentially expressed between blood monocytes and alveolar mac-rophages.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Immunogenetics 1996; 43:246-7; PMID:8575829; http://dx.doi.org/ 10.1007/s002510050057 [9] Yang M, Yao M, Gao G, Wang L, Zhang W, Rao Z.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"J Biol Chem 2003; 278:27966- 70; PMID:12783876; http://dx.doi.org/10.1074/jbc.C300223200 [10] Yang M, Xu G, Li S, Sun L, Shi N, Zeng W, Pang H, Zhang W, Rao Z. Crystallization and preliminary crystallographic analysis of the extra-cellular fragment of Fc aRI/CD89.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Acta Crystallog Section D 2003; 59:2251-3; ; http://dx.doi.org/10.1107/S0907444903020602 [11] Wenig K, Sendermann P. Puri ﬁcation, crystallization and X-ray dif- fraction analysis of the extracellular part of the human Fc receptorfor IgA, Fc aRI (CD89).",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Acta Crystallog Section D 2003; 59:2247-50; ; http://dx.doi.org/10.1107/S0907444903016421 [12] Herr A, Ballister E, Bjorkman P. Insights into IgA-mediated immune responses from the crystal structures of human Fc aRI and its com- plex with IgA1-Fc.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Annu Rev Immunol 2003; 21:177-204; PMID:12524384; http://dx.doi.org/10.1146/ annurev.immunol.21.120601.141011 [15] Van Vuuren A, van Egmond M, Coenen M, Morton H, van de Win- kel J.",Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Immunogenetics 1999; 49:586-9; PMID:10380711; http://dx.doi.org/10.1007/s002510050544 [16] Toyabe S, Kuwano Y, Takeda K, Uchiyama M, Abo T. IgA nephropa- thy-speci ﬁc expression of the IgA Fc receptors (CD89) on blood phagocytic cells.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
Clin Exp Immunol 1997; 110:226-32; PMID:9367406; http://dx.doi.org/10.1111/j.1365-2249.1997.tb08321.,Non-OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Nucleic Acids Res 2009; 37: W435-W40; PMID:19389726; http://dx.doi.org/10.1093/nar/gkp254 [18] Petersen T, Brunak S, Helijne G, Nielsen H. SignalP 4.0: discriminat- ing signal peptides from transmembrance regions.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Nat Methods 2011; 8:785-6; PMID:21959131; http://dx.doi.org/10.1038/nmeth.1701 [19] Guo K, Li J, Tang J, Tan C, Wang H, Zeng Q.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Cancer Biol Ther 2008; 7:750-7; PMID:18364570; http://dx.doi.org/10.4161/cbt.7.5.5764 [20] Hegde R, Bernstein H. The surprising complexity of signal sequences.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
Trends Biochem Sci 2006; 31:563-70; PMID:16919958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
Protein Eng 1996; 9:1121-33; PMID:9010925;http://dx.doi.org/10.1093/protein/9.12.1121 [22] Eisenhaber F. Hydrophobic regions on protein surfaces.,OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"BMC Bioinfor-matics 2015; 15:399; ; http://dx.doi.org/10.1186/s12859-014-0399-6 [24] Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Bioinformatics 2006; 22:2695-6; PMID:16940322; http://dx.doi.org/10.1093/bioinformatics/btl461 [25] Karagiannis P, Singer J, Hunt J, Gan S, Rudman S, Mechtcheriakova D, Knittelfelder R, Daniels T, Hobson P, Beavil A, et al.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Bioinformatics 2014; 30:3270; PMID:25095882; http://dx.doi.org/10.1093/bioinformatics/btu525 [28] Katoh K, Standley D. MAFFT multiple sequence alignment software version 7: improvements in performance and usability.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Mol BiolEvol 2013; 30:772-80; PMID:23329690; http://dx.doi.org/10.1093/ molbev/mst010 [29] Durocher Y, Perret S, Kamen A.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
"Nucleic Acids Res 2002; 30: E9; PMID:11788735; http://dx.doi.org/10.1093/nar/30.2.e9 [30] Sim JZ, Nguyen PV, Lee HK, Gan S. GelApp: mobile gel electropho- resis analyser.",OADS,/arxiv_data1/oa_pdf/0a/92/kccy-16-05-1281480.PMC5351921.pdf
Nat Genet 2 016; 48(3):273-82; PMID: 26829751; http://dx.doi.org/10.1038/ng.3500.,OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"5, 390 –391 http://dx.doi.org/10.1080/15384101.2016.1260990",Non-OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"Nat Genet 2016; 48(3):273-82; PMID:26829751; http://dx.doi.org/10.1038/ng.3500 [2] P ﬁster S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, et al.",OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"J Clin Invest 2008; 118(5):1739-49; PMID:18398503;http://dx.doi.org/10.1172/JCI33656 [3] Drier Y, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJ, Kluk MJ, Carey CD, Rodig SJ, Afrogheh AH, Faquin WC.",Non-OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"Nat Genet2016; 48(3):265-72; PMID:26829750; http://dx.doi.org/10.1038/ng.3502 [4] Danan-Gotthold M, Golan-Gerstl R , Eisenberg E, Meir K, Karni, R, and Levanon EY.",OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"Nucleic Acids Res 2015; 43(10):5130-44; PMID:25908786; http://dx.doi.org/10.1093/nar/gkv210 [5] Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA, and Goodall GJ.",OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"Gut 2013;62:716-26; PMID:22490519; http://dx.doi.org/10.1136/gutjnl-2011-301083 [7] Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher, SE, Zeid R, Masoud S, et al.",OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
Clin Can- cer Res 2014; 20:912-25; PMID:24297863; http://dx.doi.org/10.1158/ 1078-0432.CCR-13-2281 Figure 1.,OADS,/arxiv_data1/oa_pdf/43/e4/kccy-16-05-1260990.PMC5351923.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/d6/ddw382.PMC5351935.pdf
"Web resources ANNOVAR, http://www.openbioinformatics.org/annovar/ Bam2fastq software: http://www.hudsonalpha.org/gsl/information/software/bam2fastq COSMIC, http://cancer.sanger.ac.uk/cosmic/ ExAC, http://exac.broadinstitute.orgGATK, http://www.broadinstitute.org/gatk/GTEx, http://www.gtexportal.org/home/ Genomic Medicine Biorepository (GMB), Genomic Medicine Institute, Cleveland Clinic (http://www.lerner.ccf.org/gmi/gmb/methods.php)Genomic Medicine Institute calculator for PTEN CC scores, http://www.lerner.ccf.org/gmi/ccscore/ IGV, https://www.broadinstitute.org/igv/home/ NHLBI Exome Sequencing Project (ESP) Exome Variant Server,http://evs.gs.washington.edu/EVS/OMIM, http://www.omim.org/TCGA Data Portal, https://tcga-data.nci.nih.gov/tcga/ Supplementary Material Supplementary Material is available at HMG online.",Non-OADS,/arxiv_data1/oa_pdf/58/d6/ddw382.PMC5351935.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.CELL CYCLE 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"5, 436 –447 http://dx.doi.org/10.1080/15384101.2017.1281477",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"The GenePattern platform (BroadInstitute, MIT) was used to analyze the microarray data.Normalization was carried out using RMA via the Normali- zeAffymetrixST module followed by the identi ﬁcation of differentially expressed genes using the LimmaGP module(http://pwbc.garvan.unsw.edu.au/gp ).",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"ORCID Guo-Jun Liu http://orcid.org/0000-0002-4278-8372 Ryan J. Middleton http://orcid.org/0000-0001-8024-7772 Winnie Wai-Ying Kam http://orcid.org/0000-0002-5508-2432 Richard B. Banati http://orcid.org/0000-0003-3558-597X References [1] Eshleman AJ, Murray TF.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
J Neurochem 1989; 53:494-502; PMID:2746235; http://dx.doi.org/10.1111/j.1471-4159.,Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Cell Tissue Res 1998; 294:161-8; PMID:9724466; http://dx.doi.org/10.1007/s004410051166 [4] Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, et al.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Trends Pharmacol Sci 2006; 27:402-9; PMID:16822554; http://dx.doi.org/10.1016/j.tips.2006.06.005 [5] Antkiewicz-Michaluk L, Guidotti A, Krueger KE.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Science 2015; 347:551-5; PMID:25635100; http://dx.doi.org/10.1126/science.aaa1534 [7] Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M. Structure of the mitochondrial translocator protein in complex with a diagnos-tic ligand.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Science 2014; 343:1363-6; PMID:24653034; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Apoptosis 2010; 15:753-68;PMID:20107899; http://dx.doi.org/10.1007/s10495-010-0460-5 [10] Veenman L, Gavish M. The role of 18 kDa mitochondrial transloca- tor protein (TSPO) in programmed cell death, and effects of steroidson TSPO expression.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Steroids1997; 62:21-8; PMID:9029710; http://dx.doi.org/10.1016/S0039-128X (96)00154-7 [13] Liu GJ, Middleton RJ, Hatty CR, Kam WW, Chan R, Pham T, Harrison-Brown M, Dodson E, Veale K, Banati RB.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Brain Pathol 2014; 24:631-53; PMID:25345894; http://dx.doi.org/10.1111/bpa.12196 [14] Banati RB, Middleton RB, Chan R, Hatty CR, Kam WWY, Quin C, Graeber MB, Parmar A, Zahra D, Callaghan P, et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Nat Commun 2014; 5:5452; PMID:25406832;http://dx.doi.org/10.1038/ncomms6452 [15] Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Endocrinology 2014;155:89-97; PMID:24174323; http://dx.doi.org/10.1210/en.2013-1556 [16] Sileikyte J, Blachly-Dyson E, Sewell R, Carpi A, Menabo R, Di Lisa F, Ricchelli F, Bernardi P, Forte M. Regulation of the mitochondrialpermeability transition pore by the outer membrane does not involvethe Peripheral Benzodiazepine Receptor (TSPO).",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
J Biol Chem 2014; 289:13769-81; PMID:24692541; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"J Biol Chem 2014; 289:27444-54; PMID:24936060;http://dx.doi.org/10.1074/jbc.M114.578286 [18] Gut P, Zweckstetter M, Banati RB.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Trends Endocrinol Metab 2015; 26:349-56; PMID:26026242; http://dx.doi.org/10.1016/j.tem.2015.04.001 [19] Middleton RJ, Liu G-J, Banati RB.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Biochem SocTrans 2015; 43:553-8; PMID:26551692; http://dx.doi.org/10.1042/BST20150039 [20] Middleton RJ, Liu GJ, Banati RB.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Epigenetic silencing of the human 18 kDa translocator protein (TSPO) in a T-cell leukemia cell line.DNA Cell Biol 2017; 36:103-8; PMID:28004979; http://dx.doi.org/10.1089/dna.2016.3385 [21] Bertomeu T, Zvereff V, Ibrahim A, Zehntner S, Aliaga A, Rosa-Neto P, Bedell B, Falardeau P, Gourdeau H. TLN-4601 peripheral benzodi-azepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-speci ﬁc accumulation.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Biochem pharma- col 2010; 80:1572-9; PMID:20655882; http://dx.doi.org/10.1016/j.bcp.2010.07.018 [22] Bribes E, Carriere D, Goubet C, Galiegue S, Casellas P, Simony- Lafontaine J. Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"J Histochem Cytochem2004; 52:19-28; PMID:14688214; http://dx.doi.org/10.1177/002215540405200103 [23] Hardwick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast can-cer: correlation of breast cancer cell aggressive phenotype with PBRexpression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Life Sci 1983; 33:449-57; PMID:6308375; http://dx.doi.org /10.1016/0024-3205(83)90794-4 [25] Hardwick M, Cavalli LR, Barlow KD, Haddad BR, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) gene ampli ﬁcation in MDA-MB-231 aggressive breast cancer cells.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Cancer Genet Cytoge- net 2002; 139:48-51; PMID:12547158; http://dx.doi.org/10.1016/ S0165-4608(02)00604-0 [26] Lacapere JJ, Papadopoulos V. Peripheral-type benzodiazepine recep- tor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Steroids 2003; 68:569-85; PMID:12957662; http://dx.doi.org/10.1016/S0039-128X(03)00101-6 [27] Brown RC, Degenhardt B, Kotoula M, Papadopoulous V. Location- dependent role of the human glioma cell peripheral-type benzodiaze- pine receptor in proliferation and steroid biosynthesis.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Cancer Lett 2000; 156:125-32; PMID:10880761; http://dx.doi.org/10.1016/S0304-3835(00)00451-1 [28] Alvarez-Maubecin V, Garcia-Hernandez F, Williams JT, Van Bock- staele EJ.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Nat Chem Biol 2013; 9:97-104; PMID:23201900;http://dx.doi.org/10.1038/nchembio.1136 [30] Xiao J, Liang D, Zhang H, Liu Y, Li F, Chen YH.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Exp Biol Med (Maywood) 2010; 235:478-86; PMID:20407080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Curr PharmDes 2007; 13:2385-405; PMID:17692008; http://dx.doi.org/10.2174/ 138161207781368710 [33] Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MGhuman glioblastoma cells.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Biochemistry 2009; 48:4652-61; PMID:19358520; http://dx.doi.org/10.1021/bi900064t [34] Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A. Enigma of the peripheral benzodiazepine receptor.Pharmacol Rev 1999; 51:629-50; PMID:10581326 [35] Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Implications for drug development.Pharmacol Ther 2006; 110:503-24; PMID:16337685; http://dx.doi.org/10.1016/j.pharmthera.2005.09.007 [36] Carayon P, Portier M, Dussossoy D, Bord A, Petitpretre G, Canat X, Le Fur G, Casellas P. Involvement of peripheral benzodiazepinereceptors in the protection of hematopoietic cells against oxygen rad- ical damage.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Glia 2002; 40:206-17; PMID:12379908; http://dx.doi.org/10.1002/glia.10144 [38] Banati RB.,Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Br Med Bull 2003; 65:121-31; PMID:12697620; http://dx.doi.org/10.1093/bmb/65.1.121 [39] Banati RB, Cagnin A, Brooks DJ, Gunn RN, Myers R, Jones T, Birch R, Anand P. Long-term trans-synaptic glial responses in the human thala- mus after peripheral nerve injury.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Neuroreport 2001; 12:3439-42;PMID:11733686; http://dx.doi.org/10.1097/00001756-200111160-00012446 G.-J.,OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Neuropsychologia 2000; 38:115-24;PMID:10660224; http://dx.doi.org/10.1016/S0028-3932(99)00074-3 [41] Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Lancet 2001; 358:461-7; PMID:11513911; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Brain 2001; 124:2014- 27; PMID:11571219; http://dx.doi.org/10.1093/brain/124.10.2014 [43] Kuhlmann AC, Guilarte TR.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"J Neurochem 2000; 74:1694-704; PMID:10737628; http://dx.doi.org/ 10.1046/j.1471-4159.2000.0741694.x [44] Pedersen MD, Minuzzi L, Wirenfeldt M, Meldgaard M, Slidsborg C, Cumming P, Finsen B. Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Eur J Neurosci 2006; 24:991-1000; PMID:16930426;http://dx.doi.org/10.1111/j.1460-9568.2006.04975.x [45] Venneti S, Lopresti BJ, Wiley CA.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Prog Neurobiol 2006; 80:308-22; PMID:17156911; http://dx.doi.org/10.1016/j.pneurobio.2006.10.002 [46] Wilms H, Claasen J, Rohl C, Sievers J, Deuschl G, Lucius R. Involve- ment of benzodiazepine receptors in neuroin ﬂammatory and neuro- degenerative diseases: evidence from activated microglial cells in vitro.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Neurobiol Dis 2003; 14:417-24; PMID:14678758; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Glia 2011; 59:219-30; PMID:21125642; http://dx.doi.org/10.1002/glia.21091 [50] Eckert GP, Schiborr C, Hagl S, Abdel-Kader R, Muller WE, Rimbach G, Frank J. Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Neurochem Int2013; 62:595-602; PMID:23422877; http://dx.doi.org/10.1016/j.neuint.2013.02.014 [51] Krestinina OV, Grachev DE, Odinokova IV, Reiser G, Evtodienko YV, Azarashvili TS.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Bio- chemistry (Mosc) 2009; 74:421-9; PMID:19463096; http://dx.doi.org/ 10.1134/S0006297909040105 [52] Rosenberg N, Rosenberg O, Weizman A, Veenman L, Gavish M. In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator protein.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"J Bioenerg Biomembr 2013; 45:333-41; PMID:23475134; http://dx.doi.org/10.1007/s10863-013-9501-4 [53] Seneviratne MS, Faccenda D, De Biase V, Campanella M. PK11195 inhibits mitophagy targeting the F1Fo-ATPsynthase in Bcl-2 knock-down cells.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Anticancer Agents MedChem 2014; 14:559-77; PMID:24628235; http://dx.doi.org/10.2174/1871520614666140309230338 [55] Ko YH, Delannoy M, Hullihen J, Chiu W, Pedersen PL.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"J Biol Chem 2003; 278:12305-9; PMID:12560333; http://dx.doi.org/10.1074/jbc.C200703200 [56] McEnery MW, Snowman AM, Tri ﬁletti RR, Snyder SH.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Neurochem Int 2002; 40:475-86;PMID:11850104; http://dx.doi.org/10.1016/S0197-0186(01)00118-8 [59] Corsi L, Geminiani E, Avallone R, Baraldi M. Nuclear location- dependent role of peripheral benzodiazepine receptor (PBR) inhepatic tumoral cell lines proliferation.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Life Sci 2005; 76:2523-33;PMID:15769477; http://dx.doi.org/10.1016/j.lfs.2004.08.040 [60] Mendonca-Torres MC, Roberts SS.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Biochim Biophys Acta 2008; 1782:118-25;PMID:18190798; http://dx.doi.org/10.1016/j.bbadis.2007.12.001 [62] Wu X, Gallo KA.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"PLoS One 2013; 8:e71258; PMID:23967175; http://dx.doi.org/10.1371/journal.pone.0071258 [63] Liu GJ, Simpson AM, Swan MA, Tao C, Tuch BE, Crawford RM, Jovanovic A, Martin DK.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Am J Physiol Endocri- nol Metab 2005; 289:E578-85; PMID:16014354; http://dx.doi.org/ 10.1152/ajpendo.00054.2005 [65] Liu Y, Sato T, O ’Rourke B, Marban E. Mitochondrial ATP-depen- dent potassium channels: novel effectors of cardioprotection?",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
Circu- lation 1998; 97:2463-9; PMID:9641699; http://dx.doi.org/10.1161/01.CIR.97.24.2463 [66] O ’Rourke B.,Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Circ Res 2004; 94:420-32; PMID:15001541; http://dx.doi.org/10.1161/01.RES.0000117583.66950.43 [67] Hatty CR, Le Brun AP, Lake V, Clifton LA, Liu GJ, James M, Banati RB.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Biochim Biophys Acta 2014; 1838:1019-30; PMID:24374318; http://dx.doi.org/10.1016/j.bbamem.2013.12.013 [68] Cheng KT, Hou WC, Huang YC, Wang LF.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"J Agric Food Chem 2003; 51:7276-9; PMID:14640570; http://dx.doi.org/10.1021/jf0301549 [69] Dveksler GS, Basile AA, Dieffenbach CW.",OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"PCR Methods Appl 1992; 1:283-5; PMID:1477664;http://dx.doi.org/10.1101/gr.1.4.283 [70] Liu GJ, Nagarajah R, Banati RB, Bennett MR. Glutamate induces directed chemotaxis of microglia.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Eur J Neurosci 2009; 29:1108-18;PMID:19302147; http://dx.doi.org/10.1111/j.1460-9568.2009.06659.x [71] Milakovic T, Johnson GVW.",Non-OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
J Biol Chem 2005; 280:30773-82;PMID:15983033; http://dx.doi.org/10.1074/jbc.M504749200CELL CYCLE 447,OADS,/arxiv_data1/oa_pdf/4a/cf/kccy-16-05-1281477.PMC5351937.pdf
"Upon returning to room temperature, its functionality was judged on the basis of the sensitivity to light finger touch (in pe rcent increase in capacitance).SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602200/DC1Effects of scaling on sensorMechanical characterization: Cyclic loadingfig.",Non-OADS,/arxiv_data1/oa_pdf/a2/aa/1602200.PMC5351976.pdf
"(International Society for Optics and Photonics, 2015); http://proceedings.spiedigitallibrary.org/proceeding.aspx?articleid=2239762.",OADS,/arxiv_data1/oa_pdf/a2/aa/1602200.PMC5351976.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602262/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/36/24/1602262.PMC5351977.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601946/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/e9/75/1601946.PMC5351979.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1601430/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/57/1601430.PMC5351980.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602751/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/5a/d9/1602751.PMC5351983.pdf
Acknowledgments: We acknowledge high-performance computing support from Yellowstone (http://n2t.net/ark:/85065/d7wd3xhc) provided by NCAR ’s Computational and Information Systems Laboratory (CISL) and sponsored by the NSF.,Non-OADS,/arxiv_data1/oa_pdf/5a/d9/1602751.PMC5351983.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/3/e1602642/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/88/ed/1602642.PMC5351985.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/f8/dddt-11-705.PMC5352149.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 705–711Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  705Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12430 7 effects of dexamethasone coadministered  with oseltamivir on the pharmacokinetics  of oseltamivir in healthy volunteers Kyungho Jang1,2,* Min-Kyoung Kim3,4,* Jaeseong Oh1 seung hwan lee1 Joo-Y oun cho1 Kyung-sang Yu1 Tai Kiu choi3 sang-hyuk lee3,4 Kyoung soo lim4 1Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine and  hospital, seoul, 2center for clinical  Pharmacology and Biomedical  research institute, chonbuk  national University Medical school,   Jeonju, 3Department of Psychiatry,   4Department of clinical Pharmacology  and Therapeutics, cha  University  school of Medicine and cha Bundang  Medical center, seongnam, republic  of Korea *These authors contributed equally  to this workPurpose:  Oseltamivir is widely used in the treatment and prophylaxis of influenza A and B  viral infections.",Non-OADS,/arxiv_data1/oa_pdf/ce/f8/dddt-11-705.PMC5352149.pdf
"In particular, drug–drug interactions can affect the activity of  CES, significantly impacting the therapeutic effects of substrate drugs.4 For example,  ethanol inhibits the hydrolysis of methylphenidate, a CES1 substrate, and increases the  maximum concentration ( Cmax) and area under the concentration–time curve (AUC) of correspondence: Kyoung soo lim Department of clinical Pharmacology  and Therapeutics, cha University  school of Medicine and cha Bundang  Medical center, 59 Yatap-ro, Bundang-gu,  seongnam 463-712, republic of Korea Tel +82 31 780 5324 Fax +82 31 780 5305 email dr.kyoungsoo.lim@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Jang et al Running head recto: Effects of dexamethasone on oseltamivir pharmacokinetics DOI: http://dx.doi.org/10.2147/DDDT.S124307",Non-OADS,/arxiv_data1/oa_pdf/ce/f8/dddt-11-705.PMC5352149.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ce/f8/dddt-11-705.PMC5352149.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/f8/dddt-11-705.PMC5352149.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/bb/copd-12-813.PMC5352150.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 813–815International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  813Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S13099 1 the Barthel index-dyspnea a tool for respiratory  rehabilitation: reply to the letter by Chuang  [Letter of clarification] Mauro Carone1 Michele Vitacca2 Mara Paneroni2 Paola Baiardi3 Antonio Spanevello4,5 Giorgio Bertolotti6 1respiratory Division, ICS MAUGerI  SPA SB, Institute of Cassano Murge  (BA) IrCCS, Italy; 2respiratory  rehabilitation Division, ICS MAUG erI  SPA SB, Institute of Lumezzane (BS)  IrCCS, Italy; 3Scientific Direction, ICS  MAUGerI SPA SB, Institute of Pavia,  IrCCS, Italy; 4respiratory rehabilitation  Division, ICS MAUGerI SPA SB,  Institute of tradate (VA) IrCCS, Italy;  5respiratory Diseases Unit, University  of Insubria, Varese; 6Psychology Unit,  ICS MAUG erI SPA SB, Institute of  tradate (VA) IrCCS, ItalyDear editor We read the remarkable letter by Chuang.1 We thank him for his valid suggestions  on our paper.",Non-OADS,/arxiv_data1/oa_pdf/8c/bb/copd-12-813.PMC5352150.pdf
"The metric qualities are good and  the variability is acceptable, with 95% confidence intervals of correlation coefficient  of BI-d versus 6-minute walking test being −0.609 and −0.352, respectively.Correspondence: Mauro Carone Via per Mercadante km 2, 70010 Cassano  delle Murge (BA), Italy email mauro.carone@icsmaugeri.i tJournal name: International Journal of COPD Article Designation: Letter Y ear: 2017 Volume: 12 Running head verso: Carone et al Running head recto: The Barthel index-dyspnea: a tool for respiratory rehabilitation DOI: http://dx.doi.org/10.2147/COPD.S130991",Non-OADS,/arxiv_data1/oa_pdf/8c/bb/copd-12-813.PMC5352150.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/8c/bb/copd-12-813.PMC5352150.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/bb/copd-12-813.PMC5352150.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/amep-8-211.PMC5352152.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b1/e2/amep-8-211.PMC5352152.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2017:8 211–218Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 211 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S127626 Applying team-based learning of diagnostics  for undergraduate students: assessing teaching  effectiveness by a randomized controlled trial study Rui Zeng1,*  Lian-rui Xiang2,*  Jing Zeng3  Chuan Zuo4  1Department of Cardiovascular  Diseases, 2Department of Public  Affairs Development, 3Department  of Internal Medicine, 4Department  of Rheumatology and Immunology,   West China Hospital, School of Clinic Medicine, Sichuan University,  Chengdu, People’s Republic of China *These authors contributed equally to  this workBackground:  We aimed to introduce team-based learning (TBL) as one of the teaching  methods for diagnostics and to compare its teaching effectiveness with that of the traditional  teaching methods.",Non-OADS,/arxiv_data1/oa_pdf/b1/e2/amep-8-211.PMC5352152.pdf
"2–4 Compared with the traditional teaching method that is dominated by a  teacher’ s lectures, TBL more underscores the students’ main actor role in the learning process while teachers act as guides and advisers; TBL attaches more importance to Correspondence: Chuan Zuo   Department of Rheumatology and  Immunology, West China Hospital, School of Clinic Medicine, 37 Guoxuexiang, Sichuan University, Chengdu 610041, Sichuan Province, People’s Republic of China   Email zengrui_0524@126.comJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Zeng et alRunning head recto: Applying team-based learning of diagnostics for undergraduate studentsDOI: http://dx.doi.org/10.2147/AMEP .S127626",Non-OADS,/arxiv_data1/oa_pdf/b1/e2/amep-8-211.PMC5352152.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b1/e2/amep-8-211.PMC5352152.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 218 Zeng et al  3.,Non-OADS,/arxiv_data1/oa_pdf/b1/e2/amep-8-211.PMC5352152.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/2a/cia-12-499.PMC5352153.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 499–503Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  499OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13242 5 Correlation between movement complexity  during static standing and balance function in  institutionalized older adults Momoko Yamagata1 T ome Ikezoe1 Midori Kamiya1 Mitsuhiro Masaki2,3 noriaki Ichihashi1 1human health sciences, graduate  school of Medicine, Kyoto University,   Kyoto, 2Department of Physical  Therapy, 3Institute for human  Movement and Medical sciences,   niigata University of health and  Welfare, niigata, JapanPurpose:  Sample entropy (SampEn) is an analysis to evaluate movement complexity of the  center of pressure (COP).",Non-OADS,/arxiv_data1/oa_pdf/6b/2a/cia-12-499.PMC5352153.pdf
"Based on  previous investigations, it has been pointed out that the magnitude of COP variability  may not reflect balance function during static standing.5,6 On the other hand, some  authors focus on the complexity of COP variability in postural control.7 The movement complexity in the system of postural control, which is different from  random noise, is determined by the behavioral system factors, such as integration of Correspondence: Momoko Yamagata human health sciences, graduate  school of Medicine, Kyoto University,  53 Kawahara-cho, shogoin, sakyo-ku,  Kyoto 606-8507, Japan Tel +81 75 751 3935 Fax +81 75 751 3909 email yamagata.momoko.82w@ st.kyoto-u.ac.j p Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Y amagata et al Running head recto: Correlation between movement complexity and balance function DOI: http://dx.doi.org/10.2147/CIA.S132425",OADS,/arxiv_data1/oa_pdf/6b/2a/cia-12-499.PMC5352153.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6b/2a/cia-12-499.PMC5352153.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6b/2a/cia-12-499.PMC5352153.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/ee/copd-12-817.PMC5352154.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 817–827International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  817OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12340 5 soluble common gamma chain exacerbates  COPD progress through the regulation of  inflammatory T cell response in mice Byunghyuk Lee1 eunhee Ko1 Jiyeon Lee2 Yuna Jo1 Hyunju Hwang1 Tae Sik Goh1,3 Myungsoo Joo2 Changwan hong1 1Department of Anatomy and Cell  Biology, Pusan National University  school of Medicine, 2Division of  applied Medicine, school of Korean  Medicine, Pusan National University,   Yangsan, 3Department of Orthopedic  Surgery, Medical Research Institute,   Pusan National University School of  Medicine, Busan, south KoreaAbstract:  Cigarette smoking (CS) is a major cause of considerable morbidity and mortality  by inducing lung cancer and COPD.",Non-OADS,/arxiv_data1/oa_pdf/67/ee/copd-12-817.PMC5352154.pdf
"The expression of IFN γ in infiltrated T cells into the peripheral  airways was observed in bronchial biopsies of COPD patients.10 Furthermore, the  phosphorylation of STAT4, which is activated by IL-12, a primary cytokine in Th1  differentiation,11,12 is enhanced in CD4 T cells of smokers with COPD.10 Accord - ingly, the induction of phosphor-STAT4 and IFN γ correlates with the degree of  airflow limitation in patients with COPD.Correspondence: Myungsoo Joo Division of applied Medicine, school  of Korean Medicine, Pusan national  University, Rm 411, 49 Busandaehak-ro,  Yangsan, Gyeongsangnam-do, 50612,  south Korea Tel +82 10 5590 6211 Fax +82 51 510 8420 email mjoo@pusan.ac.k r  Changwan hong Department of Anatomy and Cell  Biology, Pusan National University School  of Medicine, 49 Busandaehak-ro, Yangsan,  Gyeongsangnam-do, 50612, South Korea Tel +82 51 510 8041 Fax +82 51 510 8049 email chong@pusan.ac.k r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lee et al Running head recto: Effects of s γc in a CSE mouse model DOI: http://dx.doi.org/10.2147/COPD.S123405",Non-OADS,/arxiv_data1/oa_pdf/67/ee/copd-12-817.PMC5352154.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/67/ee/copd-12-817.PMC5352154.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/ee/copd-12-817.PMC5352154.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f0/51/dddt-11-677.PMC5352155.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 677–683Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  677Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12670 1 Does remifentanil attenuate renal ischemia– reperfusion injury better than dexmedetomidine  in rat kidney?",Non-OADS,/arxiv_data1/oa_pdf/f0/51/dddt-11-677.PMC5352155.pdf
"Keywords:  ischemia–reperfusion, dexmedetomidine, remifentanil, neutrophil gelatinase- associated lipocalinCorrespondence: E Erkılıç Ahmet Taner Kışlalı mh Park cd Rönesans  evleri a-11 Çayyolu ankara 06530,  Turkey Tel +90 505 366 3491 email eerkilic72@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Erkılıc et al Running head recto: Protective effects of remifentanil compared to dex in rat kidney DOI: http://dx.doi.org/10.2147/DDDT.S126701",Non-OADS,/arxiv_data1/oa_pdf/f0/51/dddt-11-677.PMC5352155.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f0/51/dddt-11-677.PMC5352155.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/51/dddt-11-677.PMC5352155.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/8c/dddt-11-695.PMC5352156.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 695–704Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  695Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12788 9 Transcriptome analysis of endometrial tissues  following gnrh agonist treatment in a mouse  adenomyosis model song guo1,* Xiaowei lu1,* ruihuan gu2 Di Zhang3 Yijuan sun2 Yun Feng1 1Department of Obstetrics and  gynecology, reproductive Medicine  center, ruijin hospital affiliated to  shanghai Jiaotong University school  of Medicine, shanghai, People’s  republic of china; 2gynecology,   shanghai Ji ai genetics & in Vitro  Fertilization institute, Obstetrics  and gynecology hospital, Fudan  University, shanghai, People’s republic  of china; 3Department of gynecology  and Obstetrics, Jinan Military general  hospital, Jinan, People’s republic of  china *These authors contributed equally  to this workPurpose:  Adenomyosis is a common, benign gynecological condition of the female reproductive  tract characterized by heavy menstrual bleeding and dysmenorrhea.",Non-OADS,/arxiv_data1/oa_pdf/66/8c/dddt-11-695.PMC5352156.pdf
"Keywords:  adenomyosis, GnRH agonist, mouse, RNA-seq, pregnancy outcome Introduction Uterine adenomyosis is a benign gynecological disease that occurs in 19.5% of women of  childbearing age.1 The pathological features of adenomyosis are invasion of the endome - trium into the myometrium and ectopic endometrial glands surrounded by hypertrophic  and hyperplastic myometrium.2 Menorrhagia, pelvic pain, dysmenorrhea, and infertility  are the main clinical manifestations.3,4 Patients with adenomyosis have lower implanta - tion, clinical pregnancy, and ongoing pregnancy rates, and an increased miscarriage rate correspondence: Yijuan sun shanghai Ji ai genetics & iVF institute,  Obstetrics and gynecology hospital,  Fudan University, 588 Fangxie road,  shanghai 200011, People’s republic  of china Tel +86 21 6345 5468 Fax +86 21 3318 0478 email yijuansss@163.co m  Yun Feng Department of Obstetrics and  gynecology, reproductive Medicine  Center, Ruijin Hospital Affiliated to  shanghai Jiaotong University school  of Medicine, 197 rui-Jin 2nd road,  shanghai 200025, People’s republic  of china Tel +86 21 6437 4262 Fax +86 21 6437 4262 email artruijin1@sina.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Guo et al Running head recto: Endometrial transcriptome analysis following GnRH agonist treatment in adenomyosis DOI: http://dx.doi.org/10.2147/DDDT.S127889",Non-OADS,/arxiv_data1/oa_pdf/66/8c/dddt-11-695.PMC5352156.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/66/8c/dddt-11-695.PMC5352156.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/8c/dddt-11-695.PMC5352156.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 829–837International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  829OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S12524 0 Does urinary peptide content differ between  COPD patients with and without inherited  alpha-1 antitrypsin deficiency?",Non-OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
"The advantage of this method is that it prompts various hypothesis-generating Correspondence: sabina Janciauskiene Department of respiratory Medicine,  hannover Medical school, Feodor-lynen  str 23, 30625 hannover, germany Tel +49 511 532 7297 Fax +49 511 532 7294 email janciauskiene.sabina@ mh-han nover.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Carleo et al Running head recto: Urinary peptide content in COPD patients with or without A1ATD DOI: http://dx.doi.org/10.2147/COPD.S125240",Non-OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
"Functional  analysis was performed using Gene Group Functional Profil - ing, g:Profiler ( http://biit.cs.ut.ee/gprofiler /).23 Results Patient characteristics General patient characteristics are summarized in Table 1.",OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
"We used  the web server g:Profiler to predict the function of 36 proteins  (http://biit.cs.ut.ee/gprofiler /).23 Functional analysis revealed  that the differentially expressed peptides were clustered  in significant gene ontology categories related to biologic  processes, cellular components, molecular functions and  biologic pathways.",OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/5a/copd-12-829.PMC5352160.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/dddt-11-685.PMC5352161.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 685–694Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  685Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10932 5 Development of venetoclax for therapy of  lymphoid malignancies Huayuan Zhu1,2 Alexandru Almasan1 1Department of Cancer Biology,   Lerner Research institute, Cleveland  Clinic, Cleveland, OH, USA;   2Department of Hematology, The First  Affiliated Hospital of Nanjing Medical  University, Jiangsu Province Hospital,   Nanjing, People’s Republic of ChinaAbstract:  B-cell lymphoma-2 (BCL-2) family dysfunction and impairment of apoptosis are  common in most B-cell lymphoid malignancies.",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/dddt-11-685.PMC5352161.pdf
"Under cell stress signals, Correspondence: Alexandru Almasan Department of Cancer Biology, Lerner  Research institute, Cleveland Clinic,  Cleveland, OH 44195, USA Tel +1 216 444 9970 Fax +1 216 445 6269 email almasaa@ccf.or g Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Zhu and Almasan Running head recto: Venetoclax in lymphoid malignancies DOI: http://dx.doi.org/10.2147/DDDT.S109325",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/dddt-11-685.PMC5352161.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d2/3f/dddt-11-685.PMC5352161.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/3f/dddt-11-685.PMC5352161.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4f/81/ccid-10-087.PMC5352163.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4f/81/ccid-10-087.PMC5352163.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 87–92Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 87 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S130319 Skin disorders in Parkinson’s disease: potential  biomarkers and risk factors Astrid-Helene Ravn Jacob P Thyssen Alexander Egeberg Department of Dermatology and  Allergy, Herlev and Gentofte Hospital,  University of Copenhagen, Hellerup,  DenmarkAbstract:  Parkinson’ s disease (PD) is one of the most common neurodegenerative disorders,  characterized by a symptom triad comprising resting tremor, rigidity, and akinesia.",Non-OADS,/arxiv_data1/oa_pdf/4f/81/ccid-10-087.PMC5352163.pdf
"3Correspondence: Alexander Egeberg Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, 2900 Hellerup, DenmarkTel +45 2421 5421Email alexander.egeberg@gmail.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2017V olume: 10Running head verso: Ravn et alRunning head recto: Parkinson’ s disease and skin disordersDOI: http://dx.doi.org/10.2147/CCID.S130319",Non-OADS,/arxiv_data1/oa_pdf/4f/81/ccid-10-087.PMC5352163.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/4f/81/ccid-10-087.PMC5352163.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 92 Ravn et al 12.,Non-OADS,/arxiv_data1/oa_pdf/4f/81/ccid-10-087.PMC5352163.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/91/5f/ccide-9-007.PMC5352164.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/91/5f/ccide-9-007.PMC5352164.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).",Non-OADS,/arxiv_data1/oa_pdf/91/5f/ccide-9-007.PMC5352164.pdf
"5,9,10 However, few studies have reported Correspondence: Tatiana Miranda  DeliberadorDepartment of Dentistry, Positivo University, Rua Prof Pedro Viriato Parigot de Souza, Curitiba 5300, BrazilTel +55 41 3317 3180Fax +55 41 3317 3438Email tdeliberador@gmail.com Journal name:  Clinical, Cosmetic and Investigational Dentistry Article Designation: CASE REPORTY ear: 2017V olume: 9Running head verso: Santos et alRunning head recto: Comparison of the conventional and semilunar techniquesDOI: http://dx.doi.org/10.2147/CCIDE.S119040",Non-OADS,/arxiv_data1/oa_pdf/91/5f/ccide-9-007.PMC5352164.pdf
" Clinical, Cosmetic and Investigational Dentistry 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress  Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/91/5f/ccide-9-007.PMC5352164.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/91/5f/ccide-9-007.PMC5352164.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54952 | Page 1 of 9Video Article From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes  Tü6028 Anja Greule1, Songya Zhang1, Thomas Paululat2, Andreas Bechthold1 1Department of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-Universität Freiburg, Germany 2Department of Chemistry and Biology, Universität Siegen Correspondence to: Andreas Bechthold at andreas.bechthold@pharmazie.uni-freiburg.de URL: https://www.jove.com/video/54952 DOI: doi:10.3791/54952 Keywords: Genetics, Issue 119, natural products, polyketomycin, Streptomyces diastatochromogenes  Tü6028, extraction, purification, HPLC, biosynthetic gene cluster, genome sequencing, genome mining, single crossover.",Non-OADS,/arxiv_data1/oa_pdf/65/91/jove-119-54952.PMC5352224.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54952/ Introduction Natural products from plants and microorganisms have always been an important source for clinical drug development and research.,Non-OADS,/arxiv_data1/oa_pdf/65/91/jove-119-54952.PMC5352224.pdf
", Chapter 16 at <http://www.ncbi.nlm.nih.gov/books/NBK21097/> (2003).",Non-OADS,/arxiv_data1/oa_pdf/65/91/jove-119-54952.PMC5352224.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2017:10 79–86International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 79 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S126241Undernutrition and associated factors among  24–36-month-old children in slum areas of   Bahir Dar city, Ethiopia Yeshalem Mulugeta  Demilew1 Dagninet Derebe Abie2 1Department of Nutrition, School  of Public Health, College of  Medicine and Health Sciences, Bahir Dar University,  2Department of  Pharmacology, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, EthiopiaBackground: This study aimed to assess undernutrition and associated factors among  24–36-month-old children in the slum areas of Bahir Dar city.",Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
"3Correspondence: Yeshalem Mulugeta  DemilewSchool of Public Health, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, EthiopiaTel +251 91 878 3819 Email yeshalem_mulugeta@yahoo.com Journal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Demilew and AbieRunning head recto: Undernutrition and associated factors among 24–36-month-old childrenDOI: http://dx.doi.org/10.2147/IJGM.S126241",Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
"International Journal of General Medicine 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 86 Demilew and Abie  4.,Non-OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
Available from http://apps.who.int/iris/bit-stream/10665/37003/1/WHO_TRS_854.pdf.,OADS,/arxiv_data1/oa_pdf/4f/e3/ijgm-10-079.PMC5352227.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/6a/ndt-13-767.PMC5352228.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 767–768Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  767CorrigeNDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12094 2 Confirmation of the factorial structure of the Japanese short version of the  TEMPS-A in psychiatric patients and general adults [Corrigendum] Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R,  Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I.  Neuropsychiatr Dis Treat .",Non-OADS,/arxiv_data1/oa_pdf/ed/6a/ndt-13-767.PMC5352228.pdf
"Journal name: Neuropsychiatric Disease and Treatment Article Designation: Corrigendum Y ear: 2017 Volume: 13 Running head verso: Nakato et al Running head recto: Confirmation of the factorial structure of the Japanese short version of the TEMPS-A DOI: http://dx.doi.org/10.2147/NDT.S12094 2 HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH&\F &\F &\F &\F &\F &\F &\F &\F &\F &\F &\F &\F 'HS 'HS 'HS 'HS 'HS 'HS 'HS 'HS ,UU ,UU ,UU ,UU ,UU ,UU ,UU ,UU +\S +\S +\S +\S +\S +\S +\S +\S $Q[ $Q[ $Q[)DFWRU )DFWRU )DFWRU )DFWRU       )DFWRU    *),  $*),  &),  506($  506($ &), $*), *),  )DFWRU )DFWRU  &\F H HHHHHHHHHHHHHHHHH&\F&\F&\F&\F&\F'HS'HS'HS,UU,UU,UU,UU+\S+\S+\S$Q[$Q[           )DFWRU )DFWRU )DFWRUThe correct version of Figure 2 is shown below.",Non-OADS,/arxiv_data1/oa_pdf/ed/6a/ndt-13-767.PMC5352228.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ed/6a/ndt-13-767.PMC5352228.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/6a/ndt-13-767.PMC5352228.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/2c/ndt-13-755.PMC5352229.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 755–766Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  755Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12670 8 Lithium in late-life mania: a systematic review Pasquale De Fazio1 Raffaele Gaetano1 Mariarita Caroleo1 Maria Pavia2 Giovanbattista De Sarro3 Andrea Fagiolini4 Cristina Segura-Garcia1 1Department of Health Sciences,   Psychiatric Unit, University Magna  Græcia of Catanzaro, 2Department  of Health Science, University Magna  Græcia, 3Department of Health  Sciences, institute of Pharmacology,   University Magna Græcia, Catanzaro,   4Department of Molecular Medicine,   Division of Psychiatry, University of  Siena, Siena, italyAbstract:  The prevalence of mania among .65-year-olds ranges from 0.1% to 0.4% and its  treatment is a particular challenge for clinicians.",Non-OADS,/arxiv_data1/oa_pdf/d6/2c/ndt-13-755.PMC5352229.pdf
"Recent data support the hypothesis that in older  patients the onset of BD may be related to neurologic or vascular diseases.13 Many  neuroimaging studies have shown brain atrophy and cerebrovascular lesions in patients  with BD.14 Frequently, mania in the elderly is due to medication or other medical conditions.15  Decisions about the pharmacologic treatment of elderly BD patients must consider  safety and tolerability as much as effectiveness.Correspondence: Pasquale De Fazio Department of Health Sciences,  University Magna Græcia, viale europa,  88100 Catanzaro, italy Tel +39 33 1671 8231 Fax +39 961 71 2393 email defazio@unicz.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: De Fazio et al Running head recto: Lithium in late-life mania DOI: http://dx.doi.org/10.2147/NDT.S12670 8",Non-OADS,/arxiv_data1/oa_pdf/d6/2c/ndt-13-755.PMC5352229.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d6/2c/ndt-13-755.PMC5352229.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/2c/ndt-13-755.PMC5352229.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 495–503Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  495OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12714 7 lay health educators within primary care practices  to improve cancer screening uptake for south  Asian patients: challenges in quality improvement AK lofters1–4 M Vahabi5 V Prakash6 l Banerjee7 P Bansal8 s goel7,8 s Dunn1,2,9 1Department of Family and  community Medicine, 2Dalla lana  school of Public health, University of  T oronto, 3Department of Family and  community Medicine, 4centre for  Urban health solutions, st Michael’s  hospital, 5Daphne cockwell school  of nursing, ryerson University,   T oronto, 6screening saves lives  Program, canadian cancer society,   Mississauga, 7Wise elephant Family  health T eam, Brampton, 8Mississauga  halton central West regional  cancer Program, Mississauga,   9Women’s college research institute,   Women’s college hospital, T oronto,   On, canadaBackground:  Cancer screening uptake is known to be low among South Asian residents of  Ontario.",Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
"Keywords:  quality improvement, cancer screening, ethnicity, health equity, health promotion,  primary care Introduction The province of Ontario, Canada’s most populous province with 13 million people,  has well-established screening disparities for breast, cervical, and colorectal cancer,  particularly for people of low socioeconomic status and people who are foreign-born.1–10  Ontarians of South Asian ethnicity, that is those from India, Pakistan, Bangladesh,  and Sri Lanka, have been identified as an immigrant group particularly vulnerable  to underscreening for all three cancers.8,11–13 Despite generally having good access  to primary care, and better access than many other immigrant groups, South Asian  Ontarians appear to be the most underscreened group for all three cancers.3,5,8correspondence: AK lofters Department of Family and community  Medicine, University of Toronto,  30 Bond st Toronto, On,   M5B1W8, On, canada Tel +1 416 867 7428 email aisha.lofters@utoronto.c a Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Lofters et al Running head recto: Lay health educators in improving cancer screening uptake for South Asian patients DOI: http://dx.doi.org/10.2147/PPA.S127147",Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
Available from: https://www.cancercare.on.ca/pcs/screening/breast - screening/OBSP /.,Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
Available from:  https://www.cancercare.on.ca/pcs/screening/cervscreening /.,Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
Available from: http://ocp.cancercare.,Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
Available from: http://www.hqontario.ca/Portals/0/documents/ qi/qi-report-learningcollaborative1-0909-en.p df.,Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
"Available  from: http://www.hqontario.ca/quality-improvemen t. Accessed  October 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
"Available from: http://www.institute.nhs.uk/quality_and_ service_improvement_tools/ quality_and_service_improvement_tools / plan_do_study_act.htm l. Accessed October 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/65/5e/ppa-11-495.PMC5352230.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4e/3e/nss-9-067.PMC5352231.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4e/3e/nss-9-067.PMC5352231.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2017:9 67–79Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  67 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S129203Classical conditioning for preserving the effects  of short melatonin treatment in children with  delayed sleep: a pilot study Annette van Maanen1 Anne Marie Meijer1 Marcel G Smits2 Frans J Oort1 1Research Institute Child  Development and Education,   University of Amsterdam, Amsterdam,   2Centre for Sleep-Wake Disorders  and Chronobiology, Hospital Gelderse Vallei, Ede, the NetherlandsAbstract: Melatonin treatment is effective in treating sleep onset problems in children with  delayed melatonin onset, but effects usually disappear when treatment is discontinued.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/nss-9-067.PMC5352231.pdf
"Exogenous Correspondence: Annette van Maanen Research Institute Child Development and Education, University of Amsterdam, PO Box 15776, 1001 NG Amsterdam, the NetherlandsTel +31 20 525 1235Fax +31 20 525 1500Email a.vanmaanen@uva.nlJournal name: Nature and Science of Sleep Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: van Maanen et alRunning head recto: Classical conditioning and melatonin treatmentDOI: http://dx.doi.org/10.2147/NSS.S129203",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/nss-9-067.PMC5352231.pdf
"The abstract of this research has been published in  SLEEP-WAKE Research in the Netherlands, V olume 26, 2015, and has been published online: http://www.nswo.nl/userfiles/files/publications/Jaarboek-2015/NSWO%20Jaarboek%202015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/nss-9-067.PMC5352231.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/4e/3e/nss-9-067.PMC5352231.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/65/ijn-12-1841.PMC5352232.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1841–1851International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1841OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12286 4 In vitro and in vivo drug release and antibacterial  properties of the novel vancomycin-loaded  bone-like hydroxyapatite/poly amino acid scaffold Zhidong cao1 Dianming Jiang2 ling Yan3 Jun Wu4 1Department of Orthopedics, The  emergency Medical center of  chongqing city, chongqing, People’s  republic of china; 2Department of  Orthopedics, The First affiliated  hospital of chongqing Medical  University, chongqing, People’s  republic of china; 3Department  of Orthopedics, The First People’s  hospital of Zunyi city, Zunyi, People’s  republic of china; 4Department of  Orthopedics, children’s hospital  affiliated to chongqing University of  Medical sciences, chongqing, People’s  republic of chinaAbstract:  Antibiotic-loaded carriers were developed to fill cavities and locally deliver antibiotics  following implantation.",Non-OADS,/arxiv_data1/oa_pdf/32/65/ijn-12-1841.PMC5352232.pdf
"Additionally, these systems  decrease the plasma drug concentration, which in turn decreases systemic toxicity and correspondence: Dianming Jiang Department of Orthopedics, The First  Affiliated Hospital of Chongqing Medical  University, No 1 Youyi road Yuzhong  District, chongqing city, People’s  republic of china Tel +86 13 8838 94301 email czd2445@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Cao et al Running head recto: Drug release and antibacterial properties of V -BHA/PAA scaffold DOI: http://dx.doi.org/10.2147/IJN.S122864",Non-OADS,/arxiv_data1/oa_pdf/32/65/ijn-12-1841.PMC5352232.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/32/65/ijn-12-1841.PMC5352232.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/65/ijn-12-1841.PMC5352232.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/07/ijn-12-1877.PMC5352233.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1877–1890International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1877OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12952 6 Investigation of silk fibroin nanoparticle-decorated  poly( l-lactic acid) composite scaffolds for  osteoblast growth and differentiation Biao-Qi Chen1 Ranjith Kumar Kankala1,2 Ai-Zheng Chen1,2 Ding-Zhu Yang1 Xiao-Xia Cheng1 Ni-Na Jiang1,2 Kai Zhu3,4 Shi-Bin Wang1,2 1Institute of Biomaterials and Tissue  engineering, 2Fujian Provincial Key  Laboratory of Biochemical T echnology,   huaqiao University, Xiamen, Fujian,   3Department of cardiac surgery,   Zhongshan Hospital, Fudan University,   4Shanghai Institute of Cardiovascular  Disease, Shanghai, People’s Republic  of ChinaAbstract:  Attempts to reflect the physiology of organs is quite an intricacy during the tissue  engineering process.",Non-OADS,/arxiv_data1/oa_pdf/9e/07/ijn-12-1877.PMC5352233.pdf
"A biodegradable scaffold can serve as a framework as well as a  temporary carrier before occupancy of new tissue and also modulate various important  cell behaviors.8,9 Cells are inherently sensitive to their supporting substrate.10–12  Interconnected macroporous scaffold network facilitates cell infiltration, growth,  nutrient diffusion and removal of metabolic waste during tissue development.13,14 Recently, construction of surface topography has attracted a great interest in the  development of micrometric to nanometric range in different types of cells.6,15–19 Correspondence: Ai-Zheng Chen Institute of Biomaterials and Tissue  engineering, huaqiao University, 668  Jimei avenue, Xiamen, Fujian 361021,  People’s Republic of China Tel/fax +86 592 616 2326 email azchen@hqu.edu.c n  Shi-Bin Wang Fujian Provincial Key Laboratory of  Biochemical Technology, Huaqiao  University, 668 Jimei avenue, Xiamen,  Fujian 361021, People’s Republic of China Tel/fax +86 592 616 2208 email sbwang@hqu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Chen et al Running head recto: Investigation of SF nanoparticle-decorated PLLA composite scaffolds DOI: http://dx.doi.org/10.2147/IJN.S129526",Non-OADS,/arxiv_data1/oa_pdf/9e/07/ijn-12-1877.PMC5352233.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9e/07/ijn-12-1877.PMC5352233.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/07/ijn-12-1877.PMC5352233.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/39/ijn-12-1905.PMC5352234.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1905–1915International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1905OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12795 7 gold nanoparticles-based electrochemical  method for the detection of protein kinase  with a peptide-like inhibitor as the bioreceptor Kai sun Y ong chang Binbin Zhou Xiaojin Wang lin liu henan Province of Key laboratory  of New Optoelectronic Functional  Materials, college of chemistry and  chemical engineering, anyang Normal  University, anyang, henan, People’s  republic of chinaAbstract:  This article presents a general method for the detection of protein kinase with a  peptide-like kinase inhibitor as the bioreceptor, and it was done by converting gold nanoparticles  (AuNPs)-based colorimetric assay into sensitive electrochemical analysis.",Non-OADS,/arxiv_data1/oa_pdf/25/39/ijn-12-1905.PMC5352234.pdf
"In recent years, a few novel methods have been developed for kinase detection,  including colorimetry,10–17 electrochemistry,18–32 fluorescence,33–40 resonance  light scattering,41 quartz crystal microbalance (QCM),42 photoelectrochemistry,43 correspondence: lin liu henan Province of Key laboratory  of New Optoelectronic Functional  Materials, college of chemistry and  chemical engineering, anyang Normal  University, 436 Xian’ge road, anyang,  henan 455000, People’s republic of  china Tel +86 732 330 0925 email liulin@aynu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Sun et al Running head recto: Detection of protein kinase with a peptide-like kinase inhibitor DOI: http://dx.doi.org/10.2147/IJN.S12795 7",Non-OADS,/arxiv_data1/oa_pdf/25/39/ijn-12-1905.PMC5352234.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/25/39/ijn-12-1905.PMC5352234.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/39/ijn-12-1905.PMC5352234.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/73/ndt-13-745.PMC5352235.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 745–753Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  745OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13117 4 a chinese version of the Psychotic symptom  rating scales: psychometric properties in  recent-onset and chronic psychosis Wai-T ong chien1 isabella Yuet-Ming lee2 li-Qun Wang3 1school of Nursing, Faculty of  health and social sciences, The  hong Kong Polytechnic University,   hung hom, Kowloon, hong Kong,   People’s republic of china; 2central  Nursing Division, ruttonjee Tang  shiu King hospital, Wan chai, hong  Kong, People’s republic of china;   3school of Nursing, Jilin Medical  college, Jilin city, Jilin Province,   People’s republic of chinaAbstract:  The purpose of this study was to test the reliability, validity, and factor structure of  a Chinese version of the Psychotic Symptom Rating Scale (PSYRATS) in 198 and 202 adult  patients with recent-onset and chronic psychosis, respectively.",Non-OADS,/arxiv_data1/oa_pdf/6b/73/ndt-13-745.PMC5352235.pdf
"Among those correspondence: Wai-Tong chien school of Nursing, Faculty of health  and social sciences, PQ 402, The hong  Kong Polytechnic University, hung  hom, Kowloon, hong Kong, People’s  republic of china Tel +852 2766 5648 Fax +852 2364 9663 email wai.tong.chien@polyu.edu.h k Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chien et al Running head recto: Psychometric properties of a Chinese version of PSYRATS DOI: http://dx.doi.org/10.2147/NDT.S131174",Non-OADS,/arxiv_data1/oa_pdf/6b/73/ndt-13-745.PMC5352235.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6b/73/ndt-13-745.PMC5352235.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/73/ndt-13-745.PMC5352235.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/68/ott-10-1475.PMC5352236.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1475–1485OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1475Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9238 9 investigating the expression, effect and  tumorigenic pathway of P aDi2 in tumors Wei guo1,2,* Yabing Zheng2,* Bing Xu1 Fang Ma1 chang li3 Xiaoqian Zhang4 Yao Wang1 Xiaotian chang1 1Medical research center, shandong  Provincial Qianfoshan hospital,   2Obstetrical Department, shandong  Provincial Qianfoshan hospital,   shandong University, Jinan, shandong,   3Pathology Department, Tengzhou  central People’s hospital, T engzhou,   4clinical laboratory, PKU care  luzhong hospital, Zibo, shandong,   People’s republic of china *These authors contributed equally  to this workBackground:  Peptidylarginine deiminase (PAD) catalyzes the conversion of arginine residues  to citrulline residues, termed citrullination.",Non-OADS,/arxiv_data1/oa_pdf/4c/68/ott-10-1475.PMC5352236.pdf
"Five mammalian PAD family members (PAD or PADI 1–4 and 6) are all encoded  by a cluster of genes on chromosome 1p36.13 and have a described tissue-specific  distribution in most body tissues.1 PAD-mediated post-translational citrullination is correspondence: Xiaotian chang Medical research center, shandong  Qianfoshan hospital, shandong  University, Jingshi road 16766,  Jinan, shandong 250014, People’s  republic of china Tel +86 531 8926 8970 email changxt@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Guo et al Running head recto: Investigating the expression, effect and tumorigenic pathway DOI: http://dx.doi.org/10.2147/OTT.S92389",Non-OADS,/arxiv_data1/oa_pdf/4c/68/ott-10-1475.PMC5352236.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4c/68/ott-10-1475.PMC5352236.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/68/ott-10-1475.PMC5352236.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/47/ott-10-1503.PMC5352237.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1503–1512OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1503Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13013 9 silencing Trim59 inhibits invasion/migration and  epithelial-to-mesenchymal transition via TgF- β/ smad2/3 signaling pathway in bladder cancer cells Wei chen1,* Kai Zhao2,* chenkui Miao2,* aiming Xu2 Jianzhong Zhang2 Jundong Zhu2 shifeng su2 Zengjun Wang2 1Department of Urology, nanjing  First hospital, nanjing Medical  University, 2state Key laboratory  of reproductive Medicine and  Department of Urology, The First  affiliated hospital of nanjing Medical  University, nanjing, People’s republic  of china *These authors contributed equally  to this workAbstract:  The evolutionarily conserved genes that encode the tripartite motif (TRIM) protein  family are involved in various biological processes, including cellular immunity, inflammatory  reaction, antiviral activity, and tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/8c/47/ott-10-1503.PMC5352237.pdf
"Trim59 was first detected as a tumorigenic gene of various cancer types correspondence: Zengjun Wang;   shifeng su state Key laboratory of reproductive  Medicine and Department of Urology,  The First Affiliated Hospital of Nanjing  Medical University, no 300 guangzhou  road, nanjing, Jiangsu 210029, People’s  republic of china Tel +86 25 6813 6498 Fax +86 25 8378 0079 email zengjunwang@njmu.edu.c n;  1074253104@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Chen et al Running head recto: Silencing Trim59 inhibits metastasis and EMT in bladder cancer cells DOI: http://dx.doi.org/10.2147/OTT.S130139",Non-OADS,/arxiv_data1/oa_pdf/8c/47/ott-10-1503.PMC5352237.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8c/47/ott-10-1503.PMC5352237.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/47/ott-10-1503.PMC5352237.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 1487–1502OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1487Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10945 3 Spotlight on atezolizumab and its potential in the  treatment of advanced urothelial bladder cancer Ahmet Murat Aydin1,* Solomon L woldu1,* Ryan C Hutchinson1 Martin Boegemann2 Aditya Bagrodia1 Yair Lotan1 vitaly Margulis1 Laura-Maria Krabbe1,2 1Department of Urology, University  of Texas Southwestern Medical  Center, Dallas, TX, USA; 2Department  of Urology, University of Münster  Medical Center, Münster, Germany *These authors contributed equally  to this workAbstract:  Metastatic urothelial carcinoma of the bladder is an aggressive malignancy with poor  prognosis, reflecting a lack of effective systemic therapies.",Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
"Numerous permutations of these platinum-containing regimens have been  studied, including high-intensity MVAC, coadministration of growth-factor support,  and substitution of other platinum agents (eg, carboplatin) for those unable to receive Correspondence: Laura-Maria Krabbe Department of Urology, University of  Texas Southwestern Medical Center,  5323 Harry Hines Boulevard – J8.124,  Dallas, TX 75390-9110, USA Tel +1 214 648 0567 Fax +1 214 648 8786 email laura-maria.krabbe@ utsouthwestern.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2017 Volume: 10 Running head verso: Aydin et al Running head recto: Atezolizumab for advanced urothelial carcinoma DOI: http://dx.doi.org/10.2147/OTT.S109453",Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0210865 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0295176 7.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT0280763 6.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0245033 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available  from: https://clinicaltrials.gov/ct2/show/record/NCT0279219 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available  from: https://clinicaltrials.gov/ct2/show/record/NCT0266230 9.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0245142 3.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0284481 6.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from: https://clinicaltrials.gov/ct2/show/ record/NCT0265582 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0229815 3.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from:  https://clinicaltrials.gov/ct2/show/record/NCT0260343 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0251624 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/6c/ott-10-1487.PMC5352238.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ndt-13-721.PMC5352239.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 721–722Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  721LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S12285 4 Monitoring brain multiparameters and  hypothermia in severe traumatic brain injury Fernando roberto de  Vasconcelos Almir Ferreira de Andrade Manoel Jacobsen T eixeira Wellingson Silva Paiva Division of Neurological Surgery,   Department of Neurology, University  of São Paulo Medical School, São  Paulo, BrazilDear editor We read with great interest the recent study by Sun et al1 published in Neuropsychiatric  Disease and Treatment .",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ndt-13-721.PMC5352239.pdf
"The study has already demonstrated  the benefits of all these five parameters by emphasizing the improvement due to Correspondence: Wellingson Silva Paiva Division of Neurological Surgery,  Department of Neurology, University  of São Paulo Medical School, 255 eneas  Aguiar, 05403000 São Paulo, Brazil Tel +55 11 2661 7226 Fax +55 11 2548 6906 email wellingsonpaiva@yahoo.com.b r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Letter Y ear: 2017 Volume: 13 Running head verso: Vasconcelos et al Running head recto: Brain multiparameters and hypothermia in TBI DOI: http://dx.doi.org/10.2147/NDT.S12285 4",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ndt-13-721.PMC5352239.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ndt-13-721.PMC5352239.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ndt-13-721.PMC5352239.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/c2/tcrm-13-287.PMC5352240.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 287–297Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  287ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12686 9 The influence of surgical technique on early  posttransplant atrial fibrillation – comparison  of biatrial, bicaval, and total orthotopic heart  transplantation Rasmus Rivinius1 Matthias helmschrott1 arjang Ruhparwar2 Christian Erbel1 Christian a gleissner1 Fabrice F Darche1 Dierk Thomas1 T om Bruckner3 hugo a Katus1 Andreas O Doesch1 1Department of Cardiology,   Angiology and Pneumology,   2Department of Cardiac Surgery,   Heidelberg University Hospital,   3Institute for Medical Biometry and  Informatics, University of Heidelberg,   Heidelberg, GermanyPurpose:  Early posttransplant atrial fibrillation (AF) has been associated with worse clinical  outcomes after heart transplantation (HTX).",Non-OADS,/arxiv_data1/oa_pdf/37/c2/tcrm-13-287.PMC5352240.pdf
"The initial “standard technique” for HTX, also known as “biatrial  technique (BA)”, was developed by Lower and Shumway.3 It consists of two long  anastomoses of donor and recipient atria resulting in enlarged cavities with distorted Correspondence: Andreas O Doesch Department of Cardiology, Angiology  and Pneumology, Heidelberg University  Hospital, Im Neuenheimer Feld 410,  69120 Heidelberg, Germany Tel +49 6221 563 9936 Fax +49 6221 564 105 email andreas.doesch@med.uni- heidelberg.d e Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Rivinius et al Running head recto: Influence of surgical technique on posttransplant atrial fibrillation DOI: http://dx.doi.org/10.2147/TCRM.S12686 9",Non-OADS,/arxiv_data1/oa_pdf/37/c2/tcrm-13-287.PMC5352240.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/37/c2/tcrm-13-287.PMC5352240.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/c2/tcrm-13-287.PMC5352240.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/c2/ijn-12-1891.PMC5352242.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1891–1903International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1891OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12937 5 Involvement of PINK1/parkin-mediated mitophagy  in ZnO nanoparticle-induced toxicity in BV-2 cells limin Wei1,2,* Jianfeng Wang1,2,* aijie chen1 Jia liu1 Xiaoli Feng1 longquan shao1 1Department of stomatology,   Nanfang hospital, southern Medical  University, guangzhou, People’s  republic of china; 2Department  of Pediatric Dentistry, school and  hospital of stomatology, Wenzhou  Medical University, Wenzhou,   People’s republic of china *These authors contributed equally  to this workAbstract:  With the increasing application of zinc oxide nanoparticles (ZnO NPs) in biological  materials, the neurotoxicity caused by these particles has raised serious concerns.",Non-OADS,/arxiv_data1/oa_pdf/ff/c2/ijn-12-1891.PMC5352242.pdf
"Han et al9 used correspondence: longquan shao Department of stomatology, Nanfang  hospital, southern Medical University,  1838 North guangzhoudadao,  guangzhou, guangdong Province,  510515, People’s republic of china Tel +86 159 8928 3921 email shaolongquan@smu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wei et al Running head recto: PINK1/parkin-mediated mitophagy in ZnO NP-induced BV -2 toxicity DOI: http://dx.doi.org/10.2147/IJN.S129375",Non-OADS,/arxiv_data1/oa_pdf/ff/c2/ijn-12-1891.PMC5352242.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ff/c2/ijn-12-1891.PMC5352242.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/c2/ijn-12-1891.PMC5352242.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/81/43/idr-10-075.PMC5352243.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/81/43/idr-10-075.PMC5352243.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2017:10 75–83Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 75 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S127903Molecular detection of multidrug-resistant  tuberculosis among smear-positive pulmonary  tuberculosis patients in Jigjiga town, Ethiopia Mussie Brhane1 Ameha Kebede2 Y ohannes Petros2 1Department of T uberculosis Culture  and DST Laboratory, Harar Health  Research and Regional Laboratory,  Harar, Ethiopia;  2Department of  Biology, College of Computational and Natural Sciences, Haramaya University, Haramaya, EthiopiaBackground: Molecular methods that target drug resistance mutations are suitable approaches  for rapid drug susceptibility testing to detect multidrug-resistant tuberculosis (MDR-TB).",Non-OADS,/arxiv_data1/oa_pdf/81/43/idr-10-075.PMC5352243.pdf
"4 In 2012, Correspondence: Mussie Brhane Tuberculosis Culture and DST Laboratory, Harar Health Research and Regional Laboratory, PO Box: 819, Harar, Harar Regional State, EthiopiaTel +251 25 91 342 7484 Email musbr1836@gmail.comJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Brhane et alRunning head recto: MDR-TB in smear-positive PTB patients of EthiopiaDOI: http://dx.doi.org/10.2147/IDR.S127903",Non-OADS,/arxiv_data1/oa_pdf/81/43/idr-10-075.PMC5352243.pdf
"Infection and Drug Resistance  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/81/43/idr-10-075.PMC5352243.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 83 MDR-TB in smear-positive PTB patients of Ethiopia 33.,Non-OADS,/arxiv_data1/oa_pdf/81/43/idr-10-075.PMC5352243.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7e/46/oajsm-8-027.PMC5352244.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7e/46/oajsm-8-027.PMC5352244.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2017:8 27–32Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 27 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S112688Negative psychological responses of injury and  rehabilitation adherence effects on return to play  in competitive athletes: a systematic review and  meta-analysis Andreas Ivarsson1  Ulrika Tranaeus2,3  Urban Johnson1  Andreas Stenling4 1Center of Research on Welfare,   Health and Sport, School of Health  and Welfare, Halmstad University,  Halmstad,  2Performance and  Training Unit, The Swedish School of Sport and Health Sciences (GIH),   3Musculoskeletal & Sports Injury  Epidemiology Center, IMM, Karolinska Institutet, Stockholm,  4Department of  Psychology, Umeå University, Umeå,  SwedenAbstract:  Previous research offers evidence that psychological factors influence an injured  athlete during the rehabilitation process.",Non-OADS,/arxiv_data1/oa_pdf/7e/46/oajsm-8-027.PMC5352244.pdf
"This increased interest has resulted in several published Correspondence: Andreas Ivarsson   Center of Research on Welfare,  Health and Sport, School of Health and Welfare, Halmstad University,   PO Box 823, Halmstad SE-30118,   Sweden Tel +46 35 16 7448   Email andreas.ivarsson@hh.seJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Ivarsson et alRunning head recto: Psychological responses and return to sport after injuryDOI: http://dx.doi.org/10.2147/OAJSM.S112688",Non-OADS,/arxiv_data1/oa_pdf/7e/46/oajsm-8-027.PMC5352244.pdf
"Open Access Journal of Sports Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/7e/46/oajsm-8-027.PMC5352244.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/46/oajsm-8-027.PMC5352244.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/2a/ijn-12-1863.PMC5352245.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1863–1875International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1863OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13185 0 a potential in situ gel formulation loaded with  novel fabricated poly(lactide-co-glycolide)  nanoparticles for enhancing and sustaining the  ophthalmic delivery of ketoconazole Tarek abdelnapy ahmed1,2 Bader M aljaeid1 1Department of Pharmaceutics,   Faculty of Pharmacy, King abdulaziz  University, Jeddah, Kingdom of saudi  arabia; 2Department of Pharmaceutics  and Industrial Pharmacy, Faculty  of Pharmacy, al-azhar University,   cairo,  egyptAbstract:  Oral ketoconazole therapy is commonly associated with serious hepatotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/ijn-12-1863.PMC5352245.pdf
"When ketoconazole is administered for treatment  of fungal eye infections, it is characterized by a very short duration of action since its  elimination half-life in the aqueous humor and cornea is ~19 and 43 min, respectively.3,4  Although ketoconazole is characterized by its high lipid solubility (log P=4.74), which correspondence: Tarek abdelnapy  ahmed Department of Pharmaceutics, Faculty  of Pharmacy, King abdulaziz University,  Jeddah, Kingdom of saudi arabia Tel +966 12 640 0000x22250 email dr_tarek_nour@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ahmed and Aljaeid Running head recto: Ophthalmic delivery of ketoconazole DOI: http://dx.doi.org/10.2147/IJN.S13185 0",Non-OADS,/arxiv_data1/oa_pdf/df/2a/ijn-12-1863.PMC5352245.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/df/2a/ijn-12-1863.PMC5352245.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/2a/ijn-12-1863.PMC5352245.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/89/ppa-11-487.PMC5352246.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 487–494Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  487OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12628 3 evaluating the patient experience after  implantation of a 0.4 mg sustained release  dexamethasone intracanalicular insert  (Dextenza™): results of a qualitative survey Joseph P gira1 reginald sampson2 steven M silverstein3 Thomas r Walters4 Jamie lynne Metzinger5 Jonathan h Talamo5 1Ophthalmology consultants, st louis,   MO, 2Montebello Medical center,   inc., Montebello, cA, 3silverstein eye  centers, Kansas city, MO, 4T exan eye,   Austin, TX, 5Ocular Therapeutix, inc.,   Bedford, MA, UsAPurpose:  The purpose of this study is to evaluate the patient experience of sustained release  dexamethasone intracanalicular insert (Dextenza™) following cataract surgery as part of a  Phase III clinical trial program.",Non-OADS,/arxiv_data1/oa_pdf/a6/89/ppa-11-487.PMC5352246.pdf
"Keywords:  dexamethasone, cataract, sustained release, drug delivery, corticosteroid,  Dextenza Introduction Untreated cataract is the leading cause of vision loss in the US, and as the size of the  aging population increases, the problem is expected to intensify.1,2 According to US  Census data, by the year 2020, it is estimated that the number of Americans diagnosed  with cataract is expected to rise to 30.1 million, representing a 31.9% increase over  current prevalence estimates.1 Given these numbers, it is not surprising that cataract  removal is the most commonly performed surgical procedure in the US Medicare- eligible population.3 Approximately 3.6 million cataract surgeries were performed in  the US in 2015, and .20 million surgeries were performed worldwide.4 In parallel correspondence: Jamie lynne Metzinger Ocular Therapeutix, inc., 34 crosby  Drive, suite 105, Bedford, MA 01730,  UsA Tel +1 781 357 4010 Fax +1 781 357 4001 email jm etzinger@ocutx.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Gira et al Running head recto: Patient-reported outcomes survey for Dextenza™ DOI: http://dx.doi.org/10.2147/PPA.S12628 3",Non-OADS,/arxiv_data1/oa_pdf/a6/89/ppa-11-487.PMC5352246.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a6/89/ppa-11-487.PMC5352246.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/14/ijn-12-1917.PMC5352247.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1917–1925International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1917OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13204 3 Improved chemotherapeutic efficacy of injectable  chrysin encapsulated by copolymer nanoparticles Kyoung Mee Kim1,2 Hyun Kyung Lim1,2 Sang Hee Shim1,2 Joohee Jung1,2 1College of Pharmacy, 2Innovative  Drug Center, Duksung Women’s  University, Seoul, Republic of KoreaAbstract:  Chrysin is a flavone that is found in several plants and in honeycomb and possesses  various biological activities.",Non-OADS,/arxiv_data1/oa_pdf/11/14/ijn-12-1917.PMC5352247.pdf
"Currently, many researchers con - sider chrysin a drug sensitizer in integrative therapies because chrysin alone has low Correspondence: Joohee Jung College of Pharmacy, Duksung  Women’s University, #33, 144-gil,  Samyang-ro, Dobong-gu, Seoul 01369,  Republic of Korea Tel +82 2 901 8731 Fax +82 2 901 8386 email joohee@duksung.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Kim et al Running head recto: Chemotherapeutic efficacy of chrysin-NPs DOI: http://dx.doi.org/10.2147/IJN.S132043",Non-OADS,/arxiv_data1/oa_pdf/11/14/ijn-12-1917.PMC5352247.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/11/14/ijn-12-1917.PMC5352247.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/14/ijn-12-1917.PMC5352247.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/83/ijn-12-1853.PMC5352248.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1853–1862International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1853OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13123 5 codelivery of doxorubicin and triptolide  with reduction-sensitive lipid–polymer hybrid  nanoparticles for in vitro and in vivo synergistic  cancer treatment Bo Wu1,2,* shu-Ting lu1,* liu-Jie Zhang2 ren-Xi Zhuo2 hai-Bo Xu1 shi-Wen huang2 1Department of radiology, Zhongnan  hospital of Wuhan University, 2Key  laboratory of Biomedical Polymers of  Ministry of education, Department of  chemistry, Wuhan University, Wuhan,   People’s republic of china *These authors contributed equally  to this workAbstract:  Codelivery is a promising strategy to overcome the limitations of single  chemotherapeutic agents in cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/9a/83/ijn-12-1853.PMC5352248.pdf
"correspondence: hai-Bo Xu Department of radiology, Zhongnan  hospital of Wuhan University,  169 Donghu road, Wuhan 430071,  People’s republic of china Tel +86 27 6781 2533 email xuhaibo1120@hotmail.co m  shi-Wen huang Key laboratory of Biomedical Polymers  of Ministry of education, Department of  chemistry, Wuhan University, 299 Bayi  road, Wuhan 430072, People’s republic  of china Tel +86 27 6875 5317 email swhuang@whu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wu et al Running head recto: Codelivery of DOX and TPL for cancer treatment DOI: http://dx.doi.org/10.2147/IJN.S131235",Non-OADS,/arxiv_data1/oa_pdf/9a/83/ijn-12-1853.PMC5352248.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9a/83/ijn-12-1853.PMC5352248.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/83/ijn-12-1853.PMC5352248.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 505–512Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  505OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12631 6 involvement in shared decision-making for  patients in public specialist outpatient clinics  in hong Kong richard h Xu eliza lY Wong school of Public health and Primary  care, The chinese University of hong  Kong, hong Kong, People’s republic  of chinaObjective:  This study is a preliminary exploration of the association between patient  involvement in decision-making and patient socioeconomic characteristics and experience in  specialist outpatient clinics (SOPCs) in Hong Kong.",Non-OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"The latest “Five Y ear Forward View” of the  UK’s National Health Service (NHS) continues to stress the importance of increasing  patients’ direct control over how and where they receive care.2 Currently, however,  in the majority of clinical encounters, doctors are treated as the best exponent of  modern medicine, providing updated treatment options to improve the quality of correspondence: eliza lY Wong 4/F, school of Public health and Primary  care, Prince of Wales hospital, shatin,  new Territories, hong Kong, People’s  republic of china email lywong@cuhk.edu.h k Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Xu and Wong Running head recto: Involvement in SDM for patients in public SOPCs DOI: http://dx.doi.org/10.2147/PPA.S126316",Non-OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
Available from: http://www.england.nhs.uk/ourwork/futur - enhs/.,Non-OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"Available from: http://www.ha.org.hk/haho/ho/stat/HASR1415_2.pd f.  Accessed March 15, 2016.",OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
Available from:  http://www.b27association.org/news/2014%E5%B9%B4%E5%B0%8 8 %E7%A7%91%E9%96%80%E8%A8%BA%E7%97%85%E4%BA% BA%E7%B6%93%E9%A9%97%E5%8F%8A%E6%9C%8D%E5%8 B%99%E6%BB%BF%E6%84%8F%E5%BA%A6%E8%AA%BF%E 6%9F%A5%E5%A0%B1%E5%91%8A /.,Non-OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"Available from: http://www.cmc.org.hk/haho/ho/ cad_bnc/HAB_P211.pd f. Accessed February 15, 2016.",OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"Available  from: https://www.gov.uk/government/uploads/system/uploads/ attachment_data /file/228836/7432.pd f. Accessed February 15, 2016.",OADS,/arxiv_data1/oa_pdf/a9/3f/ppa-11-505.PMC5352249.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/71/ijn-12-1927.PMC5352250.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 1927–1939International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1927OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12107 5 In vivo biodistribution and behavior of cdT e/Zns  quantum dots Yan Zhao1,* Yue Zhang2,* gaofeng Qin1 Jinjun cheng1 Wenhao Zeng2 shuchen liu1 hui Kong1 Xueqian Wang1 Qingguo Wang1 huihua Qu3 1school of Basic Medical sciences,   2school of chinese Materia  Medica, 3center of scientific  experiment, Beijing University of  chinese Medicine, Beijing, People’s  republic of china *These authors contributed equally  to this workAbstract:  The unique features of quantum dots (QDs) make them desirable fluorescent tags  for cell and developmental biology applications that require long-term, multitarget, and highly  sensitive imaging.",Non-OADS,/arxiv_data1/oa_pdf/d1/71/ijn-12-1927.PMC5352250.pdf
"These have been used as selective inorganic ion probes to detect  pesticides,16 nitrobenzene,17 and Hg2+,18 or to label functional groups.19 Recently, we  reported the development of a novel biosensor using CdTe/ZnS QD-conjugated  monoclonal antibody as a highly sensitive probe.20 The passive targeting of QDs also  allows their application in drug delivery21,22 and imaging.21,23,24 Despite the significant  attention given to CdTe/ZnS QDs, however, studies on the in vivo biodistribution and correspondence: huihua Qu Center of Scientific Experiment, Beijing  University of chinese Medicine, 11  Beisanhuandong road, chaoyang District,  Beijing, People’s republic of china Tel +86 10 6428 6705 Fax +86 10 6428 6821 email quhuihuadr@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Zhao et al Running head recto: In vivo biodistribution and behavior of CdTe/ZnS quantum dots DOI: http://dx.doi.org/10.2147/IJN.S121075",Non-OADS,/arxiv_data1/oa_pdf/d1/71/ijn-12-1927.PMC5352250.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d1/71/ijn-12-1927.PMC5352250.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/71/ijn-12-1927.PMC5352250.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ca/7a/ppa-11-513.PMC5352251.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 513–518Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  513OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12967 8 Psychosocial predictors of patient adherence to  disease-modifying therapies for multiple sclerosis Fahad D Alosaimi1 Alaa AlMulhem2 hanan Alshalan2 Mohammad Alqazlan3 Abdulgader Aldaif4 Matthew Kowgier5 Janooshsheya  Balasundaram6 sanjeev sockalingam6,7 1Department of Psychiatry, 2college  of Medicine, King saud University,   3Department of Mental health, King  Faisal specialist hospital and research  centre, 4Department of neurology,   King saud University, riyadh, saudi  Arabia; 5Dalla lana school of Public  health, University of T oronto, 6centre  for Mental health, University health  network, 7Department of Psychiatry,   University of T oronto, T oronto, On ,   canadaObjectives:  Our aim was to identify the impact of psychosocial predictors, specifically  relationship style, depressive symptoms, anxiety symptoms, cognitive impairment, and culture- specific disease beliefs, on treatment adherence for multiple sclerosis (MS) patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/7a/ppa-11-513.PMC5352251.pdf
"Several  factors have been found to contribute to reduced patient adherence to MS treatment  with DMTs, including more frequent dosing regimen of DMTs, anxiety, depression,  cognitive impairment, medication adverse effects, and patients’ belief that treatment  will not be efficacious.8–14 Moreover, there is a geographic variability with treatment  outcomes, with notably lower MS discontinuation rates in countries such as Spain  and Italy.15correspondence: sanjeev sockalingam Toronto general hospital,  200 elizabeth street-8en-228,  Toronto, On M5g 2c4, canada Tel +1 416 340 3762 Fax +1 416 340 4198 email sanjeev.sockalingam@uhn.c a Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Alosaimi et al Running head recto: Psychosocial predictors of adherence in multiple sclerosis DOI: http://dx.doi.org/10.2147/PPA.S129678",Non-OADS,/arxiv_data1/oa_pdf/ca/7a/ppa-11-513.PMC5352251.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ca/7a/ppa-11-513.PMC5352251.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 737–744Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  737Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10894 8 Update on the treatment of Parkinson’s disease  psychosis: role of pimavanserin Brianna L Combs Arthur G Cox Department of Pharmaceutical  Sciences, Sullivan University College  of Pharmacy, Louisville, KY, USAAbstract:  Parkinson’s disease (PD) has a prevalence of nearly 1 million people in the USA,  with increasing incidence in the elderly population.",Non-OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
"Clozapine and quetiapine are  the second-generation antipsychotics (SGAs) usually utilized for PDP, but quetiapine Correspondence: Arthur G Cox Department of Pharmaceutical Sciences,  Sullivan University College of Pharmacy,  2100 Gardiner Lane, Louisville, KY  40205, USA Tel +1 502 413 8945 email acox@sullivan.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2017 Volume: 13 Running head verso: Combs and Cox Running head recto: Update on the treatment of Parkinson’s disease psychosis DOI: http://dx.doi.org/10.2147/NDT.S108948",Non-OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
"Avail - able from: http://www.fda.gov/Drugs/ DevelopmentApprovalProcess / DrugInnovation/ucm483775.ht m. Published: unknown; updated 2016  Sept. Accessed September 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/6c/70/ndt-13-737.PMC5352252.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55064 | Page 1 of 5Video Article Use of the Soft-agar Overlay Technique to Screen for Bacterially Produced Inhibitory Compounds Kevin L. Hockett1, David A. Baltrus1 1School of Plant Sciences, University of Arizona Correspondence to: Kevin L. Hockett at hockettk@email.arizona.edu URL: https://www.jove.com/video/55064 DOI: doi:10.3791/55064 Keywords: Infection, Issue 119, bacteria, bacteriophage, bacteriocin, tailocin, antimicrobial agent, bacterial antagonism, PEG precipitation Date Published: 1/14/2017 Citation: Hockett, K.L., Baltrus, D.A.",Non-OADS,/arxiv_data1/oa_pdf/b1/05/jove-119-55064.PMC5352255.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55064/ Introduction Recently, there has been significant interest in deepening our understanding of microbial ecology (particularly the microbiomes of various environments), as well as new antibacterial compounds to use in combating antibiotic resistant pathogens1,2.",Non-OADS,/arxiv_data1/oa_pdf/b1/05/jove-119-55064.PMC5352255.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55281 | Page 1 of 13Video Article A Model of Free Tissue Transfer: The Rat Epigastric Free Flap Diogo Casal1,4, Diogo Pais1, Inês Iria3,4, Eduarda Mota-Silva5, Maria-Angélica Almeida2, Sara Alves6, Cláudia Pen6, Ana Farinho4, Luís Mascarenhas-Lemos1,6, José Ferreira-Silva6, Mário Ferraz-Oliveira6, Valentina Vassilenko5, Paula A. Videira3,4, João Gory O'Neill1,5 1Anatomy Department, NOVA Medical School, Universidade NOVA de Lisboa 2Plastic and Reconstructive Surgery Department and Burn Unit, Centro Hospitalar de Lisboa Central - Hospital de São José 3UCIBIO, Life Sciences Department, Faculty of Sciences and Technology, Universidade NOVA de Lisboa 4CEDOC, NOVA Medical School, Universidade NOVA de Lisboa 5Physics Department, Faculty of Sciences and Technology, LIBPhys 6Pathology Department, Centro Hospitalar de Lisboa Central – Hospital de São José Correspondence to: Diogo Casal at diogo_bogalhao@yahoo.co.uk URL: https://www.jove.com/video/55281 DOI: doi:10.3791/55281 Keywords: Medicine, Issue 119, Flap, Free Tissue Transfer, Free Flap, Rats, Epigastric Artery, Anatomy, Physiology, Animal Experimentation, Surgical Procedures, Teaching, Learning Date Published: 1/15/2017 Citation: Casal, D., Pais, D., Iria, I., Mota-Silva, E., Almeida, M.A., Alves, S., Pen, C., Farinho, A., Mascarenhas-Lemos, L., Ferreira-Silva, J., Ferraz-Oliveira, M., Vassilenko, V., Videira, P.A., Gory O'Neill, J.",Non-OADS,/arxiv_data1/oa_pdf/bf/0d/jove-119-55281.PMC5352260.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55281/ Introduction Free tissue transfer has been increasingly used in clinical practice for reconstructing missing tissues since the 1970s1-5.,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/jove-119-55281.PMC5352260.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54660 | Page 1 of 9Video Article High Pressure Single Crystal Diffraction at PX^2 Dongzhou Zhang1, Przemyslaw K. Dera1, Peter J. Eng2, Joanne E. Stubbs2, Jin S. Zhang1, Vitali B. Prakapenka2, Mark L. Rivers2 1Hawai’i Institute of Geophysics and Planetology, University of Hawai’i at Manoa 2Center for Advanced Radiation Sources, University of Chicago Correspondence to: Dongzhou Zhang at dzhang@hawaii.edu URL: https://www.jove.com/video/54660 DOI: doi:10.3791/54660 Keywords: Chemistry, Issue 119, high pressure, synchrotron radiation, single crystal diffraction, diamond anvil cell, crystallography, geophysics, geochemistry, mineralogy, X-ray Date Published: 1/16/2017 Citation: Zhang, D., Dera, P.K., Eng, P.J., Stubbs, J.E., Zhang, J.S., Prakapenka, V.B., Rivers, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/e8/jove-119-54660.PMC5352262.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54660/ Introduction Single crystal X-ray diffraction is one of the most efficient and well-established ways to determine the chemical composition and structure of a crystalline material at different experimental conditions.,Non-OADS,/arxiv_data1/oa_pdf/c4/e8/jove-119-54660.PMC5352262.pdf
URL URL https://github.com/pdera/GSE_ADA.,Non-OADS,/arxiv_data1/oa_pdf/c4/e8/jove-119-54660.PMC5352262.pdf
URL https://github.com/pdera/GSE_ADA/blob/master/Documentation/Refinement%20tutorial.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/e8/jove-119-54660.PMC5352262.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54770 | Page 1 of 6Video Article Film Extrusion of Crambe abyssinica /Wheat Gluten Blends Mikael Gällstedt1, Henrik Pettersson2, Therese Johansson2, William R. Newson3, Eva Johansson3, Mikael S. Hedenqvist4 1SIG Combibloc 2Innventia 3Department of Plant Breeding, The Swedish University of Agricultural Sciences 4Fibre and Polymer Technology, KTH Royal Institute of Technology Correspondence to: Mikael Gällstedt at mikael.gallstedt@sig.biz , Mikael S. Hedenqvist at mikaelhe@kth.se URL: https://www.jove.com/video/54770 DOI: doi:10.3791/54770 Keywords: Bioengineering, Issue 119, Crambe meal, side stream, barrier, packaging, extrusion, gluten Date Published: 1/17/2017 Citation: Gällstedt, M., Pettersson, H., Johansson, T., Newson, W.R., Johansson, E., Hedenqvist, M.S.",Non-OADS,/arxiv_data1/oa_pdf/97/42/jove-119-54770.PMC5352268.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54770/ Introduction When upgrading a material from a low value to a higher value, two main issues need to be considered: the type of potential end-product(s) and the required properties.",Non-OADS,/arxiv_data1/oa_pdf/97/42/jove-119-54770.PMC5352268.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55044 | Page 1 of 9Video Article Light Sheet Fluorescence Microscopy of Plant Roots Growing on the Surface of a Gel Daniel von Wangenheim1, Robert Hauschild2, Jiří Friml1 1Developmental and Cell Biology of Plants, Institute of Science and Technology Austria 2Bioimaging Facility, Institute of Science and Technology Austria Correspondence to: Daniel von Wangenheim at daniel.von.wangenheim@ist.ac.at , Jiří Friml at jiri.friml@ist.ac.at URL: https://www.jove.com/video/55044 DOI: doi:10.3791/55044 Keywords: Plant Biology, Issue 119, Lightsheet Microscopy, Light-sheet, Light Sheet Fluorescence Microscopy, LSFM, Selective Plane Illumination Microscopy, SPIM, Arabidopsis, plants, fluorescence microscopy, organogenesis, development Date Published: 1/18/2017 Citation: von Wangenheim, D., Hauschild, R., Friml, J.",Non-OADS,/arxiv_data1/oa_pdf/02/2e/jove-119-55044.PMC5352271.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55044/ Introduction One of the key questions in understanding plant development is how single cells behave during organ differentiation and growth.,Non-OADS,/arxiv_data1/oa_pdf/02/2e/jove-119-55044.PMC5352271.pdf
1.Set a stack of 217 images with 3 µm z-spacing (650 µm) and set the time lapse with 15 min imaging interval for a total period of 17 h.   NOTE: A detailed documentation on how to operate the OpenSPIM software can be found on (http://openspim.org/ Acquisition#Acquiring_a_Stack).,Non-OADS,/arxiv_data1/oa_pdf/02/2e/jove-119-55044.PMC5352271.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Journal of Visualized Experiments January 2017 |  119  | e55042 | Page 1 of 8Video Article Imaging Metals in Brain Tissue by Laser Ablation - Inductively Coupled Plasma - Mass Spectrometry (LA-ICP-MS) Dominic J. Hare1,2, Kai Kysenius3, Bence Paul4, Beate Knauer5,6, Robert W. Hutchinson7, Ciaran O'Connor7, Fred Fryer8, Tom P. Hennessey8, Ashley I. Bush2, Peter J. Crouch3, Philip A. Doble1 1Elemental Bio-imaging Facility, University of Technology Sydney 2Florey Institute of Neuroscience and Mental Health, The University of Melbourne 3Department of Pathology, The University of Melbourne 4School of Earth Sciences, The University of Melbourne 5Research School, Ruhr University 6Department of Physiology, Monash University 7ESI Ltd., Bozeman 8Agilent Technologies, Mulgrave Correspondence to: Dominic J. Hare at dominic.hare@uts.edu.au URL: https://www.jove.com/video/55042 DOI: doi:10.3791/55042 Keywords: Medicine, Issue 119, imaging, laser ablation, inductively coupled plasma-mass spectrometry, metals, metallomics, neuroscience Date Published: 1/22/2017 Citation: Hare, D.J., Kysenius, K., Paul, B., Knauer, B., Hutchinson, R.W., O'Connor, C., Fryer, F., Hennessey, T.P., Bush, A.I., Crouch, P.J., Doble, P.A.",Non-OADS,/arxiv_data1/oa_pdf/01/31/jove-119-55042.PMC5352277.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55042/ Introduction The unique redox chemistry of metals facilitates a range of neurological functions, including signal transduction, energy production and neurotransmitter synthesis.",Non-OADS,/arxiv_data1/oa_pdf/01/31/jove-119-55042.PMC5352277.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54788 | Page 1 of 7Video Article Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses Angela Yarnell Bonino1,2, Lori J. Leibold3 1Department of Allied Health Sciences, The University of North Carolina at Chapel Hill 2Department of Speech, Language, and Hearing Sciences, University of Colorado Boulder 3Center for Hearing Research, Boys Town National Research Hospital Correspondence to: Angela Yarnell Bonino at angela.bonino@colorado.edu URL: https://www.jove.com/video/54788 DOI: doi:10.3791/54788 Keywords: Behavior, Issue 119, Hearing, children, auditory development, audiology, preschooler, tone detection, psychophysics, perception, behavioral assessments Date Published: 1/23/2017 Citation: Bonino, A.Y., Leibold, L.J.",Non-OADS,/arxiv_data1/oa_pdf/0b/cd/jove-119-54788.PMC5352283.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54788/ Introduction It is difficult to obtain reliable estimates of behavioral hearing thresholds for toddlers and preschoolers.,Non-OADS,/arxiv_data1/oa_pdf/0b/cd/jove-119-54788.PMC5352283.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55226 | Page 1 of 6Video Article Hydraulic Extrusion of the Spinal Cord and Isolation of Dorsal Root Ganglia in Rodents Mette Richner1, Sara B. Jager1, Piotr Siupka1, Christian B. Vaegter1 1Department of Biomedicine, Aarhus University Correspondence to: Mette Richner at mette.richner@biomed.au.dk URL: https://www.jove.com/video/55226 DOI: doi:10.3791/55226 Keywords: Neuroscience, Issue 119, rat, mouse, hydraulic spinal cord extrusion, lumbar enlargement, dorsal root ganglia Date Published: 1/22/2017 Citation: Richner, M., Jager, S.B., Siupka, P., Vaegter, C.B.",Non-OADS,/arxiv_data1/oa_pdf/21/20/jove-119-55226.PMC5352284.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55226/ Introduction The overall goal of this method is to isolate the spinal cord as well as to identify and isolate DRGs1,2.",Non-OADS,/arxiv_data1/oa_pdf/21/20/jove-119-55226.PMC5352284.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Journal of Visualized Experiments January 2017 |  119  | e55150 | Page 1 of 10Video Article Unravelling the Function of a Bacterial Effector from a Non-cultivable Plant Pathogen Using a Yeast Two-hybrid Screen Katrin Janik1, Katja Schlink1 1Department of Molecular Biology - Functional Genomics, Laimburg Research Centre Correspondence to: Katrin Janik at Katrin.Janik@provinz.bz.it URL: https://www.jove.com/video/55150 DOI: doi:10.3791/55150 Keywords: Infection, Issue 119, yeast two-hybrid, Y2H, bacteria, phytoplasma, self-activation, effector, protein-protein interaction Date Published: 1/20/2017 Citation: Janik, K., Schlink, K. Unravelling the Function of a Bacterial Effector from a Non-cultivable Plant Pathogen Using a Yeast Two-hybrid Screen.",Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55150/ Introduction Yeast two-hybrid screens (Y2H) were developed about 27 years ago1 and have since been widely used in various fields to determine specific protein-protein interactions2,3,4,5,6,7,8,9,10,11.",Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
https://www.applichem.com/fileadmin/datenblaetter/A7402_en_GB.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
https://www.applichem.com/fileadmin/datenblaetter/A1108_en_GB.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
https://www.applichem.com/fileadmin/datenblaetter/A3928_en_GB.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
https://www.applichem.com/fileadmin/datenblaetter/A3928_en_GB.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
https://www.applichem.com/fileadmin/datenblaetter/A1493_en_GB.pdf (2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
http://www.sigmaaldrich.com/MSDS/MSDS/DisplayMSDSPage.do?country=IT&language=EN- generic&productNumber=A8056&brand=SIGMA&PageToGoToURL=http%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fproduct %2Fsigma%2Fa8056%3Flang%3Dit (2016).,OADS,/arxiv_data1/oa_pdf/ad/85/jove-119-55150.PMC5352286.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55100 | Page 1 of 11Video Article How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression Aron Tendler1, Yiftach Roth1, Noam Barnea-Ygael2, Abraham Zangen2 1Brainsway LTD 2Department of Life Sciences, Ben Gurion University of the Negev Correspondence to: Aron Tendler at aronte@brainsway.com URL: https://www.jove.com/video/55100 DOI: doi:10.3791/55100 Keywords: Behavior, Issue 119, dTMS, rTMS, TMS, H1, Depression, PTSD, Tinnitus, Schizophrenia, Negative Symptoms, Hallucinations, Anxiety, Alcohol Dependence, Alcoholism, Alcohol Addiction, Parkinson's, Multiple Sclerosis, MS Fatigue, Migraine, Bipolar Depression Date Published: 1/23/2017 Citation: Tendler, A., Roth, Y., Barnea-Ygael, N., Zangen, A.",Non-OADS,/arxiv_data1/oa_pdf/63/5c/jove-119-55100.PMC5352287.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55100/ Introduction Until recently, only superficial, repetitive transcranial magnetic stimulation (rTMS) coils, such as the circular, figure-8, or double-cone coils, were available.",Non-OADS,/arxiv_data1/oa_pdf/63/5c/jove-119-55100.PMC5352287.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55282 | Page 1 of 8Video Article Preparation of Giant Vesicles Encapsulating Microspheres by Centrifugation of a Water-in-oil Emulsion Yuno Natsume1, Hsin-i Wen2, Tong Zhu2, Kazumi Itoh1, Li Sheng2, Kensuke Kurihara2,3,4 1Department of Mathematical and Physical Sciences, Faculty of Science, Japan Women's University 2Department of Bioorganization Research, Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences 3Department of Life and Coordination-Complex Molecular Science, Institute for Molecular Science, National Institutes of Natural Sciences 4Research Center for Complex Systems Biology, The University of Tokyo Correspondence to: Yuno Natsume at natsumey@fc.jwu.ac.jp , Kensuke Kurihara at kkurihara@ims.ac.jp URL: https://www.jove.com/video/55282 DOI: doi:10.3791/55282 Keywords: Biochemistry, Issue 119, Giant vesicle (GV), Microspheres, Water-in-oil (w/o) emulsion centrifugation method, Model protocell, Constructive biology Date Published: 1/24/2017 Citation: Natsume, Y., Wen, H.i., Zhu, T., Itoh, K., Sheng, L., Kurihara, K. Preparation of Giant Vesicles Encapsulating Microspheres by Centrifugation of a Water-in-oil Emulsion.",Non-OADS,/arxiv_data1/oa_pdf/ee/0c/jove-119-55282.PMC5352288.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/55282/ Introduction The constructive, or synthetic, biology approach is a fascinating avenue for exploring the boundary between living and nonliving matter.",Non-OADS,/arxiv_data1/oa_pdf/ee/0c/jove-119-55282.PMC5352288.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54826 | Page 1 of 12Video Article Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro Lena Lavie1, Larissa Dyugovskaya1, Andrey Polyakov1, Oksana Rogovoy1, Eva Leder1 1The Lloyd Rigler Sleep Apnea Research Laboratory, Unit of Anatomy and Cell Biology, The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Insitute of Technology Correspondence to: Lena Lavie at lenal@technion.ac.il URL: https://www.jove.com/video/54826 DOI: doi:10.3791/54826 Keywords: Immunology, Issue 119, Neutrophil-derived giant phagocytes, human neutrophils, cluster of differentiation (CD)66b, microtubule- associated protein-1 light chain 3B (LC3B), autophagocytosis, oxidized low density lipoprotein (oxLDL), scavenger receptors, confocal microscopy Date Published: 1/25/2017 Citation: Lavie, L., Dyugovskaya, L., Polyakov, A., Rogovoy, O., Leder, E. Development and Identification of a Novel Subpopulation of Human Neutrophil-derived Giant Phagocytes In Vitro.",Non-OADS,/arxiv_data1/oa_pdf/41/ac/jove-119-54826.PMC5352295.pdf
"Video Link The video component of this article can be found at https://www.jove.com/video/54826/ Introduction Polymorphonuclear neutrophils (PMN) constitute the largest population of leukocytes in the blood, serving as the first line of defense against invading pathogens by producing a wide range of cytotoxic molecules.",Non-OADS,/arxiv_data1/oa_pdf/41/ac/jove-119-54826.PMC5352295.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e54771 | Page 1 of 9Video Article A New Method for Qualitative Multi-scale Analysis of Bacterial Biofilms on Filamentous Fungal Colonies Using Confocal and Electron Microscopy Cora Miquel Guennoc1, Christophe Rose2, Frédéric Guinnet1, Igor Miquel1, Jessy Labbé3, Aurélie Deveau1 1Interactions Arbres – Microorganismes, UMR1136, INRA Université de Lorraine 2Ecologie et Ecophysiologie Forestières - PTEF, UMR 1137, INRA Université de Lorraine 3Biosciences Division, Oak Ridge National Laboratory Correspondence to: Aurélie Deveau at aurelie.deveau@inra.fr URL: https://www.jove.com/video/54771 DOI: doi:10.3791/54771 Keywords: Immunology, Issue 119, Biofilm, fungal-bacterial interaction, matrix, multiscale, confocal microscopy, scanning electron microscopy Date Published: 1/25/2017 Citation: Miquel Guennoc, C., Rose, C., Guinnet, F., Miquel, I., Labbé, J., Deveau, A.",Non-OADS,/arxiv_data1/oa_pdf/c4/d0/jove-119-54771.PMC5352296.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/54771/ Introduction Fungi and bacteria have many opportunities to interact with each other because they cohabit in most terrestrial environments.,Non-OADS,/arxiv_data1/oa_pdf/c4/d0/jove-119-54771.PMC5352296.pdf
http://imagej.nih.gov/ij (2016).,OADS,/arxiv_data1/oa_pdf/c4/d0/jove-119-54771.PMC5352296.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2017  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJanuary 2017 |  119  | e55344 | Page 1 of 7Video Article Isolating and Analyzing Cells of the Pancreas Mesenchyme by Flow Cytometry Alona Epshtein1, Lina Sakhneny1, Limor Landsman1 1Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University Correspondence to: Limor Landsman at limorl@post.tau.ac.il URL: https://www.jove.com/video/55344 DOI: doi:10.3791/55344 Keywords: Developmental Biology, Issue 119, pancreas, pancreas microenvironment, pancreas development, pancreatic cancer, pancreatic mesenchyme, pancreatic ductal adenocarcinoma Date Published: 1/28/2017 Citation: Epshtein, A., Sakhneny, L., Landsman, L. Isolating and Analyzing Cells of the Pancreas Mesenchyme by Flow Cytometry.",Non-OADS,/arxiv_data1/oa_pdf/0d/0f/jove-119-55344.PMC5352303.pdf
Video Link The video component of this article can be found at https://www.jove.com/video/55344/ Introduction Energy homeostasis and food digestion in mammals depend on proper pancreatic function.,Non-OADS,/arxiv_data1/oa_pdf/0d/0f/jove-119-55344.PMC5352303.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   189Urticaria is one of the most common skin disease, character - ized by the development of wheals (hives), angioedema, or  both and it is classified as acute or chronic form based on the  duration of illness.",Non-OADS,/arxiv_data1/oa_pdf/61/66/aair-9-189.PMC5352569.pdf
"This  cross-sectional study examined children from the general pedi -Prevalence and Causes of Childhood Urticaria  Meeyong Shin,1 Sooyoung Lee2* 1Department of Pediatrics, Soonchunhyang University School of Medicine, Bucheon, Korea 2Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/66/aair-9-189.PMC5352569.pdf
2017 May;9(3):189-190. https://doi.org/10.4168/aair.2017.9.3.189 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/61/66/aair-9-189.PMC5352569.pdf
"2017 May;9(3):189-190.  https://doi.org/10.4168/aair.2017.9.3.189 Volume 9, Number 3, May 2017 190  http://e-aair.orgatric population aged 4-13 years, and a total of 4,076 children  who completed full sets of questionnaire were enrolled.",Non-OADS,/arxiv_data1/oa_pdf/61/66/aair-9-189.PMC5352569.pdf
ORCID Sooyoung Lee  http://orcid.org/0000-0003-1734-4101 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/61/66/aair-9-189.PMC5352569.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Diseasehttp://e-aair.org   191INTRODUCTION Asthma is a chronic inflammatory disorder characterized by  variable airway obstruction.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"Studies with a hypothesis-driven approach Although asthma is currently believed to be a heterogeneous  disease, an allergic asthma characterized by Th2-type T cells,  IgE, eosinophils, mast cells, and cytokines is a traditional con - cept in terms of immunopathology.13 The early and pioneering Genetic Signatures of Asthma Exacerbation Heung-Woo Park,1,2 Kelan G. Tantisira2,3*  1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea 2The Channing Division of Network Medicine, Department of Medicine, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, USA 3Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
2017 May;9(3):191-199. https://doi.org/10.4168/aair.2017.9.3.191 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 Volume 9, Number 3, May 2017 192  http://e-aair.orgstudies driven by a prior  hypothesis focused on this Th2 asth - ma phenotype.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 AAIR http://e-aair.org   193data mining methods is a way to handle this type of problems.25  Random Forests (RF) are a classification algorithm that is com - posed of a set of random decision trees,26,27 and we can inte - grate hundreds of SNPs and clinical traits to predict complex  clinical phenotypes by RF .",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 Volume 9, Number 3, May 2017 194  http://e-aair.orginfection.5 Taken together, genetic predispositions may play a  role in virus-induced AE.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 AAIR http://e-aair.org   195Pharmacogenetics The current primary therapies for asthma are focused on in - creasing bronchial smooth muscle relaxation (bronchodilation)  and decreasing airway inflammation.,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 Volume 9, Number 3, May 2017 196  http://e-aair.org Figure.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 AAIR http://e-aair.org   197pharmacogenetic analysis of 2 prospective clinical trials under - taken in adult asthmatics showed no effect of ADRB2  variation,  including rs1042713, on severe AE when they were treated with  LABA plus (ICS).48 This difference suggests that there might be  a specific genetic mechanism regulating AE in response to a  LABA in children that does not carry over to adults.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 Volume 9, Number 3, May 2017 198  http://e-aair.orget al.",Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
2017 May;9(3):191-199.  https://doi.org/10.4168/aair.2017.9.3.191 AAIR http://e-aair.org   19948.,Non-OADS,/arxiv_data1/oa_pdf/b0/a1/aair-9-191.PMC5352570.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease200  http://e-aair.orgINTRODUCTION Allergic diseases, hypersensitivity disorders of the immune  system, are a major global health concern.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"Prenatal Maternal Distress and Allergic Diseases in Offspring:  Review of Evidence and Possible Pathways Dong In Suh,1 Hyoung Yoon Chang,2 Eun Lee,3 Song-I Yang,4 Soo-Jong Hong5*  1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea 2Department of Psychiatry, Ajou University School of Medicine, Suwon, Korea 3Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea 4Department of Pediatrics, Hallym University Sacred Heart Hospital, Anyang, Korea 5 Department of Pediatrics, Childhood Asthma Atopy Center, Environmental Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  Korea This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
2017 May;9(3):200-211. https://doi.org/10.4168/aair.2017.9.3.200 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 AAIR http://e-aair.org   201EVIDENCE OF THE IMPACT OF PRENATAL MATERNAL  DISTRESS ON ALLERGIC DISEASES IN THEIR OFFSPRING To locate current evidence on the topic, we conducted a key - word search through the PubMed databases (see Supplemen - tary Table available from http://www.e-aair.org).",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
"2017 May;9(3):200-211.  https://doi.org/10.4168/aair.2017.9.3.200 Volume 9, Number 3, May 2017 202  http://e-aair.orgTable.",Non-OADS,/arxiv_data1/oa_pdf/91/66/aair-9-200.PMC5352571.pdf
